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The accuracy of protein biosynthesis determines the quality of the proteome and regulates the fitness 
of the cell. A comprehensive quantification of miscoding events in the cell is essential to understand 
the basic mechanisms that ensure fidelity as well as the evolutionary consequences of errors of 
protein synthesis. Impairment in cellular fidelity is associated with numerous diseases and is, due to 
the increasing number of protein therapeutics, of central biotechnological importance. However, the 
systematic analysis of miscoding events in vivo is precluded by the limited dynamic range of the 
available analytical methods. We have developed a method for the quantification of miscoding events 
such as amino acid misincorporations, which relies on the separation and enrichment of the error-
containing peptides from their correct parental ones through multiple rounds of orthogonal 
chromatography and their absolute quantification by targeted mass spectrometry using isotope-
labeled internal standards (AQUA peptides). The dynamic range of the method is linear over more 
than seven orders of magnitude and it is not restricted to any particular miscoding event, organism, 
strain or model protein. 
The analysis of the model protein EF-Tu revealed that near-cognate missense errors are less 
frequent than expected (median error frequency 10-6) and that the error frequency varies over three 
orders of magnitude depending on the type of misincorporation and source of EF-Tu. Among the 
substitutions tested, histidine misincorporations at arginine codons are the most abundant. 
Furthermore, error frequency varies depending on the amino acid position in EF-Tu by more than one 
order of magnitude. Positions at which errors are rare are clustered in the EF-Tu/tRNA interface, 
indicating either an extensive quality control or an higher encoded fidelity of translation.  
We have also analyzed the effect of aminoglycosides on fidelity and stress response. Most 
aminoglycosides induce significant miscoding which correlates with the induction of proteins from the 
the heat-shock stress response and growth defects, underlining the central contribution of miscoding 
to the bactericidal effect of aminoglycosides. In addition to single-position substitutions, 
aminoglycosides can induce multiple miscoding events leading to peptides with two or three amino 
acid substitutions. The frequency of multiple consecutive errors is unexpectedly high and because of 
the detrimental effects on protein stability, such error clusters may contribute substantially to the 
































1.1 Errors of bacterial protein synthesis 
1.1.1 Error frequency at different steps of protein synthesis 
Protein synthesis is a pivotal cellular process in which the genetic information stored in the DNA is 
transcribed into RNA by the RNA polymerase and subsequently decoded on the ribosome with the 
help of transfer RNA (tRNA) molecules into an amino acid sequence and yield functional proteins. 
Despite the importance of preserving the genetic message, errors might arise at every stage (Parker, 
1989) (Table 1). DNA replication is undoubtedly the most accurate step, because the DNA polymerase 
works with extremely high fidelity and an error frequency that ranges from 10-10- 10-6 (Kunkel, 2004; 
Kunkel and Bebenek, 2000; Schaaper, 1993). Incorporation of errors during the transcription of DNA 
is, instead, more frequent because the responsible enzyme, RNA polymerase, incorporates incorrect 
nucleotides with a frequency of 10-5 - 10-4 (Traverse and Ochman, 2016). The least accurate step is the 
translation of mRNA, which shows error frequencies of up to 10-2 (Table 1). The fidelity of this process, 
whose average error rate is estimated to be 10-4 - 10-3 (Ribas de Pouplana et al., 2014; Rodnina and 
Wintermeyer, 2001b) is the result of a combination of different error-prone events. First, the 
aminoacyl-tRNAs (aa-tRNAs) delivering the amino acid to the ribosome must be correctly charged by 
their respective aminoacyl-tRNA synthetases. Second, the ribosome must select the correct aa-tRNA 
corresponding to the codon exposed in the decoding site of the ribosome and, after peptide bond 
formation, translocate along the mRNA by exactly three nucleotides at a time. Because tRNA 
misacylation, ribosome frameshifting and nonsense errors are rather infrequent events, occurring 
with a frequency of 10-6 - 10-4, ~10-5 and 10-6 - 10-3 respectively (Freistroffer et al., 2000; Hopfield et 
al., 1976; Ibba and Soll, 2000; Jorgensen and Kurland, 1990; Sin et al., 2016; Soll, 1990), most of the 
errors that occur during translation are mainly attributed to erroneous decoding (Drummond and 
Wilke, 2009).  Cells have evolved sophisticated mechanisms to avoid errors, such as proofreading of 
DNA and RNA polymerases and editing of aminoacyl-tRNA synthetases (aaRSs) (Jakubowski and 
Goldman, 1992; Kunkel, 2004; Sydow and Cramer, 2009) or kinetic mechanisms of aa-tRNA selection 
on the ribosome (Rodnina and Wintermeyer, 2001a). Errors that still arise can be removed by the 
quality control machinery of the cell, such as chaperones and proteases (Wickner et al., 1999). 
Thus, the steady state level of missense errors in proteins reflects the error contributing processes of 
protein biosynthesis and the correcting processes of the quality control. This steady state level is not 
static but is modulated by naturally occurring mutations of the translational apparatus such as 
ribosomes (Rosset and Gorini, 1969; Zaher and Green, 2010a), aaRSs (Li et al., 2011), tRNAs (Bjork et 
al., 1999; Ranjan and Rodnina, 2016), modifications of translation factors (Van Noort et al., 1986), by 




external stress factors such as ethanol (Haft et al., 2014), aminoglycosides antibiotics (Davies et al., 
1964) and oxidative agents (Ling and Soll, 2010; Netzer et al., 2009). 
 
Table 1. Error frequencies of the individual substeps of protein biosynthesis. The estimated 
frequencies of error incorporation for every substep of protein synthesis are reported. 
Cellular process Type of errors Error frequency Reference 
DNA replication Nucleotide misincorporation 10-10  10-6 
(Kunkel, 2004; Kunkel and Bebenek, 
2000; Schaaper, 1993) 
RNA transcription Nucleotide misincorporation 10-5  10-4 (Traverse and Ochman, 2016) 
tRNA 
aminoacylation 
Incorrect aminoacylation 10-6  10-4 (Ibba and Soll, 2000; Soll, 1990) 
mRNA translation 
Initiation on non-start codon 10-2 (Milon and Rodnina, 2012) 
Premature termination 10-6  10-3 
(Freistroffer et al., 2000; Jorgensen and 
Kurland, 1990; Sin et al., 2016) 
Stop codon readthrough 10-4  10-2 (Sydow et al., 2014) 
Amino acid misincorporation 10-4  10-3 
(Bouadloun et al., 1983; Drummond and 
Wilke, 2009; Loftfield and Vanderjagt, 
1972; Parker, 1989; Parker et al., 1980; 
Ribas de Pouplana et al., 2014; Rodnina 
and Wintermeyer, 2001b; Toth et al., 
1988) 
Frameshifting 10-5  10-4 (Atkins et al., 1991) 
 
1.1.2 Consequences of translation errors on cellular fitness  
Errors of protein synthesis alter the sequence of amino acids in proteins and may cause the production 
of dysfunctional proteins, the consequences of which can be rather severe not only for the fitness of 
the single cell but, in case of eukaryotes, for the entire organism e.g., in Escherichia coli, ribosome 
biogenesis and thus translation are limiting the growth of the bacterial cell (Dennis et al., 2004). It 
requires up to 10 min to synthetize and assemble functional ribosomes, comparable to the time 
needed for cell duplication, 20 min (Scott et al., 2010). Indeed, translation is by far the most energy 
consuming phase (Russell and Cook, 1995) and most anabolic processes are devoted to it (Bremer and 
Dennis, 2008). In prokaryotes, which have rapid cell cycles optimized to outcompete other 
microorganisms, the synthesis of flawed proteins hijacks the cellular protein synthesis capacity,  
reduces the absolute levels of active proteins in the cell and directly leads to fitness defects (Andrews 
and Hegeman, 1976). Eukaryotes, on the other hand, do not exhaust their resources for rapid growth 
(Kafri et al., 2016); therefore errors of protein synthesis can have less pronounced effects.  
The accumulation of random errors into protein is likely to cause loss of function, structural 
destabilization (Guo et al., 2004) and misfolding (Lee et al., 2006), with an effect which is predicted to 





of errors and protein misfolding may in turn cause abnormal aggregation (Vermulst et al., 2015) or 
induce protein oxidative damage (Dukan et al., 2000).  Additionally, incorrectly folded and unstable 
proteins seize the working capacity of the chaperones system (Gidalevitz et al., 2006) potentially 
promoting further cellular damage. 
Increased miscoding can be caused by aminogycoside antibiotics and  the consequent misfolding 
and aggregation phenomena have been demonstrated by treating the cells with streptomycin (Ling et 
al., 2012). Upon antibiotic treatment, mistranslation occurs and more erroneous proteins that favour 
aggregation are produced. Mass spectrometric analysis of such aggregates has revealed that they 
mostly consist of heat shock-induced proteases and chaperones (especially IbpA and IbpB) whose 
response is known to associate with accumulation of errors in proteins (Ruan et al., 2008). Although 
the proteotoxic stress caused by error accumulation can be alleviated by the concerted action of 
chaperones and proteases, the clean-up costs – in addition to the energy already spent for their 
synthesis – impose a energetic burden that can compromise the overall cellular fitness (Drummond 
and Wilke, 2009). Ultimately, mistranslation can lead to membrane depolarization, radical formation 
and finally to growth arrest and cell death (Kohanski et al., 2007). 
 
1.2 Cellular mechanisms that ensure the fidelity of protein biosynthesis 
1.2.1 General sources of protein synthesis fidelity 
The high fitness cost of errors in protein synthesis increases the evolutionary pressure to keep the 
error frequency low. This led to the development of sophisticated cellular mechanisms that ensure 
high fidelity of protein biosynthesis or increase the tolerance towards those errors that could not be 
avoided. An example for this adaptive evolution comes from the study of an error prone E. coli strain 
expressing the TEM1 β-lactamase resistance protein. Under relaxed conditions, where the antibiotic 
is not present and the resistance protein is not essential, the cells reduce the costs for the synthesis 
of a superfluous and error-containing protein by lowering its expression level. However, when the 
antibiotic is present and the protein is required for the cell survival, the cell balances the unavoidable  
incorporation of errors by promoting the incorporation of amino acids which stabilize the the protein 
structure (Bratulic et al., 2015). Error-mitigating mechanisms can also be already imprinted in the 
genetic code.  The amino acid sequence of a protein is determined by the sequence of bases in the 
mRNA and one sequence of nucleotide triplets, a codon, specifies for one amino acid (Crick et al., 
1961). However, because the genetic code is degenerate, a particular amino acid may be coded by 
more that one triplet (Crick et al., 1961) in which the first two positions are strict, but some wobble is 
accepted at the third base (Crick, 1966). The structure of the genetic code ensures that if a codon is 




minimizing the impact on protein stability (Archetti, 2006) as it happens for the frequent third-position 
mismatches (Woese, 1965). A second mechanism is based on the codon usage optimization. 
Numerous studies have demonstrated a correlation between the tRNA abundance and the occurrence 
of the respective codon (Ikemura, 1985), and genes that need to be more efficiently translated display 
an optimized codon sequence preferentially containing codons decoded by abundant tRNAs. In this 
regard, the elongation factor Tu (EF-Tu), the most abundant protein in bacteria, contains only 
abundant codons (Kurland, 1992) whereas rare ones are avoided (Akashi, 1994). In addition, 
bioinformatics studies revealed that cluster of translationally optimal codons at sites that are 
important for the function or stability of proteins are highly conserved and that codons whose 
mistranslation results in less severe amino acid substitutions are preferred at these positions (Lee et 
al., 2010; Zhou et al., 2009). 
 
1.2.2 Thermodynamic and kinetic sources of accuracy 
While the evolution of the genetic template does not bring about significant fitness costs for the cell 
(Drummond and Wilke, 2009), the accuracy of the enzymes involved in protein biosynthesis cannot 
improve without a trade-off between speed and accuracy. In general, most enzymes use highly specific 
binding sides that are complementary to the steric and electronic features of their unique substrates 
to idiosyncratically recognize them. Kinetically, such tailored binding sites often reflect in dramatically 
different dissociation constants in the ground state (GS) that almost exclude incorrect substrates in 
the binding step (Figure 1, A). In contrast, enzymes involved in protein synthesis, such as DNA and RNA 
polymerases or ribosomes, cannot achieve such high selectivity by evolving idiosyncratic binding sites, 
because they have to recognize and incorporate with high fidelity different substrates in subsequent 
cycles of elongation. Different nucleotides or aa-tRNAs are recognized on the basis of only few 
discriminating interactions, such as for Watson-Crick base pairs. The affinity differences between 
correct and incorrect substrates are <102 for single mismatched nucleotides (Grosjean et al., 1978) 
and can be even lower between cognate and non-cognate triplets (Kurland et al., 1975). Thus, the 
affinity differences alone fail to explain the high fidelity of all substeps of protein biosynthesis (Rodnina 
and Wintermeyer, 2001b) (Table 3) and additional sources of fidelity such as induced fit (Gromadski 
and Rodnina, 2004a; Pape et al., 1999) and proofreading (Ruusala et al., 1982; Thompson and Stone, 
1977) apply. First, in the different substeps of protein synthesis, nucleotide mismatches are 
recognized on the base of their shape through interactions between the minor groove of DNA (or wide 
shallow groove of tRNA) and the amino acids and rRNA nucleotides of polymerases and ribosome, 





On the ribosome, this recognition leads to conformational changes (Ogle et al., 2002) which then 
strongly accelerate the productive forward rates for correct aa-tRNAs relative to near and non-
cognate tRNAs in terms of an induced-fit mechanism (Gromadski and Rodnina, 2004a; Pape et al., 
1999) Second, kinetic proofreading mechanisms are applied in which the same discriminating 
interactions are energetically and kinetically used several time to amplify the accuracy. This is possible 
when both selection phases are irreversibly separated by an energy dissipating step (Ruusala et al., 
1982; Thompson and Stone, 1977), as happens during decoding where GTP hydrolysis separates two 
subsequent selection steps which are both based on the same codon-anticodon helix mismatch. 
However, substrates selection at the ground state can lead to a trade-off between speed and accuracy 
which are negatively correlated for ground state selection (reviewed in (Tawfik, 2014)). Kinetically, in 
this scenario, fast forward rates do not allow the substrate binding  involved in selection to equilibrate 
completely and thus the affinity differences between correct and incorrect substrate can be only 
partially utilized (Gromadski and Rodnina, 2004a). In fast growing E.coli cells, ribosomes seem to be 
optimized for fast translation at the cost of accuracy (Aqvist and Kamerlin, 2015; Wohlgemuth et al., 
2010). A concrete example of this trade-off and its reflection on the cellular fitness comes from 
streptomycin-dependent (SmD) E. coli mutants whose viability necessarily depends on the antibiotic 
(Ruusala et al., 1984). SmD cells, indeed, possess excessively accurate, or hyper-accurate, ribosomes 
that – in the absence of the drug – slow down the translation process to such an extent that it leads 
to cells death. Indeed, the presence of streptomycin, which reduces ribosome fidelity (Gromadski and 
Rodnina, 2004b) and favours a faster translation rate, restores cell viability.   
An alternative to GS selection is the transition-state (TS) discrimination where correct and incorrect 
substrates bind the enzyme with similar affinities but not all interactions of the correct substrate in 
the TS are realized for the non-cognate ones. Thus, for TS selection, fidelity positively correlates with 
catalytic efficiency allowing high accuracy at high speed. TS selection is reported for the DNA 
polymerase Pol1. Upon binding of the correct substrate, the active-site dipoles of the binding sites are 
organized to maximize TS stabilization, which does not occurs in the presence of a non-cognate 
substrate (Ram Prasad and Warshel, 2011) allowing for a high synthesis rate (kcat > 100 s-1) and a high 
accuracy (<10-3 even in the absence of proofreading (Caglayan and Bilgin, 2012)) and leads to the 
predicted positive correlation of speed and accuracy which is determined by a much higher activation 
entropy for the non-cognate than for the cognate substrate (Caglayan and Bilgin, 2012) (Figure 1, B). 
In many cases, especially when incorrect substrates differ by only a few atoms, positive GS or TS 
selection might not be sufficient to guarantee high accuracy. Thus, many enzymes evolved explicit 




as it happens for aminoacyl-synthetases or DNA and RNA polymerases (Fersht, 1977; Reha-Krantz, 




Figure 1. Enzymes ensure their accuracy in different ways. Substrate discrimination can be achieved at the ground state (A) 
or transition state (B). In red and green are represented the catalytic curves for non-cognate and cognate substrates, 
respectively.  
 
1.3 Fidelity during mRNA translation and decoding 
The most important player of translation is the ribosome. The ribosomes are large macromolecular 
machines, of approximately 2.5 MDa in bacteria, composed of two unequal subunits, the small 30S 
and the large 50S, assembled together to form the 70S ribosome. The 30S subunit contains twenty-
one proteins and one ribosomal RNA (16S rRNA). It houses the decoding center where mRNA is 
decoded by tRNA molecules. The 50S subunit is composed of thirthy-six proteins and two rRNAs, 5S 
and 23S. The 50S subunit harbors the peptidyl transferase center where the peptide bond between 
two adjacent tRNAs is formed and makes the ribosome a ribozyme (Steitz and Moore, 2003). Each 
ribosome presents three tRNA binding sites, the A site for binding of aa-tRNA, the P site for binding of 
peptidyl-tRNA, and the E site from which deacylated tRNA exits the ribosome. The translation process 
progresses through four consecutive phases of initiation, elongation, termination and recycling, during 








Figure 2. The phases of translation. Synthesis of protein proceeds through consecutive phases of initiation, elongation, 
termination and recycling. During initiation, the 70S initiation complex assembles on the mRNA starting codon. Upon 
repetitive elongation rounds, new amino acids are incorporated to form growing polypeptide chain. When a stop codon is 
read the process terminated and the subunits are recycled for a new round of translation. Figure reproduced from (Schmeing 
and Ramakrishnan, 2009).  
 
During the initiation phase the 30S subunit, supported by initiation factors (IFs) 1, 2 and 3, 
stochastically binds the initiation fMet-tRNAfMet and, thanks to its 16S partial complementarity, the 
mRNA (Shine and Dalgarno, 1974), to form the 30S initiation complex (IC). Correct assembly of the 30S 
IC allows the joining of the 50S subunit with consequent release of all the IFs. This leaves the newly 
assembled 70S IC with the fMet-tRNAfMet interacting with the mRNA start codon in the P site (Gualerzi, 
2010). During the elongation phase, the mRNA is decoded and amino acids are cyclically added to the 
growing polypeptide chain. Aa-tRNA is delivered to the ribosome in a ternary complex with EF-Tu and 
GTP (Figure 3). Upon codon recognition, the geometry of the base pairs at the codon:anticodon helix 
is recognized by ribosomes to discriminate between base matches and mismatches. Correct codon-
anticodon interaction causes the first two bases of codon-anticodon helix to interact with A1492, 
A1493 and G530 (E. coli numbering throughout) of 16S rRNA and induces a series of fast 
conformational changes (Ogle et al., 2001) which are fundamental for the GTPase activation of EF-Tu 
and the subsequent GTP hydrolysis and part of the induced-fit rearrangement (Gromadski and 
Rodnina, 2004a; Pape et al., 1998; Rodnina et al., 1995a). Mismatches at the codon:anticodon helix 




preventing the conformational changes required to trigger GTPase activation (Ogle et al., 2002) and 
resulting in its reduced rate or complete inhibition. The binding of near-cognate tRNAs, displaying one 
mismatch, is weaker than that of cognate ones so that they tend to dissociate more easily from the 
ribosome (Gromadski and Rodnina, 2004a; Pape et al., 1999). While non-cognate tRNAs bearing two 
or more mismatches are normally rapidly rejected in this initial selection phase, near-cognate aa-
tRNAs may escape the selection and are further discriminated at the proofreading phase after the 
irreversible hydrolysis of GTP. At this stage, the acceptor stem of the aa-tRNA is released from the EF-
Tu-GDP complex and accommodates in the peptidyl-transferase center of the ribosome. Also in this 
case, the accommodation of the cognate substrates is much faster and more efficient than for near-
cognates which normally results in their rejection (Pape et al., 1999). Once the tRNA is accommodated 
into the A site, the complex formed by EF-Tu and GDP dissociates from the ribosome and the new 
peptide bond can eventually form. The polypeptide chain is then transferred to the aa-tRNA in the A 
site ready to be translocated back into the P site. Translocation is promoted by another ribosomal 
GTPase, the elongation factor G (EF-G) and the translating ribosome moves on the mRNA one codon 
at a time translating 4 - 22 amino acids per second at 37°C (Bhattacharjee et al., 2012; Wohlgemuth 
et al., 2010)). Translation proceeds until one of the mRNA stop codons (UAA, UAG or UGA) enters the 
A site and marks the beginning of the termination phase. In the termination phase, the ribosome is 
assisted by two classes of release factors (RFs). To class I belong RF1 and RF2 that recognize the stop 
codon (UAG and UAA for RF1 and UAA and UGA for RF2) (Ito et al., 2000) and bind to the ribosome 
promoting the hydrolysis and release of the peptide chain. The second class includes RF3, another 
GTPase, that promotes the dissociation of class I factors from the ribosome after the peptide release. 
After termination, subunits are recycled by the combined action of EF-G, ribosome recycling factor 









Figure 3. Kinetic scheme of mRNA decoding. Aminoacylated tRNA is delivered to the ribosome in complex with EF-Tu and 
GTP. The correct codon recognition triggers a series of conformational changes that cause GTPase activation, GTP hydrolysis 
and inorganic phosphate (Pi) release. The tRNA is released from EF-Tu-GDP complex and accommodates into the A-site of 
the 50S subunit and peptidyl transfer can occur. Eventually, the presence of one mismatch at codon-anticodon helix might 
induce the tRNA dissociation before transpeptidylation.    
 
1.3.1 Ribosomal quality control following peptide bond formation 
For a long time it was thought that accuracy of mRNA decoding on the ribosome and the selectivity of 
aminoacyl-tRNA synthetases are the only sources of fidelity in translation. However, an additional step 
has been discovered recently that acts after the misincorporation of substrates has occurred (Zaher 
and Green, 2009). Presumably, mismatches in the codon:anticodon interaction of the peptidyl-tRNA 
in the P site lead to distortions in the ribosome structure  and cause a general loss of specificity in the 
A site promoting in turn repetitive miscoding events (Figure 4) (Zaher and Green, 2009, 2010b). 
Accummulation of errors in the nascent peptide, which is observed regardless of the type of ribosome 
used (wild type, error prone rpsD or error restricted rpsL (Zaher and Green, 2010b)), promotes the 
termination factor-mediated release of the nascent chain resulting in an abortive termination of the 








Figure 4. Mechanism of selection triggered by error accumulation. PT, peptidyl transfer. Following the first misincorporation 
event and translocation of a near-cognate tRNA into the P-site, the probability that the nascent peptide is release by the RFs 
is less than 2 %, while the probability that a correct aa-tRNA is accepted in the A site is only 10-30 %. In most cases, a second 
incorrect aa-tRNA is accepted (70-90 %). The second miscoding event reduces the possibility of correct and incorrect PT to 
5-30 % and 35-85 %, respectively, but strongly favours the termination of the protein synthesis and the release of the nascent 
chain (5-50 %). Figure adapted from (Zaher and Green, 2009). 
 
1.3.2 Base pair tautomerization and its effect on decoding 
The recognition of Watson-Crick (WC) base pairs is at the core of many processes of gene expression, 
such as replication, transcription, and translation. In general, complementary Watson-Crick and non-
complementary base pairs at the first two positions of the codon-anticodon helix are efficiently 
discriminated on the ribosome on the basis of their geometry, while the third base pair, i.e  the wobble 
position, is less strictly controlled allowing for non-Watson-Crick interactions and the tRNAs to read 
synonymous codons.  
However, crystal structures showed that some mismatches such as G/U and C/A at the first or 
second position, can adopt a WC geometry which is isosteric to the canonical WC base pairs and can 
thus escape this selection (Demeshkina et al., 2013). This occurs because nucleotide bases, although 
with a low probability of 10-5 - 10-4, can adopt alternative tautomeric or anionic forms that cause them 
to be isosteric with WC bases (Kimsey et al., 2015; Westhof et al., 2014) (Figure 5) and be recognized 
as cognate by the ribosome. Thus, in these cases the ribosomes lose the ability to discriminate 
matches against mismatches (Rozov et al., 2015, 2016). This type of loss in fidelity has also been 





expressed in E. coli revealed that a correlation exists between GU mismatches and an increased level 




Figure 5. G-U base pair tautomerism. Natural bases of nucleic acids form base pairs with at least two hydrogen bonds 
between them. Standard complementary base pairs G-C and A-U  (upper panel) are compared with Wobble base pair GU 
and AC (center panel) and the isosteric tautomers (bottom panel) imino and enol forms. Wobble pairs present a different 
geometry which is recognized by the ribosome as a mismatch. However, the Watson-Crick-like geometry of tautomers 





1.4 Aminoglycosides and decoding  
Reduced fidelity of decoding can be caused by aminoglycosides that target the 16S rRNA of the 30S 
subunit and affect protein synthesis and decoding.  Aminoglyocosides were the first antibiotic class 
effective against tubercolosis and, despite the fact that their use has helped millions of people, their 
current clinical application is hampered by their poor bioavailability, the emergence of resistant 
pathogenic strains and their pronounced nephro- and ototoxicity (Fischel-Ghodsian, 2005) which are 
likely caused by their interaction with the A site of human mitochondrial ribosomes (Hong et al., 2015). 
Nevertheless, they remain in use as pivotal tools for the investigation of translation mechanism and 
ribosome dynamics and as clinically important drugs for the treatment of the symptoms caused by 
hereditary diseases. In some genetic pathologies, such as the Duchenne muscular dystrophy (Malik et 
al., 2010a; Malik et al., 2010b), the primary ciliary dyskinesia (Bukowy-Bieryllo et al., 2016) and the 
phenylketonuria (Ho et al., 2013), the premature insertion of a stop codon in the mRNA causes the 
generation of shorter, non-functional proteins and the translational readthrough induced by 
aminoglycosides is used to effectively restore the expression of a functional full-length protein. 
Aminoglycosides are positively charged oligosaccharides which usually share a 2-deoxystreptamine 
ring (also known as 2-DOS or ring II) as a common characteristics, although some exceptions exist such 
as spectinomycin and streptomycin. Depending on the type of linkages between the 2-DOS ring and 
the other rings, they can be classified in 4,5-disubstituted, 4,6-disubstituted, 4- and 5-
monosubstituted aminoglycosides (Figure 33). To enter the cell, aminoglycosides must first cross the 
plasma membrane and, in the case of gram-negative bacteria, the outer membrane. Their uptake is 
an energy-consuming process that is thought to occur in three phases. In the first phase, the positively 
charged aminoglycosides are adsorbed to the surface of bacteria by electrostatic interactions with the 
lipopolysaccharides of the outer membrane. The following two steps are dependent on the 
transmembrane potential generated by the respiratory chain, which is the reason why anaerobic 
bacteria appear to be impermeable and resistant to aminoglycosides (Bryan and Kwan, 1983; Hancock, 
1981; Taber et al., 1987). Once inside the cell, they affect translation by binding to the ribosome. Most 
aminoglycosides specifically target the 30S ribosomal subunit and bind to the helix 44 (h44) (Carter et 
al., 2000; Moazed and Noller, 1987), although spectinomycin only binds to helix 34 (h34) (Bilgin et al., 
1990; Carter et al., 2000) and some of them such as gentamycin, tobramycin, neomycin and 
paromomycin have a secondary binding site on the helix 69 (H69) of 50S subunit (Borovinskaya et al., 
2007a; Misumi et al., 1978) (Figure 6 and Table 2). 
Neamine (Nea) is constituted by the universal two-ring structure which characterizes the base of 





A1493 to bulge out in a conformation simar to those induced by codon:anticodon interaction (Francois 
et al., 2005; Ogle et al., 2001). 
Kanamycin (Kan) binds to h44 of the 16S rRNA. It induces a high-affinity conformation of the ribosome 
for A-site tRNA and promotes the displacement of the 16S rRNA residues A1492 and A1493 affecting 
both translocation and miscoding (Davies et al., 1965b; Feldman et al., 2010).  
Neomycin B (Neo B) has two binding sites, the first on h44 and the second on H69 (Borovinskaya et 
al., 2007a) affecting decoding fidelity, translocation and also ribosome recycling. It inhibits aa-tRNA 
translocation and  ribosome recycling by stabilizing an intermediate state of subunits rotation and 
causing a conformational change that negatively effects subunits dissociation (Borovinskaya et al., 
2007a; Wang et al., 2012). 
Gentamicin (Gen) has two binding sites on h44 and H69. Its effect on the ribosome is similar to those 
of Neomycin inducing miscoding and affecting translocation (Borovinskaya et al., 2007a; Davies et al., 
1965b). 
Paromomycin (Par) exerts its main effect on decoding. It displaces A1492 and A1493 of h44 into a 
position where they could not contact anymore the codon:anticodon helix (Carter et al., 2000; Ogle 
et al., 2001; Ogle et al., 2003; Ogle et al., 2002) and induces a deformation of the near-cognate 
codon:antidocon helix and a movement of H69 (Demeshkina et al., 2012). Par specifically increases 
the GTPase activation for near-cognate ternary complexes, whereas the GTPase activity in the cognate 
complexes is unaffected (Pape et al., 2000). 
Tobramycin (Tob) binds to both h44 and H69 (Borovinskaya et al., 2007a; Scheunemann et al., 2010). 
It stabilizes the bulged out conformation of the residues A1492 and A1493 (Vicens and Westhof, 2002) 
Ribostamycin (Rib) shares the same identical structure of Neo but lacks ring IV. As Nea, it bings to h44 
and affects decoding by causing the conformational rearrangement of the the two adenines 1492 and 
1493 (Francois et al., 2005). 
Apramycin (Apr) binds h44 and is a strong inhibitor of protein synthesis. It inhibits the translocation 
step but its effect on miscoding is controversial (Matt et al., 2012; Perzynski et al., 1979). 
Hygromycin B (Hyg B) binds at the very top of h44 but does not induce any conformational change in 
the rRNA (Brodersen et al., 2000). However, it might exert its effect as translocation inhibitor (Peske 
et al., 2004) by blocking the movements of the h44, which are necessary during translocation (Frank 
and Agrawal, 2000) . In addiction, by increasing the affinity of the A-site tRNA, Hyg B also has a small 
effect on decoding (Eustice and Wilhelm, 1984a, b; Peske et al., 2004).  
Streptomycin (Str) tightly binds to the phosphate backbone of 16S rRNA and makes contact with 
protein S12 of the small subunit (Carter et al., 2000). Structural works showed that Str shifts the 




A1492 and A1493 to flip out from h44 (Demirci et al., 2013a). Str increases the affinity of tRNA binding 
in the A site (Peske et al., 2004) and acts on the ribosome by reducing the rate of GTPase activation 
for ternary complexes with cognate aa-tRNAs and accelerating it for those with near cognate aa-
tRNAs, thereby reducing ribosomal selectivity (Gromadski and Rodnina, 2004b; Pape et al., 2000).  
Spectinomycin (Spc) binds in the minor groove at one end of h34, where it contacts C1064 and C1192 
(Carter et al., 2000). The antibiotic sterically blocks swiveling of the head domain of the small 
ribosomal subunit and has a strong inhibitory effect on translocation thereby blocking the 
translocation cycle (Borovinskaya et al., 2007b; Peske et al., 2004).  
 
 
Figure 6. Aminoglycosides binding sites on the ribosome. The binding site of aminoglycosides is shown with respect to the 
A) 70S and the B) 30S subunit. C) The biding site in h44 of tobramycin (Tob), paromomycin (Par), streptomycin (Str), 
hygromycin B (Hyg), gentamicin (Gen) and neomicin (Neo). Only the primary sites are shown; Tob, Gen, Neo and Par  also 
have a second binding site in h69. Spectinomycin (Spc) has a binding site in h34. [PDB files: 4ji1 (Demirci et al., 2013b), 4v56 
(Borovinskaya et al., 2007b), 4woi (Wasserman et al., 2015), 4lfc , 4w29 (Zhou et al., 2014), 4v64 (Borovinskaya et al., 2008), 





Table 2. Aminoglicosides binding sites and their effects. The binding sites and effects for the most 
common aminoglycosides are reported. 
 
Aminoglycoside Binding site Effect Reference 
Neamine h44 and H69 Miscoding (Francois et al., 2005; Pape et al., 2000) 
Kanamycin h44 Miscoding and translocation inhibition  
(Feldman et al., 2010; Francois et al., 
2005) 
Neomycin B h44 and H69 
Ribosome recycling and subunit rotation 
inhibition 
(Borovinskaya et al., 2007a; Wang et 
al., 2012; Wasserman et al., 2015)  
Gentamycin h44 and H69  
Miscoding and ribosome recycling 
inhibition 
(Borovinskaya et al., 2007a) 
Paromomycin h44 and H69 Miscoding and translocation inhibition  
(Carter et al., 2000; Demeshkina et al., 
2012; Pape et al., 2000; Peske et al., 
2004; Wasserman et al., 2015) 
Tobramycin h44 and H69 Miscoding and translocation inhibition 
(Cabanas et al., 1978; Fosso et al., 
2015; Vicens and Westhof, 2002) 
Ribostamycin h44 and H69 Miscoding (Francois et al., 2005) 
Apramycin h44 mRNA translocation inhibition  
(Matt et al., 2012; Perzynski et al., 
1979) 
Hygromycin B h44 
Inhibits translocation in both 
prokaryotes and eukaryotes, by a lesser 
extent causes misreading 
(Brodersen et al., 2000; Eustice and 
Wilhelm, 1984a, b; Gonzalez et al., 
1978; Peske et al., 2004) 
Streptomycin h44 
Misreading, h44 distortion,               
codon-anticodon stabilization, 
equalization of ribosome selectivity for 
cognate- and near-cognate ones. 
(Carter et al., 2000; Demirci et al., 
2013a; Gromadski and Rodnina, 
2004b) 
Spectinomycin h34  Translocation inhibition 
(Bilgin et al., 1990; Carter et al., 2000; 
Peske et al., 2004) 
 
 
1.4.1 Cellular effects of aminoglycosides-induced miscoding  
Whereas the primary binding sites of aminoglycosides on the ribosome are well established, the 
sequence of events that leads to cell death has been under debate for decades. Accumulation of errors 
in proteins is considered one of the most essential steps contributing to the bactericidal action of 
aminoglycosides. The insertion of erroneous proteins into the cell membrane is responsible for a 
membrane damage that, in turn, enhances the antibiotic-mediated killing (Davis et al., 1986). After an 




miscoding and production of erroneous proteins. The insertion of such proteins into the cell 
membrane creates abnormal channels that increase the influx and the irreversible entry of more 
aminoglycoside triggering a positive loop of misreading, membrane damage and antibiotic entrance.   
The link between aminoglycosides, miscoding and membrane permeability is also suggested by the 
following findings: i) when cells containing Str-resistant ribosomes are treated with another 
aminoglycoside to which they are sensitive, they can then take up more Str (Holtje, 1978, 1979); ii) 
simultaneous addition of chloramphenicol, a bacteriostatic antibiotic that inhibits protein synthesis, 
and Str reveals an antagonistic effect of the first on the latter resulting in a decrease Str uptake (Jawetz 
et al., 1951); iii) the addition of chloramphenicol after the secondary uptake of Str has begun, does 
not block Str uptake anymore (Holtje, 1978, 1979). These results together suggests that an active, 
translation-engaged ribosome is necessary for aminoglycosides effect to develop (that is, erroneous 
proteins must be first synthetized). At the same time, ribosomes that actively synthesize proteins in 
the presence of an aminoglycoside do not promote its uptake by a direct participation in the process 
of entry, but rather have an indirect effect involving insertion of erroneous protein into the 
membrane, which persists even when the ribosome activity is blocked.  
In more recent studies, another killing mechanism has been proposed, in which mistranslation of 
membrane proteins activates a cascade reaction that triggers redox alteration, destabilization of iron-
sulfur (Fe-S) clusters (Ezraty et al., 2013) and generation of hydroxyl radicals (Dwyer et al., 2014; 
Kohanski et al., 2008). Mistranslated proteins are translocated either across the inner membrane into 
the periplasmic space or are directly inserted into the membrane. As a consequence of the reduced 
translation fidelity induced by aminoglycosides, many of these proteins are misfolded and activate the 
two-component stress response sensor consisting of CpxA, which monitors the quality of proteins 
trafficked through the membrane, and CpxR, which is phosphorylated by CpxA (Dong et al., 1993). This 
triggers the expression of the envelope stress response proteins, such as degP (Danese et al., 1995; 
Pogliano et al., 1997), which degrades misfolded proteins and suppresses the toxicity associated with 
their intracellular accumulation (Isaac et al., 2005). 
 In addition, CpxA may also activate the redox-responsive two-component transcription factor, 
ArcA (Iuchi et al., 1989; Ronson et al., 1987). The activation of the envelope stress response system, 
together with ArcA-regulated changes in metabolic and respiratory systems, leads to the 
hyperactivation of the respiratory chain and the generation of hydroxyl radicals which cause oxidative 
stress, generation of 8-oxo-guanine, nucleic acids damage, toxic metabolic perturbations, apoptosis 
and ultimately cell death (Belenky et al., 2015; Dwyer et al., 2012; Foti et al., 2012). However, the 
notion that aminoglycosides induce an hydroxyl-radical-mediated killing, has been recently challenged 





protein errors which accumulate during stress conditions and aminoglyocosides treatment remains 
elusive and a comprehensive view of aminoglyocosides effects, miscoding and cellular response is still 
missing.   
 
1.5 Available estimates of error frequencies  
A number of estimates for the in-vivo abundance of amino acid misincorporations are available in 
literature (Table 3). Most of the published error frequency values were estimated by biochemical 
assays that quantified only one specific protein or misincorporation at a time, e.g., incorporation of 
not naturally encoded amino acids, restoration of the activity of an enzyme variant inactivated by 
introducing an amino acid replacement at the active site (Kramer and Farabaugh, 2007; Manickam et 
al., 2014), separation of correct and erroneous proteins by 2D gel electrophoresis. All these techniques 
share the same common limitations, i.e., use of a reporter system, the choice of the position and type 
of misincorporation to investigate, and the low sensitivity and the narrow dynamic range associated 
with the analytical methods being used. Only in recent years mass spectrometry has emerged as a 
new tool for the evaluation of error frequency (Yu et al., 2009; Zhang et al., 2013), albeit with some 
constraints due to the wide concentration range between correct and error-containing peptides which 





















Table 3. Estimated in-vivo error frequencies. A list of the techniques used so far to determine 
translation error frequency per codon is reported [adapted from (Ribas de Pouplana et al., 2014)]. Due 
to the differences which characterize each method, very different frequencies have been determined. 
 









R → C 1x10-4 




R → C; 






(Bouadloun et al., 
1983) 
N → K 2x10-4 – 2x10-3 Isoelectric focusing 




G → S 1x10-3 
lacZ activity 
restoration 
(Toth et al., 1988) 
Y → H 5x10-6 
CAT activity 
restoration 
(Stansfield et al., 
1998) 
± frameshift 2x10-5 
lacZ activity 
restoration 
(Curran and Yarus, 
1986) 
Frameshift, stop codon readthrough 2-10 % GFP fluorescence 
Meyerovich et al. 
2010 
24 codons to K 3x10-4 Firefly luciferase 
(Kramer and 
Farabaugh, 2007) 
N → D; Q → E 2x10-3  8x10-3 Renilla luciferase (Javid et al., 2014) 
tRNA 
misacylation 
Mismethionylated tRNA 1x10-2  1x10-1 
Radioactive Met on 
tRNA microarray 





N → D 1x10-1 MS/MS (Ruan et al., 2008) 
S → N 2x10-2 
Modified database 
algorithm  and 
MS/MS 
(Yu et al., 2009) 
G ↔ D, G → Q, D → E, E → K;  
M → I, M → N; S → N; S → R; V → I;  
D → N; A → T; H ↔ Q; P → L; P → S;  
R → Q, Y → N. 
10-5  10-3 
High resolution 
mass spectrometry  







1.6 Mass spectrometry: an emerging tool for the quantification of miscoded translation products 
Mass spectrometry is one of the most efficient ways to identify and quantify proteins. It relies on the 
separation of ions based on their mass-to-charge ratio and, in association with continuously improved 
techniques for the ionization of samples (e.g., electrospray ionization (ESI)), has rapidly become the 
method of choice for the analysis of peptides, single proteins and protein complexes. The advantages 
of mass spectrometry arise not only from the possibility of a fast and sensitive peptides identification, 
but also from the low amounts of sample required for the analysis. The identification of a protein can 
be attained by the direct mass spectrometric anaylsis of the intact protein (top down 
characterization), or alternatively, due to the ionization and fragmentation limitations associated with 
this technique, on the base of the peptides generated from protein hydrolysis (bottom up or shotgun 
proteomics). Peptides, which are easier to fractionate and fragment than the intact protein, are then 
analysed by tandem mass spectrometry and their spectra compared with databases and spectral 
libraries which allow their identification and their assignation to the corresponding protein (Lin et al., 
2003; Meng et al., 2002; Yates, 2004).  
Mass spectrometry has been recently used also for the identification of amino acid 
misincorporation. The identification of misincorporation-containing peptides is performed on the 
basis of the mass shift caused by the amino acid substitution, as it happens for the identification of 
post-translational modifications (PTMs). Hovewer, the extremely low abundance of error-containing 
peptides, the limited dynamic range of current mass spectrometers (3 - 5 orders of magnitude 
depending on the sample and the type of mass analyzer (Domon and Aebersold, 2010; Gallien et al., 
2012; Gillet et al., 2012; Stahl-Zeng et al., 2007)) and the limited amount of sample that can be 
tolerated by both chromatographic system and mass spectrometer, makes the identification of rare 
error-containing peptides often impossible in a sample which also contains high abundance correct 
peptides and poses a big challenge to their quantification. Indeed, recent fluorescence based in-vivo 
studies (Manickam et al., 2014) and kinetic in-vitro studies (Zhang et al., 2015) indicate that many 
misincorporations might be far less abundant (<10-5) than previously expected. This is further 
complicated by the fact that misincorporation-containg peptides are suppressed by the high abundant 
co-eluting correct tryptic peptides. To the best of our knowledge, no mass spectrometric study 
detected more than 5 % of all possible near-cognate misincorporations, presumably due to their low 
abudance.  
After the mass spectrometric analysis, erroneous peptides can be identified by several approaches. 
Erroneous peptides can be found using the database search algorythms that compare the MS/MS data 
to in-silico predicted fragmentation pattern of all possible peptides in the database e.g., MASCOT 




2007) or MassAnalyzer (Zhang, 2009). However, because the search space exponentially expands with 
the number of subsitutitions allowed per peptide, different strategies exists to overcome this 
limitation while applying traditional search engines. First, the search space can be restricted only to 
proteins or peptides whose unmodified parental peptide has been observed in the sample and the 
number of variable misincorporations per peptide can be restricted (Creasy and Cottrell, 2002). 
Database searches can also identify parental peptides and so called “dependent” peptides that derive 
from the repective parental peptide but differ by a delta mass (Cox and Mann, 2008). In this case the 
search space does not expand, because the delta masses are not interpreted in terms of defined PTMs 
or amino acid substitutions and thus could reflect different deviations from the parental peptide. In 
this approach the indentification and validation of amino acid substitutions has to occur after the 
database search. A similar peptides-dependent approach has been recently applied to study the 
proteome-wide incorporation of norvaline (Cvetesic et al., 2016). When the database search time 
needs to be reduced, tag-based hybrid methods can be applied in which a sequence tag of  2 - 4 amino 
acids  is derived from a MS/MS spectrum and only tag-containing peptides are searched in the 
database (Mann and Wilm, 1994; Shilov et al., 2007; Valledor et al., 2008). Spectral library searching 
can also be used as alternative method to reduce the search space and perform a fast and accurate 
analysis in which the query MS/MS spectra are searched against a large collection of experimental 
MS/MS spectra (Frewen et al., 2006), although this method finds its biggest limitation in the fact that 
the identification of the peptide can be performed only if it is already included in the library. Another 
approach to adapt classical search engines without restricting it to the prior identification of parental 
peptides, consists in the increase of the mass tolerance in the delta mass comparison with respect to 
the parental peptide from the database and in the interpretation of the resulting delta masses only 
subsequently. This approach was recently used to systematically analyze unassigned spectra from 
shotgun analysis of HEK cells (Chick et al., 2015). Apart from single missense errors, the algorythm was 
also able to identify more complex alterations in the amino acid sequence de novo such as polyalanine 
insertions in the ribosomal protein L14. Alternatively, when all amino acid substitutions are included 
in the database, classical database search engines can be applied (Muhlhausen et al., 2016).  
However, in specific cases as for the identification of modified peptides whose sequence is not 
included in any database, the use of alternative approaches such as  de novo sequencing can be 
favourable. This method, based on software packages such as PEAKS (Ma et al., 2003) and PepNovo 
(Frank and Pevzner, 2005), directly infers the peptide sequence from MS/MS spectra and bypass the 
need for spectra comparison with the database. With this approach, many substitutions and 
modifications can be identified; on the other hand, the high frequency of false positive results and the 





resulting mass shift is not unique or  for very low-abundance peptides whose spectra is difficult to 
obtain with good quality.  
Another drawback of current PTM identification and quantification procedures concerns the data 
interpretation and is associated with the underestimated chemical complexity of tryptic digests. 
Similar or identical delta masses might be introduced in vivo by enzymatic- (e.g., methylations or 
acetylations) or non-enzymatic posttranslational modifications (e.g., carbon, oxidative or nitrosative 
stress) (Wagner and Hirschey, 2014; Weinert et al., 2013) which could lead to false positive 
identifications. Subsequently, modifications might be introduced upon cell opening and sample 
preparation (e.g., oxidation, iodoacetamide (IAA) labelling, atryptic cleavage (Picotti et al., 2007) and 
transpeptidation (Fodor and Zhang, 2006; Schaefer et al., 2005)). Moreover, such peptide decay 
reactions are often accelerated when the individual residues of trypytic peptides are not protected by 
the protein environment (Manning et al., 2010). In the mass spectrometric workflow, co-ionizing 
adducts (e.g., sodium ions) and gas phase reactions (e.g., cyclizations, deamidations or water loss) can 
further lead to modifications that are isobaric to amino acid misincorporations. For example, a +14 Da 
∆mass might be explained by replacements D → E, G → A, N → Q, V → I, V → L, S → T, as well as by 
methylations at K, R, H, Q, N, E, D (Jung et al., 2008) that can be either introduced in vivo or artificially 
during sample processing using methanol (Chen et al., 2010), e.g., upon Coomassie staining (Sumpton 
and Bienvenut, 2009). A +14 Da ∆mass can also arise by misincorporations of β-methylnorleucine 
(Muramatsu et al., 2003) in place of I or oxidations of Y and W. Cysteinyl-S-β-propionamide, a by-
product of acrylamide adduct formation in SDS-PAGE, can produce the same mass associated with 
cysteine alkylation plus monomethylation on a proximal amino acid (Hart-Smith et al., 2016) and 
methylations which are difficult to reliably identify by conventional scoring algorythms due to high 
false discovery rates (Bogdanow et al., 2016). Incidentally, the identification of those errors that are 
expected to be highly abundant, because they are introduced by third position codon-anticodon 
mismatches, is particularly difficult, because they often lead to  common delta masses (i.e., -16, -14, 
+14, +16 Da). These identification problems are aggravated by the fact that low-abundance erroneous 
peptides often have incomplete fragmentation patterns precluding the exact identification of the 
position of the delta mass in the peptide sequence. In addition, isobaric peptides often co-elute during 
chromatography and thus hamper the correct quantification on the MS1 level, and lead to chimeric 
MS/MS spectra that are often hard to correctly assign to the respective sequences. Finally, the correct 
parental and erroneous peptides might differ in their ionizability which is especially relevant for 
peptide pairs with very different physicochemical properties  which reflect in deviating retention times 
and large delta masses e.g., when the amino acid substitution introduces or eliminates a tryptic 




Overall, this leads to the unfortunate situation in which most misincorporations might escape 
detection and prompted us to develop an alternative experimental approach that would allow the 
reliable and systematic identification and quantification of erroneous peptides with high sensitivity 
and over a wide dynamic range. 
 
1.7 Selected reaction monitoring (SRM) and triple quadrupoles mass spectrometer 
Selected reaction monitoring (SRM) is an attractive method for the accurate quantification of 
peptides, not only for its high sensitivity (to attomole concentration levels), but also for its broad 
dynamic range  up to five orders of magnitude  and excellent analytical reproducibility (Domon and 
Aebersold, 2010).  
During a typical LC-MS/MS analysis, the peptides of the sample are separated by reversed phase 
chromatography performed using a low-flow nano-LC system. Upon elution peptides are directly 
sprayed into the mass spectrometer from a needle which is kept at high potential (see Materials and 
Methods). The ejection of liquid from the needle in the presence of voltage gives raise to the formation 
of a cone, known as the Taylor cone (Taylor, 1964) and the sample is ionized for the mass 
spectrometric analysis using ESI (electrospray ionization) technique. At high temperature, the solvent 
evaporation and the droplet shrinking increases the charge density until ions are kinetically and 
energetically ejected from the droplet, to then pass through a transfer ion capillary and enter the 
vacuum region of the mass spectrometer for the analysis (Ho et al., 2003). For SRM analysis, a triple 
quadrupole mass spectrometer is used. The instrument consists of three consecutive quadrupoles, 
named Q1, Q2 and Q3, each constituted by an assembly of four parallel metal rods, where two 
opposite rods are electrically connected, but offset relative to one another giving two sets of rods 
pairs per quadrupole. Although a triple quadrupoles mass spectrometer can operate in a variety of 
scan types, when in SRM mode, it performes two stages of mass selection, referred to as tandem MS 
or MS/MS. At every time point, a variable combination of radio frequency (rf) and direct current (dc) 
voltages of the same amplitude and sign is applied in the Q1 and Q3 for each set of rods. This causes 
ions to oscillate and guides them through the rod assemblies. The oscillation stabilizes only selected 
ions with a specific mass-to-charge ratio (m/z) and allows them to pass, while all other ions crash on 
the rods and are eventually eliminated. Q1 and Q3 act as mass analyzers. After the Q1, only selected 
precursors will be allowed to enter the Q2. On this quadrupole, only rf voltage is applied and because 
selection of ions is not possible with the rf alone, this quadrupole only acts as transmission device 
instead of a mass analyzer. Q2 is a collision cell, where the ions that have been selected in the Q1 
collide with gas molecules (e.g., nitrogen or argon) at a defined gas pressure and electrostatic energy 





Q3 during the last stage of selection and ultimately recorded by the ion detection system (Figure 7). 
After a certain time, the dwell time, the rf and dc ratio are changed, and a new pair of ions are selected. 
The settings used for the selection of a precursor ion in the first quadrupole and the selection of its 
fragment ions in the third, are called transition. Usually 2 - 3 transitions are monitored for each 
peptide. The type of fragment ions which can be observed at the MS/MS level depends on various 
factors such as the sequence of the peptide and the charge state, and can be detected only if they 
retain a positive charge at their N terminal (a, b and c ions) or at their C terminal (x, y, z) (Roepstorff 
and Fohlman, 1984). The narrow selection windows of the first and third quadrupoles, between 0.2 
and 0.7 Da, allow the transitions of a very small set of ions, contributing to a high degree of selectivity 
and reducing the chemical noise. In this way, SRM analysis permits an instrument linearity which can 
easily span 5 orders of magnitude (Worboys et al., 2014). High degree of selectivity and sensitivity 
constitute the pivotal charachteristics that make this approach particularly suitable for biomarker 
discovery, where very low abundant marker peptides need to be found in extremely complex mixtures 
like, for example, blood sample (Stahl-Zeng et al., 2007).  
However, mass spectrometry is not quantitative per se, because the variation in the stability of ESI 
spray and the different intrinsic ionization properties of each peptide, hamper the direct comparison 
of peaks intensities. For this reason, to obtain an accurate quantification, the insertion of a mass tag 
by metabolic, enyzymatic and chemical labeling of peptides or proteins, or by spike of synthetic 
peptide standards into the sample is commonly employed (Ong and Mann, 2005). Stable isotope-
labelled peptides are chemically identical to the native light counterparts and they behave identically 
during liquid chromatography separation and mass spectrometric analysis. Nonetheless, the mass tag 
is detected by the mass spectrometer and the quantification can be performed by comparison of the 
signal intensity of light and heavy-labeled peptides (Bantscheff and Kuster, 2012). One optimized 
application of this strategy is the so called AQUA (Absolute QUAntification) approach, based on the 
use of custom designed and chemically synthetized peptide standards which contain C-terminal heavy 
amino acids labeled with carbon and nitrogen stable isotopes i.e., 13C- and 15N-, and that are spiked in 
the samples in known amount prior to the analysis (Gerber et al., 2003). Once the target peptides are 
analyzed in the sample by mass spectrometry, the area under the peptides peak is integrated, the 
peptides are detected and the ratio between the internal standard and the analyte is determined 
(Figure 7). Finally, because the amount of internal standard in the sample is known, also the amount 
of the analyte can be easily calculated. The first step in the development of the AQUA strategy is the 
selection of the peptides to be monitored during the SRM experiment. In our case, the selection is 
performed on the base of pre-existing data obtained from data-dependent acquisition, but in general, 




performances. Furthermore, some general features can be used to predict if a peptide is suitable or 
not for this analysis. Tryptic peptides length is between 5 and 20 amino acids and their sequence 
should lack reactive amino acid that could undergo modifications, e.g., methionine, or residues that 
could make the synthesis and purification of the synthetic peptides difficult, e.g., multiple serine or 
proline residues should be avoided because they cause deletion during the synthesis process (Lange 
et al., 2008; Picotti and Aebersold, 2012). Target peptides must be unique for the target protein and 
their sequence should not be shared by any other tryptic peptide from other proteins in the organism 
of choice (“proteotypic peptides” (Mallick et al., 2007)). It is also important that the peptides 
accurately represent the level of the protein (“quantotypic peptides” (Brownridge and Beynon, 2011)), 
which means that several factors that could affect their concentration  the completeness of 
proteolytic reaction, peptide stability, and the absence of post-translational modification  should be 




Figure 7. SRM analysis on a triple quadrupole mass spectrometer.Peptides are eluted from the nano-LC system and ionized 
before entering the instrument. Isotope-labeled peptides are indicated with the asterisk. Precursor ions are selected in the 
Q1, fragmented in Q2 and resulting fragment ions are ultimately selected for detection in Q3. Comparison of the peak area 
of light peptides and stable-isotope labeled peptides provides precise quantification of the endogenous analyte.  
 
1.8 Parallel reaction monitoring (PRM) to confirm the identitity of enriched peptides 
Although SRM is highly selective, some limitations arise from the resolution and mass accuracy of the 
quadrupoles mass analyzer used in triple quadrupole instruments, especially when near-isobaric 
fragment ions are analyzed (Abbatiello et al., 2010; Gallien et al., 2013; Sherman et al., 2009). Parallel 
reaction monitoring (PRM) can be an attractive alternative method for targeted quantification, 
especially when a higher degree of selectivity is required (Gallien et al., 2012; Peterson et al., 2012). 
As for SRM, peptides are separated by reversed phase chromatography on a nano-LC system and 
directly sprayed into the instrument, e.g., quadrupole-Orbitrap mass spectrometers (Gallien et al., 
2012). This instrument type consists of an Orbitrap mass analyzer (Hu et al., 2005) preceded by a 
quadrupole mass filter which is used for the selection of only specific precursor ions. When PRM is 





mass filter and transferred via the C-trap into the higher-energy collisional dissociation (HCD) cell, 
where it is fragmented. In contrast to the triple quadrupoles mass spectrometers, the quadrupole-
orbitrab mass spectrometers have a discontinuous data acquisition regime in which ions with target 
m/z values are selected by the quadrupole and collected in the C-trap while, in parallel, fragments of 
the previous measurement are still anaylzed in the Orbitrap. When enough ions are collected or the 
maximal fill time is reached, precursor peptides are transferred to the HCD cell for fragmentation. 
After fragmentation, the product ions are transferred via the C-trap to the Orbitrap and analysed 
simultenaously (Figure 8). In the Orbitrap the attraction to the central electrode is compensated by 
the initial tangential velocity of the ions. Upon measurement, the axial component of the circulation 
around the central electrode is detected as image current on the electrode encapsulating the orbitrap. 
The transient of all ions that is monitored over time is deconvoluted by Fourier transformation 
resulting in high resolution mass spectra. Longer fill times potentially increase the signal and, in 
parallel, longer analysis times allow for higher resolution spectra. On the other hand, the same factors 
limit the number of precursor masses that can be analyzed in a given time window, which results in a 
trade-off between resolution, sensitivity and the number of analytes. Because all fragments ions of a 
selected precursor can be monitored in parallel, PRM does not require the selection of only few of 
them, but all the pseudo transitions that have been recorded during the mass spectrometry run can 
be easily extracted post-acquisition, during data analysis.  This translates into a simplification of the 
protocol with respect to SRM, in which less method optimization is required, with only the precursor 







Figure 8. PRM analysis on a hybrid quadrupole/Orbitrap mass spectrometer. Peptides are eluted from the nano-LC system 
and ionized before entering the instrument. Isotope-labeled peptides are indicated with the asterisk. Precursor ion are 
selected in the Q1 and move via the C-trap to the HDC cell for fragmentation. All fragment ions are then transmitted back 
into the C-trap and injected into the Orbitrap for analysis. Comparison of the peak area of light peptides and stable-isotope 
labeled peptides provides precise quantification of the endogenous analyte.  
 
1.9 EF-Tu as a model protein 
Although a proteome-wide quantification of misincorporations would be desiderable, such large-scale 
quantification is hampered by the large difference in the abundance of many error-containing 
peptides and their cognate counterparts, whose concentration ranges often exceed the linearity of 
the instrument. Because there is no evidence that misincorporations in endogenous proteins can be 
more adundant than 10-3 (Table 1 and Table 3), the vast majority of proteins comprising the E. coli 
proteome cannot be studied in the lysate. In addition, the mechanisms that ensure the fidelity of 
protein synthesis are expected to be the same regardless of the protein choosen, because the same 





protein. These considerations prompted us to select a model protein that could be investigated 
without limitations in terms of source, strain, construct, tag or stress condition and that could be easily 
purified by affinity protocols as well as traditional tag-free chromatographic strategies (to minimize 
external interferences coming from other proteins), but that would also be abundant enough to be 
directly investigated in lysates without any enrichment. Among the high-abundance proteins in E. coli, 
EF-Tu emerged as the best candidate for our analysis. It is by far the most abundant protein of the E. 
coli proteome (Figure 9), 10-times more abundant than ribosomes (Furano, 1975; Schmidt et al., 
2016). EF-Tu is directly involved in decoding and thus manipulations such as the addition of a tag for 
affinity purifications might effect the levels of misincorporations in the cell. However, the protein is 
functional when fused to a His-tag at the C-terminus in vitro and in vivo and supports the wild type 
accuracy levels (Boon et al., 1992). 
 
Figure 9. Abundance of proteins in E.coli. Mass spectrometry analysis of the proteome of E. coli cells grown in LB medium. 
Figure based on the data from (Schmidt et al., 2016). 
 
EF-Tu is a monomeric protein of 393 amino acids and consists of three domains (Kjeldgaard and 
Nyborg, 1992). Domain I is composed of a central sheet formed by five parallel -strands plus one 
which is antiparallel and which is in turn surrounded by -helices and contains the GDP/GTP binding 
pocket (Figure 10). Domains II and III constist of  antiparallel -barrel structures. EF-Tu is encoded by 
two genes, tufA and tufB (Lindahl et al., 1975), which have almost the same sequence, except for 13 
nucleotides that result in synonymous codon substitutions. The products of the two genes share the 
same structure, almost identical molecular weight (43314 Da and 43284 for the product of tufB and 
tufA, respectively) and their amino acid sequence is identical, except for one amino acid at the C-
terminus for E. coli MRE600 (glycine in tufA and serine in tufB) (Arai et al., 1980).  Sequence variations 
can be observed in different E. coli strains. The amino acid sequence for the EF-Tu used in this project 






Figure 10. EF-Tu crystal structure.The three domains are highlighted in different colors: GTP/GDP-binding domain I (1-200 
aa) in dark blue, domain II (209-299 aa) in lime , domain III (300-393 aa) in aquamarine. The structure of GDP molecule bound 
to domain I is highlighted in red. [PDB file 1dg1 (Abel et al., 1996)]. 
 
1.10 Aim of the study  
The aim of this project is to develop a mass spectrometric assay to systematically quantify the error 
frequency of amino acid misincorporation in vivo and to overcome the limitations inherent in other 
published approaches e.g., codon-specific reported systems, amino acids or positions in the protein 
sequence, narrow instrument dynamic range and sensitivity. The second aim is to apply this assay in 
order to characterize the basic features and dimensions of the fidelity landscape in vivo determining 
i) the accuracy of the proteome; ii) the range in which misincorporations occur; iii) the fidelity of 
translation at different position of the protein; iv) the potential effect of the quality control machinery. 
The third aim is to characterize the error-inducing signatures of aminoglycosides and to correlate them 
with the impact on the cell physiology, such us growth defects and induction of stress response, and 









2.1 Multidimensional chromatography for peptides enrichment  
2.1.1 An overview of the method 
Quantification of misincorporations and estimation of translational error rate are often affected by 
limitations in the type of misincorporation to be selected for the study, by poor sensitivity of the 
method or its restriction to in-vitro assays or fixed model systems. Here we describe a novel method 
to quantify amino acid misincorporations in vivo. The advantage of the method is its sensitivity and 
broad applicability to unrestricted types of substitutions and reference systems. The protocol relies 
on the separation of error-containing peptides and their enrichment against the more abundant 
correct peptides through consecutives rounds of orthogonal chromatographies including alternating 
rounds of size-exclusion and reversed phase separation. This is combined with final quantification by 
targeted mass spectrometry and SRM analysis (Figure 11). This approach has some similarities with 
the methods employed for the detection of low-abundance protein biomarkers from complex 
biological fluids, like blood plasma or urine, in which high-abundance proteins are depleted prior to 





Figure 11. Schematic of the workflow for the enrichment of error-containing peptides. A model protein, EF-Tu, is 
proteolyzed. The peptide of interest (red) is selected and the corresponding isotope-labeled reference peptide (dashed red), 
is spiked in the sample. The sample is subjected to multiple rounds of HPLC chromatography. Ultimately, peptides are 
separated on the nano-LC on-line with the mass spectrometer (LC-MS/MS). Quantification of misincorporations is performed 
on triple quadrupole mass spectrometer operated in Selected Reaction Monitoring (SRM) mode and the ratio of light/heavy 




2.1.2 Sample preparation 
The performance of the protocol depends on the accurate preparation of the sample, which in our 
case starts with proteolysis by trypsin, a protease that cleaves polypeptide chains after lysine and 
arginine residues. To optimize protein digestion, we selected four tryptic peptides from the model 
protein EF-Tu, i.e., FESEVYILSK, VGEEVEIVGIK, ELLSQYDFPGDDTPIVR and TVGAGVVAK (Figure 12, A), 
which are proteotypic within the E. coli proteome and we monitored their formation over time. At 
selected time points, an aliquot from the digestion mix is withdrawn, mixed with the heavy-labeled 
counterparts of the four reference peptides and the sample analyzed by mass spectrometry. The area 




Figure 12. Proteolysis time courses. A) Four proteotypic peptides are selected from the EF-Tu sequence [PDB file 1dg1]. B) 
The progress of the proteolysis is assessed by monitoring four quantotypic peptides. Error bars represent the standard 




The relative concentration of the endogenous peptides increases with reaction time and reaches a 
plateau after 5 hrs of incubation at 37 °C. At this point the digestion is complete and the peptides 
remain stable in the reaction tube for the next 20 hrs. The stability of the peptides indicates that they 
are potentially quantotypic for the protein, which means that an any point their concentration exactly 
reflects the amount of protein in the sample, and that their quantification is reliable and not affected 
by decay due to instability, which could lead to an underestimation of the amount of proteins (Shuford 
et al., 2012).  
After proteolysis is completed, the total amount of digested EF-Tu is quantified by mass 
spectrometry using the same four peptides employed to monitor the digestion. A small aliquot of the 
digested protein is spiked in with a known concentration of AQUA peptides containing identical 
amounts of the four reference peptides and the mixture is then analyzed by mass spectrometry. The 
ratio of endogenous and heavy peptides is determined (Figure 13) and because the concentration of 
the latter is known, the amount of EF-Tu can be easily calculated. Once the concentration of the 
correct tryptic peptides is determined, we spike in the isotope-labeled reference peptides containing 
misincorporations of interest and assess the error frequency, e.g., for the quantification of R to H 




Figure 13. Quantification of proteolysed EF-Tu. The ratio of endogenous/AQUA peptides for the reference peptides is 
calculated and used to quantify the concentration of correct tryptic peptides obtained from EF-Tu proteolysis. Digested 
peptides and AQUA peptides are not mixed in a 1:1 ratio so that the calculated endogenous/AQUA ratio does not need to 
be necessarily 1. However, comparable ratios among the four reference peptides indicate that they are are stable in the 
reaction tube. Error bars represent the standard deviation of 3 technical replicates. 
 
2.1.3 Chromatographic separation and enrichment of target peptides 
In the first chromatographic dimension, the peptides are separated based on their hydrodynamic 
radius by size-exclusion chromatography, whereas in the second dimension they are separated 




both steps, all the fractions obtained are screened by mass spectrometry, and only the ones containing 
the target peptides are processed further. At this stage, the signal from the error-containing peptides 
is still too low to be detected, so that only the respective heavy-labeled standards are monitored. For 
the subsequent quantification the peptides are loaded onto a nanoflow chromatographic system and 
separated by reverse phase at acidic pH prior to their detection in the mass spectrometer. Although 
the last two dimensions both rely on reversed phase chromatography, the different pH at which they 
are performed confer separation power, especially for those peptides which contain residues whose 
protonation status changes upon pH shift – i.e., aspartate and glutamate – and whose separation can 
be altered by using different pH range. Because our peptides normally contain one of these amino 
acids, their chromatographic behavior changes from neutral to acidic pH ensuring their efficient 
separation. For an initial screening of error frequencies, we have chosen to follow the Arg to His 
substitutions (Table 4), known to be relatively abundant (Zhang et al., 2013). In addition, this type of 
amino acid misincorporation is particularly favourable to be investigated using our enrichment 
protocols because it changes the tryptic pattern of the protein which we proteolyzed using trypsin 
(which cleaves at R and K residues). The proteolysis of the error-containing protein yields longer 
peptides that elute earlier from the size-exclusion column than the products of digestion of the correct 
protein which are shorter. Thereby, the complexity of the sample and the background noise are 
efficiently reduced. Low-abundance erroneous peptides are enriched, separated within each other 
and from the more abundant cognates allowing us to increase the column load, pulling low 
abundance-peptides in the dynamic range of the instrument so that their signal can be detected. 
 
 
Figure 14. Distribution of peptide elution intervals in the first two chromatographic dimensions. EF-Tu peptides displaying 
different chemical property can be efficiently separated according to their size and hydrophobicity. Separated peptides are 





Table 4.  General properties of R to H substituted peptides.  Distinct physicochemical characteristics 
allow for efficient separation and correct identification of error-containing peptides. Hydrophobicity 




Misincorporation Peptide Length Hydrophobicity 
R45H TYGGAAHAFDQIDNAPEEK 19 28.03 
R59H AHGITINTSHVEYDTPTR 18 24.83 
R231H GTVVTGHVER 10 13.43 
R234H VEHGIIK 7 13.53 
R270H LLDEGHAGENVGVLLR 16 32.49 
R280H AGENVGVLLHGIK 13 27.51 
R284H HEEIER 6 5.86 
R319H DEGGHHTPFFK 11 19.94 
R328H GYHPQFYFR 9 28.31 
R378H FAIHEGGR 8 13.16 
R382H EGGHTVGAGVVAK 13 15.52 
 
In some cases, enrichment and analysis of error-containing peptides which have very similar 
physicochemical characteristics to their cognate peptides (e.g., FESEVYILSK peptide (Table 5)) might 
not be achieved in the first two dimensions (Figure 15). However, the separation of target peptides 
from the highly abundant cognate peptide is essential, as without their separation the sample 
complexity cannot be reduced. To improve the separation, further chromatographic steps are 
required which are tailored to the characteristics of specific peptides. We chose to add the third 
chromatographic step, reversed phase at acidic pH prior to the reversed phase performed on the 
nanoflow system. Although three rounds of reversed phase might not be fully orthogonal, they 
synergistically provide not only a further reduction of sample complexity, but also improve the 
separation of histidine-containing peptides due to the different pH. The second reversed phase 
chromatography, therefore, enhances the separation of error-containing peptides from the correct 
FESEVYILSK, before that the sample is loaded on the LC-MS/MS system (Figure 16). This reduces local 
interferences in SRM quantification and allows to load more target peptide without saturating the LC 








Table 5. Physicochemical characteristics of peptides differing by a few amino acids may be very 
similar. When compared to the cognate peptide FESEVYILSK, peptide variants with one, two or three 
amino acid difference have very similar charachteristics in terms of both length and hydrophobicity. 
Hydrophobicity factor has been estimated using the peptide analyzer tool available on the website of 
Thermo Fischer Scientific at the link https://www.thermofisher.com/de/de/home/life-
science/protein-biology/peptides-proteins/custom-peptide-synthesis-services/peptide-analyzing-
tool.html 
Errors Peptide Length Hydrophobicity 
Cognate FESEVYILSK 10 28.2 
F305L LESEVYILSK 10 26.41 
E306D FDSEVYILSK 10 28.51 
E308D FESDVYILSK 10 27.45 
Y310H FESEVHILSK 10 23.69 
Y310N FESEVNILSK 10 25.23 
E306D-E308D FDSDVYILSK 10 27.83 
E306D-Y310H FDSEVHILSK 10 24.00 
E308D-Y310H FESDVHILSK 10 23.10 
E306D-Y310N FDSEVNILSK 10 25.56 
E308D-Y310N FESDVNILSK 10 24.64 





Figure 15. Poor separation of similar peptides in the first two chromatographic dimensions.The two-dimensional 
separation of peptides that differ in only few amino acids with respect to the correct peptide is poor. Separated peptides are 
represented by dots (error-containing peptides in red, correct FESEVYILSK in blue). The size of each dot reflects the number 






Figure 16. Elution pattern of similar peptides in reversed phase chromatography runs at neutral and acidic pH.The different 
pH of the mobile phase changes the separation profiles of peptides which contain ionizing amino acids. Separated peptides 
are represented by dots (error-containing peptides in red, correct FESEVYILSK in blue). The size of each dot reflects the 
number of fractions in which peptides elute.  
 
2.2 Identification of enriched error-containing peptides 
2.2.1 Identification of peptides by SRM analysis 
Data obtained by SRM analysis are processed using Skyline software (MacLean et al., 2010b) which 
integrates the area under peptides peak and calculates the L/H ratio between light (L) and heavy (H) 
peptides. Each peptide, both in its light and heavy forms, is identified by the precursor mass-to-charge 
ration (m/z) selected in the first quadruple of the mass spectrometer (527.7865 and 532.7856, 
respectively for the example shown in figure 17) and the m/z of 3  5 fragment ions which are selected 
in the third quadrupole. The same intensity pattern for light and heavy peptides transitions, together 
with the identical elution time, allow us to identify the endogenous target peptide (Figure 17). A 
quantitative expression for this identification is the ratio dot product (rdotp) (Sherwood et al., 2009), 
for which the maximum value 1 indicates a perfect identification, whereas a value of 0 suggests 







Figure 17. Detection of error-containing peptides. Top panel, the sequence of the peptide and its fragmentation pattern. 
Co-eluting light (A) and heavy [Arg (13C6; 15N4)] (B) versions of the R231H peptide are detected. Four transitions y6, y5, y4 
and b9 are selected, whose intensity order is identical between the light and heavy peptide. A rodtp value of 1 confirms the 
















2.2.2 Identity validation by manual annotation of MS1 and MS/MS spectra  
Even though the co-elution of light and heavy peptides and the transitions pattern alone are generally 
accepted as a proof of the peptide identity, we decided to further validate our identifications using 
high resolution MS1 and MS/MS spectra. Precursor and the fragment ions spectra are compared with 
the fragmentation pattern predicted for the peptide (Figure 18). In cases where a clear MS1 and 
MS/MS could not be acquired due to the limited dynamic range of the mass spectrometer or to signal 
interference, for example for non-cognate misincorporations,  the identity of the peptides detected 




Figure 18. Identification of error-containing peptides by high resolution MS1 and MS2 spectra.The precursor (A) and the 
fragment (B) spectra are compared with the predicted fragmentation pattern (C). Their identification in the sample is 
essential to confirm the identity of the enriched peptide. The peak of the doubly charged precursor is indicated in bold in 
both A and in the predicted fragmentation pattern. The spectra of the freagment ions are indicated in bold in the 









Figure 19. Identification of misincorporation-containing peptides by parallel reaction monitoring (PRM). Top panel, the 
sequence of the peptide and its fragmentation pattern. For peptides including non-cognate misincorporations, the validation 
is performed by PRM. In the example, the peak obtained for the light (A) and heavy (B) R231F peptide is shown. The mass of 
precursor and fragments ions are indicated, and the rodtp for the identification is reported.  
 
2.3 Quantification of enriched error-containing peptides 
2.3.1 Quantification of peptides by SRM analysis 
When the identity of the enriched error-containing peptides is confirmed and quantified using their 
L/H ratios in Skyline, the concentrations of the correct peptides is used to calculate the error rate 
according to the equation: 
 
 
𝐸𝑟𝑟𝑜𝑟 𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 =  
𝑝𝑚𝑜𝑙 𝐴𝑄𝑈𝐴 
𝑝𝑚𝑜𝑙 𝐸𝐹 − 𝑇𝑢






The purity and the labeling efficiency of the isotopic labeled AQUA peptide can alter the calculated 
L/H ratio.  Therefore, prior to the quantification, we ran a blank sample with only the heavy peptide 








Figure 20. Assessment of AQUA peptides purity. To assess the purity of the purchased AQUA peptides and to exclude any 
light-peptide contaminations, each AQUA peptide (in the reported example, R231H peptide) is analysed by SRM and the 
signal for both light (A) and heavy (B) counterpart is recorded.  
 
2.3.2 Pseudo-linear quantification assessment  
To assess the linear dynamic range of our assay, the enriched peptide, which is already mixed with the 
identifier AQUA peptide used for the identification and quantification, is titrated with increasing 
concentrations of a second quantifier AQUA peptide which has identical amino acid sequence and 
contains a second isotope-labeled residues. These features allow us to distinguish  the quantifier 
AQUA peptide from both the endogenous and the first identifier AQUA peptide and to assess the 
linearity of the quantification which extends over 7 orders of magnitude, with respect to the original 
dynamic range of the instrument, spanning 3 - 5 orders of magnitude (data provided by Dr. Ingo 








Figure 21. Pseudo-linear dynamic range of correct and erroneous peptides quantification. Quantification of correct 
peptides (black) is performed independently of the error-containing peptides (red). This allows to extend the dynamic range 
over 7 orders of magnitude. The linearity of the measurement is then assessed by titrating the enriched sample with a second 
quantifier AQUA peptide (blue). In the example is reported the titration for the peptide K249N (Appendix, Section B). 
 
2.3.3 Post translational modifications and peptide degradation  
Whereas the absolute quantification of a protein by mass spectrometry is based on the averaged 
quantification of 3 or more of its peptides, the quantification of misincorporations has to rely on the 
singular quantification of the respective unique peptide. Thus, their quantification must necessarily 
be as accurate as possible to truly reflect the error frequency and any potential sources of 
misquantification such as incomplete trypsination, peptide instability, inaccurate AQUA peptide 
concentrations or post-translational modifications must be excluded. To confirm the quality of the 
quantification by SRM, we generated EF-Tu mutants for each of the R → X and K → X amino acid 
misincorporations under analysis and analyzed the stoichiometry of the peptide carrying the mutation 
in relation to the four tryptic reference peptides used for EF-Tu quantification (Figure 22). A 
stoichiometry close to 1 for each of the peptides indicated that no modification or degradation occurs 
on the mutated peptides and, therefore, that the error frequency quantification can be considered 
reliable. Little variations for in the ratio obtained  from peptide to peptide should be acceptable 
considering that i) the quantification of the AQUA peptides is perfomed by the supplier with an 
accuracy of ± 25 %; ii) peptides with different sequence might have different ionization properties and 






Figure 22. Validation of error quantification with EF-Tu mutants. The endogenous/AQUA peptides ratio for the error-
containing peptide (R231H shown in red) and four tryptic reference peptides is calculated by SRM analysis. Error bars 
represent the standard deviation of 3 technical replicates.  
 
2.4 The steady-state error level of misincorporations in vivo 
As described in the introduction, the limitations in the available biophysical and mass spectrometric 
methods have precluded the systematic analysis of the in-vivo steady-state error frequencies. Albeit 
the strong analytical advantages of our method, the use of the internal standards and the targeted 
method used for the mass spectrometric analysis do not allow a complete analysis of all possible 
misinicorporations occurring in the protein. Therefore, to achieve a comprehensive and 
representative analysis of the cellular error frequency landscape we decided to split it into two steps 
and first focus on the quantification af all possible misincorporations at individual residues of EF-Tu, 
and subsequently on the error quantification for one particular amino acid susbstitution and monitor 
its frequency at various positions of the protein. In the last part we correlated the changes of the 
steady-state error frequencies in response to external stimuli as antibiotics, with the cellular stress 
response of the proteome. Moreover, we discovered that aminoglycosides induce highly abundant 
strings of errors that are likely to be relevant for their bactericidal effect. 
 
2.4.1 Amino acid substitutions at selected positions in EF-Tu 
To get the first insights into the relative abundance of different types of errors, we selected three 
positions in the EF-Tu sequence, R231, K249 and K314, for which we already identified individual error-
containg peptides in previous data-dependent acquisition analysis (DDA). For each position, we were 
able to enrich and quantify all peptides resulting from an incorporation of a near-cognate aa-tRNA, 
displaying one mismatch in the codon-anticodon complex. To validate the significance of the results, 




purified by conventional chromatography (Rodnina and Wintermeyer, 1995); ii) chromosomally-
encoded EF-Tu from E. coli K12 strain, engineered to contain a His-tag and purified by affinity 
chromatography; iii) plasmid-encoded EF-Tu with a His-tag, overexpressed in BL21 (DE3) upon IPTG 
induction and purified by affinity chomatography. 
The error frequencies span over 3 orders of magnitude depending on the position of the mismatch 
in the codon:anticodon helix. With an error frequency of 10-4, the arginine-to-histidine substitution at 
position 231 (Figure 23, A), referred to as R231H, is much more abundant than any other substitution. 
Notably, different error rates are obtained for EF-Tu purified from different sources. The source of EF-
Tu seems to play an important role in the fidelity of amino acids incorporation. In fact, independently 
of the position of mismatch and position in the protein sequence, the errors quantified in the 
overexpressed EF-Tu are always more abundant than the ones in the wild type protein (median values 
5.8x10-6 and 1.5x10-6, respectively), with a difference that reaches 1 order of magnitude for some 
substitutions at positions K314 (e.g., K314E with an average frequency of 1.7x10-5 for overexpressed 
and 1.3x10-6 for the wild type) and even 2 orders of magnitudes for some substitutions at position 
K249 (e.g., K249Q with an average frequency of 3.4x10-5 for overexpressed and 3.7x10-7  for the wild 
type) (Figure 23). Chromosomally-encoded EF-Tu with the His-tag has an error frequency which is 
intermediate between the overexpressed and the native EF-Tu obtained from the wild type stain. The 
results show that not only our separation and enrichment method achieves a very high sensitivity (< 
10-7), but also that the overall frequency of near-cognate misincorporation varies over orders of 
magnitude and is, in many cases, rather low and much less abundant than reported so far (Edelmann 
and Gallant, 1977; Ellis and Gallant, 1982; Kramer and Farabaugh, 2007; Loftfield and Vanderjagt, 
1972; Parker et al., 1983). The SRM peaks for R231L (Figure 24, A), K249Q (Figure 24, B) and K314Q 
(Figure 24, C) are shown as example. For a more comprehensive list of the spectra refer to the 






Figure 23. Error frequencies of near-cognate substitutions at three positions in EF-Tu.  R231(A), K314 (B) and K249 (C).  The 
results obtained from three types of EF-Tu are reported: wild type chromosomally-encoded EF-Tu from MRE600 (green), 
chromosomally-encoded EF-Tu with a His-tag isolated from K12 (blue), or plasmid-encoded overexpressed in BL21 (DE3) 








Figure 24. SRM peaks for enriched peptides. The peaks for the enriched peptides R231L (A), K249Q (B) and K314Q (C) are 
reported. Co-eluting light and heavy versions of the peptides R231L, K249 and K314Q are identified by SRM. The monitored 
transition for each peptides are reported and the sequence of the peptides, with their fragmentation pattern is shown. A 





2.4.2 Misincorporations involving non-cognate aa-tRNAs 
Given the high sensitivity and dynamic range of the method and the success in the analysis of errors 
resulting from the near-cognate decoding, we expanded our analysis to misincorporations that arise 
at position R231 of EF-Tu when arginine is replaced as a results of all the possible non-cognate 
misincorporations i.e., tyrosine, glutamic acid, aspartic acid, alanine, threonine, tryptophan, 
glutamine, valine, isoleucine and phenylalanine. In some cases, non-cognate substitutions are very 
rare and thus below the detection limit of our method. Some errors could be only quantified in the 
overexpressed EF-Tu, which confirms that its translation is error prone (Figure 25). For the 
overexpressed EF-Tu, the error frequency resulting from non-cognate decoding is comparable to that 
of near-cognate ones (10-5  10-7). It must be noted that for R231E, the observed frequency might arise 
not only from the amino acid substitution, but also from an oxidation of arginine to glutamic acid. The 
PRM traces for R231Q peptide are shown as example (Figure 26), for the other peptides refer to 




Figure 25. Non-cognate amino acid substitutions.  Misincorporations involving non-cognate amino acids were investigated 
at position R231 of EF-Tu. The results obtained from three types of EF-Tu are reported:  wild type chromosomally-encoded 
EF-Tu from MRE600 (green), chromosomally-encoded EF-Tu with a His-tag isolated from K12 (blue), or plasmid-encoded 







Figure 26. PRM analysis of enriched R213Q peptide. Top panel, the sequence of the target peptide. Co-eluting light (left) 
and heavy (B) versions of the R231Q peptide are detected. The list of fragment ions used for the analysis is indicated on the 
right. A rodtp value of 1 confirms the confidence of the detection. 
 
 
2.4.3 Distribution of misincorporations over the EF-Tu sequence 
The reported error frequencies reflect the intracellular steady-state error level, which is the result of 
the accumulation of errors through the different phases of protein synthesis and their removal by 
cellular quality control mechanisms. We next tested whether the observed errors arise during the 
translation phase. The comparison of the error frequencies in  E. coli strains harboring hyperaccurate 
and error prone mutants of the ribosome (with mutations on S12 and S4 protein of the small subunit, 
respectively) and the parental wild type strain (Zaher and Green, 2010a) confirmes that R → H errors 
are introduced by the ribosome (Figure 27). When this type of substitution was investigated at three 
positions of EF-Tu i.e R59H, R231H and R234H, the error- prone strain, which bears less accurate 
ribosomes, showed an increased error rate with a frequency which is almost one order of magnitude 
higher than the wild type, whereas the hyperaccurate strain, whose ribosomes have a higher fidelity, 
shows a lower error frequency. The fact that the error rate is modulated by the ribosome suggests a 







Figure 27. R to H misincorporation measured in error prone, hyperaccurate, and the parental wild type strains. Analysis of 
R to H substitutions in error prone (light blue), wild type (yellow) and hyperaccurate (orange). Error bars represent the 
standard deviation of 3 technical replicates. 
 
Quantification of near-cognate amino acid substitutions at specific positions of EF-Tu allowed us to 
investigate the link between fidelity, type of substitution and codon:anticodon mismatch position. 
However, to understand how errors are distributed along the protein, we expanded our error profile 
analysis to the investigation of R → H substitutions at several positions of the protein sequence (Figure 
28). Out of 21 arginine residues in the EF-Tu sequence, we selected 12 positions for the error 
quantification, while the others had to be excluded from the analysis due to an unsuitable peptide 
length or presence of reactive amino acids which preclude an accurate determination of the error 
(e.g., methionine). For the chosen type of replacement, the error frequency varied over 2 orders of 
magnitude (10-6 – 10-4) depending on the position along the sequence. At most positions, arginine is 
coded by the CGT codon, except for two cases, i.e., R45H and R234H, where the codon is CGC. 
However, codon choice does not appear to correlate with a specific effect on the error rate.  
 
 
Figure 28. R to H misincorporations at several positions of EF-Tu sequence. Distributionof R to H substitutions reveals that 
the errors are unevenly distributed along the sequence independently from the type of EF-Tu used for the analysis: wild 
type chromosomally-encoded EF-Tu from MRE600 (green), chromosomally-encoded EF-Tu with a His-tag isolated from K12 






The analysis of the distribution of R to H substitutions reveals that at four positions of the domain III 
of EF-Tu, R319, R328, R378 and R382 (Van Noort et al., 1986), the error frequency is between 1 and 2 
orders of magnitude lower than at other positions, regardless of the source of EF-Tu. As these 
positions are important for the binding of tRNA, being near the EF-Tu/tRNA  interface (Yikilmaz et al., 
2014) (Figure 29), we hypothesized that errors at these positions may be more rigorously controlled 
than elsewhere in the protein. This may be achieved by a more accurate translation to ensure a low 
steady-state error level, or by applying a more strict quality control to degrade with a higher frequency 
EF-Tu molecules that present these misincorporations and whose functionality might be impaired.   




Figure 29. Position of low-abundance R → H substitution with respect to EF-Tu/tRNA interface. R319, R328, R378 and R382 
residues are indicated in red and are localized near the interface between the protein (dark grey) and the Phe-tRNAPhe (light 
grey) [PDB file 5AFI (Fischer et al., 2015)].  
 
2.4.4 Contribution of quality control machinery to the steady-state error levels 
To investigate whether the differences in error frequencies are caused by translation or by the 
subsequent quality control steps which may selectively degrade some of the peptides, we thought to 
decouple these processes by using an in-vitro translation system that lacks all potential proteases that 




limited amount of protein (~100 pmol/kit), which is far from the amount we use for the 
chromatographic enrichment protocol (4000 - 40000 pmol), we decided to digest the purified in-vitro 
translated EF-Tu after the SDS-PAGE run, and to directly determine the frequency of misincorporations 
without prior fractionation (Figure 30). Because misincorporation-containing peptides are not 
separated from their cognates, and only a modest amount of EF-Tu can be injected for LC-MS/MS 
analysis, only a limited number of positions can be investigated using this procedure, i.e., the ones 
which appear to have the highest error rates. For these errors, the frequencies are ~10-4 and are thus 
comparable with the ones determined in vivo. The similarity of error frequencies in vivo and in vitro 
suggests that misincorporations at some positions are indeed well tolerated and are not removed by 
the cellular quality control mechanisms. Unfortunately, the error frequencies for the positions located 
in domain III remain below the detection limit. Therefore, for these positions the contribution of the 
quality control machinery cannot be directly assessed, but the error frequency remains low even in a 
protease-free environment, suggesting that these errors are rare already at the translation level. 
 
Figure 30. Error frequency in EF-Tu translated in vitro. The error frequency of R → H errors at positions R45, R59, R231 and 
R234 of EF-Tu wild type MRE600 (green), K12 chromosomal his-tag (blue), BL21 (DE3) overexpressed (teal) are compared 
with the EF-Tu synthesized in vitro (magenta). Error bars represent the standard deviation of 3 biological replicates. 
 
To provide a more comprehensive explanation to the high accuracy detected for some positions, we 
tried a further approach where the activity of the quality control machinery is eliminated. We cloned 
the nucleic acid sequences of each one of our low-abundance erroneous peptides into a pSUMO 
vector and overexpressed it to generate a polypeptide product consisting of an N-terminal 11 kDa 
SUMO-tag followed by the EF-Tu FESEVYILSK cognate peptide necessary for the quantification and the 





Figure 31. Schematic view of the pSUMO constructs. The N-terminal SUMO-tag is followed by the cognate FESEVYILSK 
peptide used for the quantification. At the C terminus the specific peptide in which we want to test the misincorporation is 
added (in the reported example the tryptic peptide comprising the amino acid position R231). 
 
 
The SUMO-tag approach is a common technique used in molecular biology to increase protein 
solubility, especially for overexpression procedures (Wang et al., 2010). Our hypothesis is that the 
SUMO-tag might prevent the aggregation and degradation of the EF-Tu peptide attached. A further 
advantage of this approach is that the errors can be studied out of the EF-Tu context, which 
circumvents a potential effect of the nascent chain on the peptidyl transferase activity of the ribosome  
(Ramu et al., 2011). When cloned in the SUMO-constructs, the peptides with the R to H substitutions 
at positions R378, R382 and R328 have up to 10-fold higher error frequency than the peptides 
obtained by overexpression of EF-Tu (Figure 32). Little or no difference is observed at position R319 
and R280, respectively. Surprisingly, translation of pSUMO-R231H peptide is 10-times more accurate 
than overexpressed EF-Tu. While these results suggest that the quality control machinery may acts on 
some of the positions tested, in some cases the effects cannot be unambiguously assigned.  
 
 
Figure 32. Misincorporation frequency in and out the EF-Tu context. R → H error frequency is compared in BL21 (DE3) 
overexpressed EF-Tu (teal) and in pSUMO construct (dark blue). Error bars represent the standard deviation of 3 biological 
replicates. 
 
2.5 Aminoglycosides as a tool to study cellular response and misincorporations 
Aminoglycosides are antibiotics that affect protein synthesis by inhibiting translation and decreasing 
the fidelity of ribosomes. We first examined the proteome response to aminoglycosides by 




treated E. coli MG1655 with increasing concentrations of aminoglycosides and monitored the 
expression of three proteins that were reported to be significantly induced by misfolded proteins and 
aminoglycoside treatment, i.e., heat shock response chaperones IbpA and IbpB, and their transcription 
sigma factor rpoH (Kohanski et al., 2008; Wu et al., 2015). EF-Tu was used as a reference and L10 was 
used to normalize the total amount of protein. For each protein, 2 - 3 peptides are selected and the 
corresponding isotope-labeled standards are spiked in the sample before SRM analysis. For the list of 
peptides used refer to Appendix (Section B). For each antibiotic, the proteome response is plotted 
together with the final optical cell density after 120 min treatment expressed as OD600/ml. In each 
case, the growth inhibition due to the antibiotic activity increases with its concentration. Surprisingly, 
cells grow even at antibiotic concentrations which correspond to the minimal inhibitory concentration 
(MIC) (Gualerzi, 2013; McGaha and Champney, 2007). Conversely to what happens for the 
determination of MIC where the growth inhibition is assessed by an over-night incubation with the 
antibiotic, in our experiment the incubation is much shorter, i.e., 2 hrs, and might be not enough to 
allow the antibiotic to fully enter the cell and lead to its death. Hyg B and Spec, both known to affect 
tRNA translocation rather than decoding fidelity, show the lowest growth inhibition efficacy and no 
stress response stimulation. This is consistent with the notion that error induction is a primary cause 
of the bactericidal effects of aminoglycosides. For other antibiotics a clear induction of the stress 
response is observed and associated with a growth defect. Str and Tob show the strongest induction 
of IbpA and IbpB by approximately 20-fold. Surprisingly, the synthesis of the monitored proteins does 
not reflect the growth defects induced by the antibiotic but their concentration continues to raise 
even after the cell growth is blocked, indicating that it is not an arrest in the protein synthesis that 











Figure 33. Effect of aminoglycosides on the cellular response and the steady-state error level. A) Changes in the 
concentrations of stress response proteins. B) Error frequency at increasing concentration of antibiotic. Error bars 




In order to correlate the cellular stress response with the increase of error frequencies, we then 
selected seven EF-Tu peptides based on our data-dependent results and determined their error 
frequencies in the same samples used for the proteome change analysis (Figure 33, B). The high 
abundance of EF-Tu in the lysate allows for the direct quantification of the more abundant errors in 
the protein without requiring the enrichment procedure. The error frequencies induced by most 
aminoglycosides, exception made for Spc, depend on the antibiotics concentration and increase by 
one order of magnitude in the presence of the antibiotic from 10-4 to > 10-3. However, the error 
induction does not affect all amino acid substitutions in the same way and some misincorporations 
appear to be more enhanced than others. With Str, which induces the highest levels of 
misincorporations, the frequency of E → D substitutions increases by almost 100-fold, whereas the 
induction of R → H errors is much milder, barely 10-fold. Surprisingly, in some cases the induction of 
errors does not reach a stable plateau but rather reaches a maximum to then decrease as if, during 
the antibiotic treatment, some cells are able to adapt to the increasing level of errors, e.g., by 
producing more chaperones, already observed to be induced during the treatment, or proteases. In 
this scenario, these cells would be able to remove error-containing proteins and this could explain the 
decreased error frequency observed. However, also with this kind of adaptive behavior, only a certain 
error threshold can be tolerated and a growth defect is observed. Overall, our analysis demostrates 
that the imprint of aminoglycosides on the proteome accuracy is far more complex than expected and 
that their phyisiological and biochemical effects depend on the type of aminoglycoside used.  
To gain a deeper understanding of aminoglycosides effect, we compared the errors induced by 
different antibiotics. The error profile induced by the treatment appears to vary depending on the 
type of antibiotic used (Figure 34, A) and in some cases aminoglycosides which belong to the same 
class are found to induce the same set of errors. The most evident example comes from the 
comparison of the structurally related Tob and Kan A, both belonging to the class of 4,6-disubstituted 
aminoglycosides, for which the error induction pattern is almost identical (Figure 34, B). On the other 
hand, the comparison of the structurally different Hyg B and Str shows that their effects are different 
(Figure 34, C), suggesting that the stimulation of specific misincorporations can then be seen as a 






Figure 34. Comparison of error profiles induced by different aminoglycosides. Different errors are stimulated to a different 
extent depending on the type of aminoglycoside used (A). Structurally related aminoglycosides such as tobramycin and 
kanamycin A (B) share similar error pattern (Pearson r= 0.9535, P value= 0.0002) while structurally distant aminoglycosides 
such as streptomycin vs Hygromycin B show a weaker correlation (Pearson r= 0.01297, P value= 0.9757) (C).  
 
2.5.1 The complex error signature of aminoglycosides 
2.5.2 Validation of doubly-substituted peptides by PRM analysis 
After we determined the conditions of maximal error induction for all aminoglycosides, we collected 
the data on the individual error profiles for a given antibiotic in a more comprehensive way by data-
dependent acquisition (DDA) (data not shown, courtesy of Dr. Ingo Wohlgemuth). In order to 
maximize the dynamic range at the MS1 level and reduce the interference by other proteins, we 
decided to analyse affinity-purified endogenous EF-Tu. Surprisingly, some of the misincorporation-
containing peptides identified by DDA contained more than one amino acid substitution. This is 
remarkable because the theoretical error frequencies calculated on the basis of the individual error 
frequencies are so low that peptides with more than one misincorporation are unlikely to be detected 
in the linear dynamic range of current mass spectrometers. In addition, the identification of amino 
acid substitutions in DDA is usually affected by false positive results, and the presence of multiple 
substitutions can further increase the false discovery rate. Thus, to exemplarily verify our 




reaction monitoring (PRM) (Figure 35). To exclude a potential impact of the C-terminal His-tag used to 
enrich EF-Tu for data-dependent analysis, we analysed EF-Tu in the lysate of wild type strain MG1655. 
While the double error was not detectable in the absence of Str, the abundance of the E308-Y310H 
peptide increased with the increasing Str concentration. This allowed us to unambiguously identify 
the double misincorporation based on its ratio dot product of 0.99. In order to test whether double 
misincorporations are common in the aminoglycoside treated samples, we studied EF-Tu in MG1655 
cells treated with three different aminoglycosides from different classes. Consistently, the double 




Figure 35. Verification of double-substituted peptide E308D-Y310H by PRM. The sequence of the peptide and its 
fragmentation patter. The presence of the peptide was determined in the wild type MG1655 cells treated with increasing 
concentration of Str (upper panel) or various amingoglycosides (bottom panel). For each reported condition, the same 
amount of sample is injected into the instrument. The elution profile of the isotope-labeled reference peptide (AQUA) is 




Once we assessed the presence of doubly-substituted peptides by PRM, we systematically analysed 
and quantified their pattern. We selected the model peptide FESEVYILSK for analysis because it has an 
optimal peptide stability, chromatographic behaviour, amino acid composition and ionization 
properties. Chromosomally-encoded His-tag EF-Tu was purified from cells grown with and without Str, 
and the error-containing peptides were enriched and ultimately identified and quantified by SRM 
(Figure 36). Double errors could not be found in the cells grown without Str suggesting that they are 
rare events. The signal for the respective peptide is under the detection limit of the assay and was 
calculated by peak integration on a high noise background. Thus, the reported values represent the 
upper limit of the error frequency rather then a defined error frequency. Incorporation of double 
errors become more frequent after Str treatment and their frequency, about 10-5, is comparable with 
the rate of the respective single errors (Figure 37). In addition, when we extended our measurements 
to other positions of the peptide we managed to quantify all the double errors included in the analysis 
(Figure 38). This suggests that the incorporation of multiple errors is not restricted to specific positions 
but is rather a generalized phenomenon. The high abundance of the double errors prompted us to 
also test a peptide that contained three misincorporations (E306D-E308D-Y310H). As expected, the 
peptide could not be detected in the untreated sample but could be easily quantified in the 
streptomycin-treated sample.  
Once the mono-substituted peptides are quantified, the estimated frequency of the independent 
incorporation of double and triple erros can be calculated in the following way: 
 
 𝑃(𝐸𝑚𝑢𝑙𝑡𝑖𝑝𝑙𝑒 ) = 𝑃(𝐸𝑓𝑖𝑟𝑠𝑡) ×  𝑃(𝐸𝑠𝑒𝑐𝑜𝑛𝑑) × 𝑃(𝐸𝑡ℎ𝑖𝑟𝑑) (2) 
 
Where Emultiple is the frequency of conseutive errors and Efirst, Esecond and Ethird the frequencies of the 
first, second and third error, respectively. Comparison between the error frequency obtained by SRM 
analysis and the predicted error frequencies, assuming that each misincorporation event is 
independent, revealed that the double errors are remarkably more abundant (10 - 1000-fold) than 
expected. This strikingly higher abundance can be explained as if double and triple errors do not occur 
independently; rather, their incorporation is synergistic.  
Several mechanism for the synergistic appearance of errors exist. The first misreading event and 
the presence of errors in the protein nascent chain might alter the A site and induce further errors. 
Alternatively, the codon-anticodon mismatch in the P site, which results from the miscoding event, 
could distort or displace the peptidyl-tRNA in the P site rendering the ribosomal A more prone to 
accept incorrect tRNAs. A similar mechanism was proposed as a mechanism of post-transfer editing 




due to stable binding of the aminoglycoside to the ribosome which, persisting for several rounds of 




Figure 36. SRM quantification of double and triple errors. The peaks for the enriched peptides E306D-Y310H (A) and E306D-
E308D-Y310H (B) are reported. The SRM signals for both light and heavy-labeled are reported. The monitored transition are 






Figure 37. Example of quantification of double and triple errors. SRM analysis of error frequencies for E306D-Y310H (A), 
E308D-Y310H (B), E306D-E308D (C) and triple error E306D-E308D-Y310H (D). Each plot shows the frequency of the single, 
double, and where indicated triple errors for the purified chromosomally-encoded EF-Tu with a His-tag from K12 cells grown 
with and without Str. The theoretical error frequency of independent double and triple errors is indicated in the chequered 
bars. The red line represents the detection limit of the measurement. Error bars represent the standard deviation of 3 




Figure 38. Abundance of the single, double and triple errors in one peptide.  Frequency of single (green), double (blue) and 
triple (red) misincorporations. The sequence of the peptide togheter with the residue positions is indicated on top. Arrows 
indicate the increase in the error frequency in the absence (arrow´s tail) and in the presence of 8 µM streptomycin (arrow´s 
head). In some cases, the error frequency for the wild type strain is below the detection limit, and the reported value is an 
estimation of the upper limit of the peptide´s concentration (  ). JPT peptides are indicated in bold. Dashed lines connect 
single-substituted peptides with their respective double-substituted peptide. Error bars represent the standard deviation of 




To test whether misincorporations in the nascent chain, mismatches in the codon-anticodon 
interaction or the presence of the aminoglycoside lead to double misincorporations, we tested error 
incorporations in an aminoglycoside-independent system. We purified wildtype EF-Tu from the rpsD 
strain containing error-prone ribosomes. These ribosomes harbour a mutation in the ribosomal 
protein S4 which affects the initial selection phase of decoding reducing the stability of the 
codon:anticodon complex with a near-cognate aa-tRNA and accelerating the subsequent step of 
GTPase activation (Zaher and Green, 2010a). For comparison, we prepared EF-Tu from the respective 
wild type strain in the presence of Str (Figure 39). Str was titrated to match the level of single 
misincorporations found in EF-Tu from the error-prone strain, which was achieved at 4 µM Str. We 
selected three double misincorporations for the enrichment, E306-Y310H, E308D-Y310H and E306D-
E308D. The experimentally determined rate for double-substituted peptides in the wild type strain 
shows that, in all cases, the calculated frequency ranges between 10-5 - 10-4 and is about 2 orders of 
magnitude higher than the theoretically estimated value, suggesting the existence of a mechanism 
that promotes the incorporation of the second error. In the error-prone strain, the error frequency of 
double-substituted peptides remains below the detection limit of the instrument and, as for the wild 
type strain in the previous experiment, their determination is rather an estimation of the upper limit 
of their concentration based solely on the background noise detected, rather than an accurately 






Figure 39. Quantification of single and double errors. Incorporation of E306D, E308D, and Y310H is measured in wild type 
in the presence of 4 µM Str in error prone strains. In each plot the error rate for the single error is shown (light blue and 
brilliant blue). The incorporation of their respective double error is monitored and indicated as follows: E306D-E308D (A), 
E360D-Y310H (B) and E308D-Y310H (C). Estimated (chequered) and calculated (dark blue solid) error frequencies. Detection 






3.1 Method development to study rare translation errors 
Incorrect mRNA decoding is a rare event, occuring with an estimated frequency of 1 error every 10000-
100000 decoded codons (Table 1 and Table 3) and misincorporation-containing peptides are present 
in the cell in an extremely low abundance with respect to the correct ones. For this reason, their 
detection is challenging and their comprehensive investigation requires the development of a high-
sensitivity detection method.  All the mass spectrometric data obtained so far on amino-acid 
misincorporations rely on data acquired by DDA analysis. Although DDA can provide a wider set of 
results than targeted mass spectrometric approaches, it is limited not only by the intrinsic lower 
sensitivity (Michalski et al., 2011; Sandhu et al., 2008) but also by the necessity to interpret the data 
by spectral matching algorithms (Cox et al., 2011; Eng et al., 1994; Perkins et al., 1999; Shilov et al., 
2007; Zhang, 2009), which might not be optimal for the analysis of isobaric amino acid 
misincorporations (see Introduction).  
Analogous challenges can be found in the protein biomarker discovery, where the low-abundance 
of the target protein and the high complexity of the sample i.e., body fluids, make the identification 
of the biomarkers extremely difficult (Surinova et al., 2011). In this field, targeted mass spectrometry 
finds large application and SRM is often applied due its high selectivity and reproducibility. However, 
because the dynamic range required for the detection often exceeds the dynamic range of currents 
mass detectors, SRM is often combined with separation techniques, e.g., immunodepletion, size-
exclusion chromatography (Liao et al., 2004), gel electrophoresis (Ang and Nice, 2010), aimed to 
reduce the complexity of the sample and eliminate high-abundance proteins that would otherwise 
hinder the efficient identification of the low-abundance biomarkers. The combination of these 
techniques with the use of heavy-labeled standards (AQUA peptides) have led to further advance of 
mass-spectroscopy in this field (Shi et al., 2012).   
Given the robustness, sensitivity and reproducibility of biomarker-oriented approaches for the 
quantification of proteins, we have adapted its strategy of target separation and mass spectrometry 
to develop an assay for the systematic investigation of peptides which contain amino-acid 
substitutions. As biomarker quantification approaches, our assay relies on the enrichment of target 
peptides by separating the error-containing peptides from the more abundant correct ones. The 
peptides enrichment and reduction of the sample complexity allows to load more target peptides on 
the LC-MS/MS system leading to higher signal intensities. Moreover, endogenous and AQUA peptides 
co-elute during several subsequent chromatographic rounds of separation and co-fragment, yielding  
a high confidence assignment. Thus, together with the validation of our results by high resolution mass 




than the traditional DDA data. In addition, the use of AQUA peptides as internal standards solves 
quantification problems of data-dependent approaches which are related to the performance 
variations of ESI stability or to the different ionization properties of cognate and misincorporation-
containing peptides. 
The disadvantages of the method are the laborious peptide enrichments, the necessity for assay 
optimization for each peptide to enrich, and the high costs of commercial peptide synthesis which 
limit the number of peptides that can be analyzed and preclude a broad or even proteome-wide 
analysis. These problems are especially aggravated when peptides of interest cannot be selected on 
the basis of previous experiments or published data. In such cases, after AQUA synthesis and 
enrichment procedures, the target peptides may turn out to have poor ionization properties, being 
undetectable in both their light and heavy forms or simply not informative, being the light counterpart 
too rare to be detected.  
Our assay provides an unprecedented flexibility in the choice of misincorporations to study 
because it allows to study most of the miscoding events which are imprinted in the amino acid 
sequence of the protein of choice, independently from reporter systems and types of substitution, as 
demonstrated for the quantification of several consecutive miscoding events (Figure 38). In this 
scenario proteomics can be considered as single molecule technique in which the translation process 
carried out by individual ribosomes can be studied, although this single molecule character is clearly 
only conserved within the individual tryptic peptide. In addition, the present approach allows to 
quantify different miscoding and misincorporation events in parallel or even correlate miscoding 
events with the cellular response, e.g., changes in the expression of proteins involved in the stress 
response.  One other important advantage of the mass spectrometry-based assay is that, the 
sensitivity is significantly increased with respect to the other approaches and that the noise is 
extremely low and can be distinguished from the signals of the target peptides, even when the latter 
are present at very low concentrations (10-7). In contrast, in fluorescence-based assays which are 
commonly used to study amino acid substitutions  (Kramer and Farabaugh, 2007; Kramer et al., 2010), 
there is often a background fluorescence (10-4) either due to the experimental setup or to a residual 
fluorescence of the mutated reporter proteins which cannot be avoided and which inevitably limits 
the dynamic range of the method. The pseudo-linear quantification of the biomarker approach 
presented here has, at least theoretically, no limit in the dynamic range, because, more starting 
material could be used for the analysis and the peptides could be separated by several orthogonal 
chromatographic steps for a better enrichment. However, the high sample losses which occurs at 
individual chromatographic dimensions and the limited numbers of truly orthogonal chromatographic 




although this limit strongly depends on the individual peptide sequences. Finally, peptides with almost 
identical physicochemical properties to the cognate ones could be difficult to separate by any 
chromatographic step and might require additional rounds of chromatography (Figure 16) or even 
remain undetected, independently of their frequency.  
 
3.2 Misincorporations are rare and occur less frequently than expected 
The systematic investigation of misincorporations has revealed that on average errors of translation 
can be much less frequent than currently described in literature. We could quantify errors occurring 
with a frequency as low as 10-7, reaching a level of sensitivity which is not achievable by other 
methods. The calculated median for the error frequency of near-cognate substitutions at three 
positions of EF-Tu (Figure 23) was 10-6. Thus, the expected higher error frequency introduced by 
translation is not reflected in the cellular steady state error level, and even R → H substitutions, the 
most abundant type of misincorporation (Manickam et al., 2014; Zhang et al., 2013), occur with a 
frequency between 10-6 - 10-4 in wild type EF-Tu (Figure 28), a result which matches the error frequency 
estimated for transcription (Table 2). Most likely, this discrepancy between the different estimations 
of error frequencies is the consequence of a lower sensitivity of the methods employed so far, which 
enabled the identification of only the most abundant errors, leading to an incomplete and biased 
picture of the translational error frequency landscape. This is supported by the results we obtained 
from the analysis of error incorporation during aminoglycosides titration.  After the addition of the 
antibiotic to the growing cells, the studied misincorporations approach a range between 10-5 - 10-3 
(Figure 33, B) which matches the range of errors reported for cells under optimal growth conditions 
(Table 1) and supports the scenario in which the error frequency of translation is lower than previously 
estimated, but its accurate detection was hampered by the limited sensitivity of the methods used. 
 
3.3 Error rate depends on the protein source 
Strikingly, regardless of the type of amino acid substitution, codon involved, mismatch and amino 
acid position, overexpressed EF-Tu always displayed a higher frequency of error incorporation. In 
contrast, wild type and chromosomally-encoded His-tag proteins showed a comparable error 
frequency confirming that the His-tag we inserted in the chromosome is well tolerated (Figure . The 
reduced accuracy of translation during recombinant-protein production is a known phenomenon 
(Scorer et al., 1991) and different explanations might be envisioned. The presence of the plasmid 
already constitutes a significant metabolic burden for the organism which, to maintain it, is usually 
grown in the presence of an antibiotic and faces the energy costs of the synthesis of the protein 




et al., 1990) and might originate from a combination of nutritional imbalance and competition for the 
expression machinery, which in turn could increase the frequency of random translational errors. The 
type of plasmid used for the overexpression may also play a role. The pET vectors we used for the 
overexpression are commonly utilized in molecular biology for the expression of recombinant 
proteins. However, their use is also associated with the cellular proteome imbalance caused by the 
very high amount of mRNA that accumulates in the cells and the resulting very high yield of the 
encoded overexpressed protein, which can reach as high 40 - 50 % of the total cell protein content. 
The presence of the pET plasmid alone (i.e without the cloned gene to be overexpressed) can be toxic 
in E. coli in the presence of IPTG (Miroux and Walker, 1996). IPTG itself has been demonstrated to be 
harmful for E. coli BL21 (DE3), the host strain which is often employed for protein overexpression 
(Dvorak et al., 2015). In addition, pET vectors are transcribed by T7 RNA polymerase. Although this 
polymerase has an estimated error frequency comparable to the bacterial one (10-4 and 10-4 - 10-5, 
respectively (Huang et al., 2000)), it cannot be excluded that an increased error rate generated by the 
overexpression stress affects T7 polymerase fidelity leading to an increase of transcriptional errors 
which are then manifested in translation. A plausible alternative explanation includes a depletion of 
the aa-tRNA pools caused by the high demand of substrates for the protein synthesis.   
Protein overexpression is known to induce the cellular stress response and the expression of 
proteases and chaperones as well as many proteins involved in the SOS regulatory system for nucleic 
acid damage repair (Gill et al., 2000). A limited capacity of the chaperone system to mediate the proper 
folding as the protein copy number dramatically increases could also induce the  accumulation of more 
erroneous proteins. 
In our setup, another source of error incorporation might stem from the type of antibiotic used to 
select the plasmid-containing cells (i.e., Kan), which is long known to induce miscoding (Davies et al., 
1965b; Tanaka et al., 1967) and which could contribute to an overall decrease of the ribosomal fidelity, 
as observed during Kan treatment (Figure 33, B). In pET vector-containing cells, the Kan resistance is 
conferred by the expression of aminoglycoside phosphotransferase which modifies and inactivates 
the antibiotic after it enters the cell (Wright, 1999), so that a residual miscoding activity of Kan cannot 
be excluded. 
Our results revealed that overexpressed EF-Tu is also more prone to non-cognate amino acid 
substitutions (Figure 25), which are for the first time quantified in vivo. Surprisingly, the frequency of 
errors due to non-cognate decoding ranges between 10-7 - 10-4, and is similar to that of the near-
cognate one. This may be a result of the strongly depleted pool of cognate tRNAs caused by the 
overexpression. However, not every possible non-cognate substitution are frequent enough to be 




3.4 Error variation and distribution 
Among the missense errors studied here, R → H substitutions are the most frequent types of errors. 
This results can be explained by the nature of the codon-anticodon mismatch that generates this 
replacement, the G-U mismatch that is reported to increase the error frequency (Westhof et al., 2014). 
Whereas in literature it is reported that different error frequencies are associated to the position 
of the mismatch at the codon:anticodon duplex, (Gromadski et al., 2006; Manickam et al., 2014; Zhang 
et al., 2016), our results reveal that no correlation between the error frequency of amino acid 
incorporation and the mismatch can be observed. When we compare our results to in-vitro data, the 
difference might be explained by the activity of the cellular quality control activity in vivo which is 
obviously not present in the in-vitro experiment and which might acts on erroneous peptides 
equalizing them. The difference to the in-vivo results can be also easily explained. The difference with 
the error frequency levels reported by Farabaugh and collegues (Kramer and Farabaugh, 2007; 
Manickam et al., 2014) can be caused by the specific experimental setup used in their work. Their 
system is based on the use of β-galactosidase, in which the catalytic glutamic acid residue (E537) is 
mutated to a set of possible near-cognate codons, causing a reduced activity of the protein. Amino 
acid substitutions are then investigated by monitoring the gain in activity caused by the replacement 
of the near-cognate mutated amino acid back to the wild type glutamic acid. This means that their 
quantification considers  the wild-type protein, whereas in our case we quantify the errors on the base 
of the abundance of a mutated protein, which may be partially degraded due to the quality control 
activity. In addition, we have to consider that, Manickam´s results for first-, second- and third-position 
mismatch errors are based on amino acid substitution at only one position of the protein and our data 
extend to only 3 amino acids positions (R231, K314 and K249). In both cases the results may be not 
completely representative of the general error rate frequency for various mismatches.  In other cases 
e.g., (Manickam et al., 2014; Zhang et al., 2013), discrepancies might be explained by their choice of 
monitoring the accuracy of heterologous proteins which are normally not expressed in E. coli and 
which might be encoded by codons which are not optimal for the bacterial translation system, leading 
to an increased error frequency.  
Analysis of the distribution of R → H substitution at 12 different positions suggests that the location 
in the protein and the context have a strong influence on the error frequency and the synthesis at 
some region of the protein, e.g., between residues 319 and 382, can be more accurate than at others 
(Figure 28). In EF-Tu, the least frequent substitutions are localized in a region which is important for 
the binding aa-tRNA (Yikilmaz et al., 2014) and might suggest that the proteins bearing amino acid 
replacements at these positions are unstable and are preferentially removed by the quality control 




translation system (Figure 30). Unfortunately, low-abundance error containing peptides could not be 
detected in vitro due to the low yield of in-vitro translation. When a general effect of the nascent chain 
and sequence context on the translation was studied (Figure 32) a  general reduction of accuracy was 
observed at these positions but whether the lower error frequency observed in figure 28 is an effect 
caused by the quality control activity or an intrinsic higher accuracy of the ribosome, remains difficult 
to discriminate.  
 
3.5 Stress response and error profiles induced by aminoglycosides 
The effect of aminoglycosides on translation is well established  (Anderson et al., 1967; Davies et al., 
1965a), and consistent with previous reports, all the aminoglycosides we tested, except Spc,  induce 
miscoding (Figure 33,B) (Bilgin et al., 1990; Borovinskaya et al., 2007b; Carter et al., 2000; Peske et al., 
2004). Among the miscoding-inducing aminoglycosides, Apr merits a special comment. At the time of 
its discovery in 1978 (Walton, 1978) a concentration-dependent miscoding effect was demonstrated 
(Perzynski et al., 1979). However, a recent study of  its effect on the frequency of R → H substitutions 
in vivo suggested that Apr has no effect on the fidelity of either bacterial or mitochondrial ribosomes 
and that the lack of the miscoding activity may be the reason for its reduced ototoxicity (Matt et al., 
2012). These findings were recently confirmed in vitro by a combination of single molecule 
fluorescence, NMR and bulk kinetics approaches (Tsai et al., 2013). Puglisi and colleagues concluded 
that Apr does not induce miscoding but it rather inhibits cell growth by blocking translocation. Instead, 
our data clearly show that Apr induces a significant level of miscoding, including errors of R → H 
substitutions. Apr also induces a concerted expression of IbpA and IbpB, whose expression is 
associated with erroneous proteins synthesis (Ruan et al., 2008) (Figure 33, A). Moreover, although 
for Apr the error frequency of single misreading events was lower than with Par, Tob, or Str (Figure 
33, B), the level of consecutive miscoding events was comparable (Figure 35), indicating that the 
contribution to the incorporation of multiple errors of Apr might be higher than those of Par, Tob and 
Str. The disagreement with the results by Matt et al. can be explained by the narrow range of Apr 
concentrations used in their experiments (0 - 10 µM) and the combination with an assay which has a 
limited dynamic range and a low sensitivity, as the detection of fluorescence of Luciferase protein. 
Overall, our data also revealed that as a result of the antibiotic treatment, the induction of 
intracellular error levels is also associated with a cell growth defect. The antibiotic-induced error 
frequency  ranges between 10-5 - 10-3 (Figure 33, B). Interestingly, each aminoglycoside has a unique 
pattern of induced error frequencies for different types of amino acid substitutions, which constitutes 
a miscoding-fingerprint of the antibiotic (Figure 33, A) and supports the notion that the mechanism of 




cellular outcome in terms of  error frequency depends on the effect of the antibiotic on the elemental 
rates of decoding (Gromadski and Rodnina, 2004b; Pape et al., 2000) and on structural and dynamic 
changes of the ribosome induced by the antibiotic binding (Carter et al., 2000; Demirci et al., 2013a). 
Surprisingly, the error frequencies observed in response to the antibiotic treatment are remarkably 
similar to those observed in the error prone strain (Figure 39). However, the growth defects of wild 
type cells observed in the presence of antibiotics are not found in the error prone strain. 
Aminoglycosides treatment induces the incorporation of consecutive errors, which are detected in 
aminoglycosides-treated cells but not in the error-prone strain. These multiple replacement in a single 
polypeptide chain may have a stronger toxic effect on the cell than single substitutions. Not 
surprisingly, the increased level of errors is associated with an increased expression of the proteins 
involved in the cellular stress response, such as IbpA and IbpB, whose induction is usually associated 
with the presence of aggregated misfolded proteins that accumulate as a consequence of the 
antibiotic treatment (Laskowska et al., 1996), although this effect is not observed in Spc-treated cells, 
where no fidelity defect is observed. In contrast to what happens for IbpA and IbpB, the concentration 
of the transcription factor rpoH, which regulates the expression of IbpA and IbpB, remains constant 
upon aminoglycoside treatment, consistent with the notion that rpoH expression increases only after 
a temperature shift (Erickson et al., 1987) and that the expression of heat-shock proteins may be also 
mediated by other transcription factors or other metabolic signals, as proposed in literature 
(Kuczynska-Wisnik et al., 2001).  Surprisingly, although Gen is known to induce significant miscoding 
(Tsai et al., 2013), only a minimum effect on the stress response is observed in Gen-treated cells 
(Figure 33, A). Although the error profile for Gen is not available yet, the lack of stress response 
induction could be explained by the high efficiency of Gen cellular uptake which might lead to a fast 
cell death which leaves no time for the stimulation of IbpA and IbpB expression. 
Notably, for many aminoglycosides such as Kan A, Tob, Par, Rib and Str, the expression levels of 
chaperones increase even when cells already display a strong growth impairment (Figure 33, A), 
suggesting that even when the cell growth is reduced, cells continue to actively translate the stress 
response proteins necessary to mediate correct protein folding and reduce their aggregation. In those 
cases where a stress response is observed, this increase reaches a maximum and then decreases with 
the error level. We hypothesize that as soon as aminoglycosides are added in the medium, the small 
amount of antibiotic which is able to enter the cells acts on the ribosome inducing miscoding and 
stimulating the expression of stress response proteins. When the intracellular concentration of 
aminoglycoside has reached a critical point, translation is completely inhibited (Tsai et al., 2013) and 





In our experiments with aminoglycosides, cells grow even at antibiotic concentrations which 
exceed the estimated MIC values (Figure 33, A). Such discrepancy might be explained by differences 
in the experimental setup. To determine the MIC values, bacteria are inoculated at low cell densities 
into a medium which is already supplemented with different concentrations of antibiotic and their 
growth is assessed after a very long incubation time (usually 16 - 20 hrs) (Wiegand et al., 2008). In our 
assay, exponentially growing cells at high cell density are monitored for a shorter time window (2h). 
Because the uptake of aminoglycosides is slow, the external and cellular aminoglycoside 
concentrations might not be equilibrated. Thus, higher concentrations may be necessary to 
completely suppress cell growth, far above the MIC values. Because the efficient uptake of the 
antibiotic increases with the incorporation of error-containing proteins into the membrane, 
aminoglycosides which do no induce significant miscoding (e.g., Spc, Hyg B) become inhibitory only at 
very high concentrations.  
 
3.6 Quantification and induction of miscoding pattern  
The aminoglycosides treatment has allowed us to identify a pattern of multiple miscoding events in 
EF-Tu. These consecutive misincorporations remain below the detection limit in the wild type cells but 
become more frequent after aminoglycoside-treatment (Figure 37, 38, 39). Their frequency is higher 
than expected for uncoupled independent events (Equation 2). We note that at the conditions of error 
accumulation, prediction of error frequencies may become a problem, unless the peptides with single 
substitutions are less abundant than the correct peptides (Equation 1).  If the error frequencies of the 
individual errors would be higher, and comparable to the cognate peptide, the frequencies of the 
cognate peptides and all its derivatives would have to be summed up to properly reflect the protein 
concentration. This would be particularly important when these values are used to predict the 
probability of two independent errors in a single peptide. However, even when cells are treated with 
high concentrations of aminoglycosides, the frequency of single errors never exceeds 10-3 (Figure 33, 
B) and the stochastic occurrence of consecutive errors can be considered negligible. Notably, 
consecutive errors are not detectable in the absence of aminoglycosides and thus can be attributed 
to the action of the antibiotics. Due to the vectorial nature of protein synthesis, the incorporation of 
consecutive C-terminal errors must depend on the first N-terminal miscoding event.  
To explain the observed effect of antibiotics on error propagation, different mechanisms can be 
envisioned. First, the first miscoding event itself might induce subsequent errors and the error 
propagation could be mediated by misincorporations in the nascent chain or by distortion of the P-
site tRNA introduced by codon:anticodon mismatches (Zaher and Green, 2009). Stalling peptides such 




regulator, i.e., erythromycin (Ramu et al., 2011). If an incorrect aa-tRNA binds to the A site and is 
translocated to the P site after peptide bond formation, the misalignment of the P-site tRNA due to 
mismatches in its codon:anticodon interaction can elicit error-prone decoding (Zaher and Green, 
2009, 2010b, 2011). This, in turn, promotes a rescue mechanism of sense codon reading by a 
translation termination factor, which stops translation of a peptide in which several consecutive error 
have already occurred. Importantly, this mechanism is supposed to increase fidelity by the preferential 
release of the highly erroneous peptides from the ribosome. Alternatively, consecutive 
misincorporations could be introduced by the presence of aminoglycosides that remain bound to the 
ribosome decoding center during several elongation cycles. Notably, the three proposed mechanisms 
are not mutually exclusive but could act synergistically. The absence of detectable error propagation 
during translation by the error-prone ribosome indicates that the proposed error-propagation 
mechanism depends on the presence of antibiotics which leads to the incorporation of consecutive 
misincorporations. Importantly, mutations that make the ribosomes error-prone do not interfere with 
the selection mechanism proposed by Green and colleagues (Zaher and Green, 2010b).  
Further indications for the sources of multiple errors come from the analysis of the 
misincorporation pattern of E306D-Y310H peptide, in which the first miscoding event (E → D 
substitution) is followed by the correct incorporation of S, E, and V (Figure 38), followed by a Y → H 
substitution. Because there are multiple isoacceptor tRNAs that can deliver S and V (6 and 3 
isoacceptors, respectively), we cannot exclude that the correct amino acid is delivered by a an 
isoacceptor that is near-cognate to the given codon However, the correct incorporation of E, which 
has only one isoacceptor, must definitely be the result of a cognate tRNA, which should terminate the 
P-site-induced error-prone decoding. Thus, we suggest that consecutive miscoding events are most 
likely introduced by aminoglycosides. In this case, the propagation efficiency should depend on the 
balance between the speed of elongation and the dissociation rate constant of the respective 
aminoglycoside. Over several elongation cycles after the initial misincorporation event, 
aminoglycosides should dissociate and the error propagation effect should drop dramatically 
approaching the low level given by the stochastic occurrence of the single errors. However, for the 
quantified consecutive misincorporation events, the error-propagation efficiencies are rather 
constant, between 3 and 10 % (Figure 40) and almost independent of the EF-Tu source, antibiotic 


























































































Figure 40. Frequencies of multiple consecutive errors. EF-Tu purified from K12 chromosomal-tag cells grown in 8 µM 
streptomycin (filled bars) or from wild type cells grown in 4 µM str (striped bars). 
 
Assuming an elongation rate of 10 amino acids per second (Young and Bremer, 1976), this implies that 
to induce several consecutive errors, Str has to be stabily bound to the ribosome for at least 0.5 
seconds. Due to the absence of kinetic data for the dissociation rate constants of aminoglycosides 
from the ribosome, the plausibility of this hypothesis is hard to evaluate. Notably, the error 
propagation efficiencies of E308D → Y310H and E306D-E308D → Y310H (Figure 40) are identical and 
thus the consecutive introduction of misincorporations is not additive or cumulative, and is consistent 
with a model in which the second misincorporation solely depends on the presence of the antibiotic.  
Notably, all multiple-substituted variants of the target peptide FESEVYILSK we tried to enrich were 
successfully detected in Str treated samples. When the contribution of the consecutive 
misincorporations relative to the single substitutions is inspected for individual residues (e.g., E306D, 
Figure 41, A) it  becomes clear that a significant part of the errors is involved in multiple errors patches 
(>15 %). This number is likely to be an underestimation because only a very small subset of all possible 
error combination has been taken into consideration in our experiments (Figure 41, B). The proposed 
mechanism implies that aminoglycosides whose binding to the ribosome lasts longer should induce a 







Figure 41. Significance of complex miscoding patterns. A) Relative contribution of consecutive misincorporation as 
quantified for the E306D peptide in EF-Tu with chromosomal tag from K12 cells grown in the presence of 8 µM Str.  B) All 
possible near-cognate replacements for the model peptide and the possible combinatorial expansion of consecutive 
misincorporation events. 
 
The qualitative contribution of error patches to protein structure can be very severe. Sequential 
misincorporations are most likely far more detrimental to the functional and structural integrity of 
proteins than single substitutions. The structural destabilization by multiple mutations may increase 
exponentially with the number of misincorporations. Membrane insertion of proteins that have a 
single incorrect amino acid can already have a dramatic impact on the integrity of the membrane. This 
is demonstrated by the importance of positively charged residues in membrane-spanning polytopic 
proteins, which are well tolerated when facing the cytoplasm, but are avoided in transmembrane 
regions. Their correct distribution constitute the major determinant in protein topology (von Heijne, 
1989) and substitutions affecting these residues are likely to cause structural problems and incorrect 
folding. Proteins with two or more replacements, as it happens upon aminoglycosides treatment, can 
have even more severe effects. 
In summary, the preferential aminoglycoside-mediated induction of certain types of 
misincorporations, e.g., E → D (Kramer and Farabaugh, 2007) (Figure 32, B), in combination with the 
discovered error propagation mechanism will most likely lead to complex misincorporation patterns 
and ultimately to error hotspots in protein sequences. Such error hotspots, in combination with the 
varying tolerance towards mutations in different proteins or parts of proteins, may explain why only 
a small subset of proteins is overrepresented in streptomycin-induced aggregates and inclusion bodies 
(Ruan et al., 2008). It is not yet clear to which extent multiple misincorporations contribute to the 
bactericidal efficacy of AGs in prokaryotes or to the oto- and nephrotoxicity in human cells. If the error 




aminoglycoside-based treatment of genetic disorders. While the curative effect is based on the 
readthrough of accidentally introduced stop codons, complex misincorporation pattern are not 
intended and may be responsible for parts of the side effects. Thus, a better molecular understanding 
of the underlying mechanisms of error-propagation effects might help to uncouple the induction of  
single substitutions and error-propagation events.  
Our findings on the mechanism of aminoglycosides-mediated bactericidal effects can be 
incorporated into the existing model for the aminoglycoside bactericidal mechanism (Davis, 1987). 
During aminoglycoside treatment, only a small amount of the antibiotic can initially enter the cell, 
where it interacts with ribosomes reducing their translational fidelity and inducing miscoding. When 
erroneous and potentially unfolded proteins are inserted in the membrane, this causes the formation 
of channels and favors membrane damage enhancing the intake of more aminoglycoside into the cell. 
When erroneous protein begin to appear, the ribosome  induces multiple sequential miscoding events, 
which stimulates termination of the synthesis of erroneous proteins and triggers their release (Zaher 
and Green, 2009). Truncated proteins can be toxic and their membrane insertion can cause abnormal 
depolarization (Hurwitz et al., 1981) and change membrane potential and permeability (Bryan and 
Kwan, 1983; Taber et al., 1987). Erroneous and truncated proteins synergistically affect the membrane 
promoting an increased influx of aminoglycosides which inevitably leads to a positive feedback loop 
in which more aminoglycoside will enter the cell and more errors will be made until , the integrity of 
the membrane is destroyed and the cell dies. It has been observed that Str treatment causes an 
increased demand for polyamines, and the induction of a polyamine transport system can be utilized 
in a competitive manner by Str (Holtje, 1979) facilitating even more the entrance of the antibiotic into 
the cell. The relationship between incorrect protein synthesis and membrane damage is thus a key 
element in the aminoglycosides-induced miscoding. The insertion of erroneous proteins in the cellular 
membrane may also generate hydroxyl radical and oxidative stress, ultimately damaging nucleic acids 
and proteins (Dwyer et al., 2014; Kohanski et al., 2008), although the latter notion has been recently 









Figure 42. Proposed mechanism of aminoglycosides activity. A small amount of aminoglycoside enters the cell and interacts 
with ribosomes reducing the fidelity of translation and inducing miscoding. Erroneous proteins are produced and the 
ribosomes promote consecutive errors incorporation and stimulate translation termination and peptide release. When 
erroneous and/or truncated proteins are inserted into the membrane they trigger the phosphorylation of members of two-
component regulatory systems such as CpxA and ArcB, which in turn activate their corresponding regulatory proteins CpxR 
and ArcA, respectively. CpxR regulates the expression of stress-response protein e.g., DegP. ArcA regulates genes involved 
in the respiratory chain, leading to its hyperactivation, culminating in the generation of hydroxyl radicals which damage 
nucleic acids and proteins. Figure adapted from (Kohanski et al., 2007; Kohanski et al., 2008). 
 
3.7 Aminoglycosides effect investigation and future perspectives 
The present work demonstrated that our developed experimental approach constitutes a robust and 
reliable tool for the investigation of amino acid misincorporation in vivo. When applied to the study 
of aminoglyocosides, our study revealed that the increased frequency of some errors during the 
treatment can be seen as a fingerprint characterizing each antibiotic. However, the results obtained 
so far are resistricted to a limited set of peptides and only 8 substitutions have been taken into 
consideration (Figure 33, B).  As part of the future perspectives, the pool of substitutions analyzed will 
be extended to provide a more comprehensive overview on the aminoglycosides charachteristics. The 
charachterization of aminoglycosides effect could also be extended to a broader analysis of the cellular 
response by systematically monitoring the expression of, not only IbpA and IbpB chaperones (Figure 
33),  but also of proteins part of the SOS response for DNA damage e.g., RecA and LexA or protein 




not the oxidative stress and the consequent nucleic acid damage are involved in the aminoglycosides 
killing mechanism.  
Our data indicate that the induction of error patches may play an important role in the mechanism 
of  aminoglycosides-mediated cell death. In the future work, consecutive errors which were never 
reported in literature so far, but which already showed promising initial results with Apr, Tob and Par 
(Figure 35), will be studied in the presence of other antibiotics, and other model peptides will be taken 
into consideration. These combined results could lead to a deeper understanding of the mechanisms 
of action of aminoglycosides. In addition, because aminoglycosides toxicity has been often associated 
with their interaction with mitochondrial ribosomes, the flexibility and sensitivity of our method could 
be employed to investigate single errors and more complex error patterns in eukaryotic systems. This 
could have  a potential medical impact, for example in the selection of the lowest-toxicity 
aminoglycosides for the palliative treatment of genetic diseases (Bukowy-Bieryllo et al., 2016; Ho et 
al., 2013; Malik et al., 2010a; Malik et al., 2010b) or to perform more focused treatments, tailored to 
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4. MATERIALS AND METHODS  
Table 6. List of equipments 
Device Supplier 
Allegra X-22R centrifuge Beckmann Coulter 
Amicon Ultra-4 30K cut-off Merck Millipore 
Avanti J-26 XP centrifuge Beckmann Coulter 
Avanti J-30I centrifuge Beckmann Coulter 
Acclaim PepMapRSLC 15 cm, 75 µm inner diameter, 3 µm 
particle size 
Thermo Fisher Scientific 
ÄKTA FPLC GE Healthcare 
Benchtop centrifuge 5415R Eppendorf 
Biostat B-plus 5 l fermenter Sartorius 
Digital sonifier cell distruptor W-250D Branson 
Dounce tissue grinder Wheaton 
Easy nLCII chromatography system Thermo Fisher Scientific 
Electrophoresis power supply PeqLab 
Emulsiflex C-3 homogenizer Avestin 
HighTrap Q HP anion exchange column GE Healthcare 
Hiload 26/60 Superdex 75 size-exclusion chromatography GE Healthcare 
Innova 44 incubator shaker New Brunswick 
Intelli-mixer ELMI Ltd. 
JA30.1 rotor Beckmann Coulter 
JLA-8.1000 rotor Beckmann Coulter 
LiChrospher WP300 RP-18 (5µm) Merck Millipore 
Low retention 1.5 ml tubes Eppendorf 
Low retention 0.5 ml tubes Eppendorf 
Nanodrop 2000 Peqlab 
Optima XPN centrifuge Beckmann Coulter 
pH-indicator strips pH 6.5-10.0 Merck Millipore 
Pierce BCA Protein Assay Kit Thermo Fisher Scientific 
Polyolefin foil for microplates HJ-Bioanalytik GmbH 
Polypropylene 96-well microplates VWR 
Protino Ni-IDA 2000 Packed Columns Macherey-Nagel 
Q-Exactive hybrid mass spectrometer Thermo Fisher Scientific 
Q-Exactive Plus hybrid mass spectrometer Thermo Fisher Scientific 
Reprosil-Pur 120 C18 3 µm column Dr Maisch 
SDS-PAGE electrophoresis chamber Bio-Rad 
SpeedVac vacuum concentrator SPD121P Thermo Fischer Scientific 
Spin-X centrifuge tube filter 0.45µm cellulose acetate Corning Inc. 
Superdex Peptide 10/300 GL GE Healthcare 
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SX4250 rotor Beckmann Coulter 
Thermomixer comfort Eppendorf 
Thermostatic oven Memmert 
TSQ Quantiva triple quadrupole mass spectrometer Thermo Fisher Scientific 
TSQ Vantage triple quadrupole mass spectrometer Thermo Fisher Scientific 
Ultimate 3000RSLC Thermo Fisher Scientific 
Ultrasonic cleaner VWR 
Vivaspin 20 centrifugal concentrator Sartorius 
Vortex Genie 2 Scientific Industries 
50.2Ti rotor Beckmann Coulter 
 
Table 7. List of softwares 
Software Provider 
DNA Star Lasergene DNASTAR, Inc 
GraphPad Prism 5.0 GraphPad Software 
Pymol 1.5 Schrödinger 
Skyline 3.5 MacCoss Lab Software 
Xcalibur 2.2 Thermo Fischer Scientific 
Adobe Illustrator CS5 Adobe Systems 
CorelDRAW X7 Corel 
 
4.1 Chemicals 
All reactions are performed in low-retention reaction cups (Eppendorf). If not indicated elsewhere, 
the chemicals are purchased from Merck Millipore or Sigma Aldrich. The chemicals used for 
chromatographic separation are of HPLC grade. Water, acetonitrile, methanol and formic acid used 
for mass spectrometric analysis are of HPLC/MS grade and purchased from Fischer Scientific. Custom-
synthetized isotopically-labeled peptides (5 µM) are obtained from Thermo Fisher Scientific (highly 
quantified Ultimate grade peptides with concentration precision ±5 % and QuantPro grade peptides 
with concentration precision ±25 %) or JPT Peptide Technologies (Berlin, Germany) (highly-quantified 
peptides SpikeTides_TQL or non-quantified SpikeTides_L grade peptides). All peptides used are listed 
in the appendix of this thesis (Table 15 and 16). Pierce Retention Time Calibration mix (PRTC) used to 
regularly assess the performances of chromatographic system and mass spectrometer is from Thermo 
Fisher Scientific.  
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Table 8. List of buffers 
Buffer Composition 
LB medium 10 g/L tryptone, 10g/L NaCl, 5g/L yeast extract 
LB agar 10 g/L tryptone, 10g/L NaCl, 5g/L yeast extract, 15g/L agar 
TB medium 12 g/L tryptone, 24 g/L yeast extract, 4 ml/L glycerol, 17 mM KH2PO4, 72 mM K2HPO4 
Buffer A 50mM HEPES pH 7.5, 50 mM KCL, 10 mM MgCl2, 5mM 2-mercaptoethanol, Complete 
Protease inhibitor 1 tablet/50 ml (Roche Diagnostics, Mannheim), DNase 
Buffer B B-PER reagent (Thermo Scientific), 200mM KCl, 3mM MgCl2, Complete Protease inhibitor 1 
tablet/50 ml (Roche Diagnostics, Mannheim), 30 µM GDP, 5mM 2-mercaptoethanol, DNase 
Buffer C 8 M Urea, 25 mM Hepes pH 7.5, 200 mM KCl, 10 mM MgCl2, 5 mM 2-mercaptoethanol 
Buffer D 25 mM HEPES pH 7.5, 200 mM KCl, 3mM MgCl2, 30 µM GDP 
Buffer E Buffer D + 500mM KCl 
Buffer F Buffer D + 200 mM Imidazole 
Buffer G Buffer C + 400 mM KCl 
Buffer H Buffer C + 150 mM Imidazole 
TAKM7 50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 7mM MgCl2 
Staking gel SDS-PAGE 4.8 % AA:Bis (29:1), 0.125 M Tris-HCl pH 6.8, 0.1 % SDS 
Resolving gel SDS-PAGE 16 % AA:Bis (29:1), 0.3 M Tris-HCl pH 8.8, 0.1 % SDS 
Coomassie Blue staining 
solution 
0.1 % Coomassie brilliant blue, 50 % ethanol, 10 % acetic acid 
Destaining solution 20 % ethanol, 10 % acetic acid 
Laemmli SDS loading 
buffer 4X 
40 % glycerol, 240 mM Tris-HCl pH 6.8, 8 % SDS, 0.04 % bromophenol blue, 5 % 2-
mercaptoethanol 
SDS running buffer 10X 250 mM Tris base, 1.92 M glycine, 1 % SDS (to be diluted 10 times to obtain SDS running 
buffer 1X) 
TBS buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl 
High salt TBS buffer TBS buffer + 500 mM NaCl 
 
Table 9. List of plasmids 
Vector Purpose Supplier Resistance Tag 
pET24a 
Overexpressed his-tag EF-Tu 
(tufA) 
Merck Millipore Kan C-terminal Hisx6 
pET21a 
Overexpressed his-tag EF-Tu 
(tufA) and sumo constructs 
Novagen Amp C-terminal Hisx6 
pSUMO Sumo-tag constructs  Kan Hisx6 






Table 10. List of bacterial strains 
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E. coli strain Purpose Supplier 
BL21 (DE3) EF-Tu (tufA) overexpression Merck Millipore 
TOP10 Plasmid replication Novagen 
MRE-600 (ATCC29417) Wild type EF-Tu UAB school of medicine 
MG1655 (K-12) Wild type EF-Tu 
Leibniz Institute DSMZ  
W3110 (K-12) EF-Tu chromosomal tag (tufA) 
E. coli UD 131 (Xac rpsD12) Error prone (ram) 
These strains have been kindly provided by Dr. 
Hani Zaher (Deptartment of Biology, Washington 
University in St. Louis, MO, USA ) 
E. coli US157 (Xac rspL141 zcg-
174::Tn10) 
Error restricted (hyperaccurate) 
E. coli (Xac ara D[lacproAB] 
gyrA rpoB argEamber) 
Wild type EF-Tu for comparison 
with hyperaccurate and error 
prone strain 
 
4.2 Primers  
Primers are designed using the SeqBuilder software (DNASTAR) and purchased from IBA Life Sciences 
or Eurofins MWG Operon. Forward and reverse primers (F and R, respectively) are listed. 
Table 11. List of primers for EF-Tu mutants 
Primers used for EF-Tu in-situ directed mutagenesis 
Mutation to introduce Sequence 5´-3´ 
R45H 
F CCTACGGCGGTGCTGCTCATGCATTCGACCAGATCG 





F  GACGACACTCCGATCGTTCATGGTTCTGCTCTGAAAGC 
R  CGCTTTCAGAGCAGAACCATGAACGATCGGAGTGTCGTC 
R231S 
F  GTGGTACCGTTGTTACCGGTAGTGTAGAACGCGGTATCATC 
R  GATGATACCGCGTTCTACACTACCGGTAACAACGGTACCAC 
R231G 
F  GTGGTACCGTTGTTACCGGTGGTGTAGAACGCGGTATCATC 
R GATGATACCGCGTTCTACACCACCGGTAACAACGGTACCAC 
R231C 
F  GTACCGTTGTTACCGGTTGTGTAGAACGCGGTATCATC 
R  GATGATACCGCGTTCTACACAACCGGTAACAACGGTAC 
R231H 
F  GTACCGTTGTTACCGGTCATGTAGAACGCGGTATCATC 
R  GATGATACCGCGTTCTACATGACCGGTAACAACGGTAC 
R231P 
F GTGGTACCGTTGTTACCGGTCCGGTAGAACGCGGTATCATC 
R  GATGATACCGCGTTCTACCGGACCGGTAACAACGGTACCAC 
R231L 
F  GTGGTACCGTTGTTACCGGTCTGGTAGAACGCGGTATCATC 
R  GATGATACCGCGTTCTACCAGACCGGTAACAACGGTACCAC 
R231A 
F  GTGGTACCGTTGTTACCGGTGCTGTAGAACGCGGTATCATC 
R  GATGATACCGCGTTCTACAGCACCGGTAACAACGGTACCAC 




F  GTGGTACCGTTGTTACCGGTGATGTAGAACGCGGTATCATC 
R  GATGATACCGCGTTCTACATCACCGGTAACAACGGTACCAC 
R231E 
F  GTGGTACCGTTGTTACCGGTGAAGTAGAACGCGGTATCATC 
R  GATGATACCGCGTTCTACTTCACCGGTAACAACGGTACCAC 
R231F 
F  GTGGTACCGTTGTTACCGGTTTTGTAGAACGCGGTATCATC 
R  GATGATACCGCGTTCTACAAAACCGGTAACAACGGTACCAC 
R231Y 
F  GTGGTACCGTTGTTACCGGTTATGTAGAACGCGGTATCATC 
R  GATGATACCGCGTTCTACATAACCGGTAACAACGGTACCAC 
R231Q 
F  GTACCGTTGTTACCGGTCAAGTAGAACGCGGTATCATC 
R  GATGATACCGCGTTCTACTTGACCGGTAACAACGGTAC 
R231T 
F  GTGGTACCGTTGTTACCGGTACCGTAGAACGCGGTATCATC 
R GATGATACCGCGTTCTACGGTACCGGTAACAACGGTACCAC 
R231V 
F  GTGGTACCGTTGTTACCGGTGTTGTAGAACGCGGTATCATC 
R  GATGATACCGCGTTCTACAACACCGGTAACAACGGTACCAC 
R234H 
F  CAACTTTGATGATACCATGTTCTACACGACCGG 
R  CCGGTCGTGTAGAACATGGTATCATCAAAGTTG 
K249Q 
F GGTAGACTTCTGAGTCTCTTGGATACCAACGATTTCAAC 





F  GGTAGACTTCTGAGTCTCTGTGATACCAACGATTTCAAC 
R  GTTGAAATCGTTGGTATCACAGAGACTCAGAAGTCTACC 
K249R 
F  GAAATCGTTGGTATCCGTGAGACTCAGAAGTCTAC 
R  GTAGACTTCTGAGTCTCACGGATACCAACGATTTC 
K249I 
F   GAAATCGTTGGTATCATCGAGACTCAGAAGTCTAC 







F  CAAACTGCTGGACGAAGGCCATGCTGGTGAGAACGTAGGTG 
R CACCTACGTTCTCACCAGCATGGCCTTCGTCCAGCAGTTTG 
R280H 
F  CGTAGGTGTTCTGCTGCATGGTATCAAACGTGAAGAAATCG 
R CGATTTCTTCACGTTTGATACCATGCAGCAGAACACCTAC 
R284H 
F  CGTTCGATTTCTTCATGTTTGATACCAC 
R  GTGGTATCAAACATGAAGAAATCGAACG 
K314Q 





R  CAAGTTCGAATCTGAAGTGTACATTCTGTCCGAAGATGAAG 





F  GTATGACGGCCGCCTTCATCTGTGGACAGAATGTACACTTC 
R GAAGTGTACATTCTGTCCACAGATGAAGGCGGCCGTCATAC 
K314R 
F   GACGGCCGCCTTCATCACGGGACAGAATGTACAC 
R  GTGTACATTCTGTCCCGTGATGAAGGCGGCCGTC 
K314I 
F  GACGGCCGCCTTCATCGATGGACAGAATGTACAC 







F  CCAAAGATGAAGGCGGCCATCATACTCCGTTCTTCAAAGGC 











Table 12. List of primers for SUMO-constructs 
Primers used to obtain SUMO-constructs 






















SUMO-R319H F TAGGATCCGGCTGCTAACAAAGCCCGAAAGG 






















Table 13. List of primers for chromosomal tag insertion 
Primers for chromosomal tag insertion 
Construct Sequence 5´-3´ 
His-tag insertion on 
chromosomal tufA 
gene (his-tag 




R  GGGCGCCGAAGCGCCCTTTTCAATTCAAAACTAATTAACGTGTAA 
TAATACGACTCACTATAGGGCTC 
 
4.3 EF-Tu constructs 
4.3.1 Site-directed mutagenesis for generation of EF-Tu mutants  
Site-directed mutagenesis has been performed in PCR tubes using Phusion High-fidelity DNA 
polymerase (New England Biolabs) following the protocol suggested by the supplier. The plasmid 
pET21 containing the tufA gene coding for EF-Tu is amplified by polymerase chain reaction (PCR) (Saiki 
et al., 1985) using the Quick Change kit (Agilent) and a set of forward and reverse primer specific for 
the mutation of choice (Table 11). Parental plasmid is digested with DpnI enzyme and the PCR product 
is used to transform TOP10 chemically competent E. coli cells (Invitrogen). Clones containing the 
plasmid are selected for resistance to Kan. The plasmid is extracted using plasmid miniprep kit 
(Macherey-Nagel). Mutation insertion is verified by plasmid sequencing performed by SeqLab 
(Göttingen, Germany). The constructs expressing the EF-Tu mutants have been kindly provided by 
Christina Kothe.  
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4.3.2 Generation of constructs containing a Sumo protein fused with an EF-Tu peptide epitope  
In order to dissect the impact of the sequence context and cellular protease activity on the measured 
error frequency from selected EF-Tu epitopes are cloned in a pSUMO vector together with a quantifier 
peptide (FESEVYILSK) for their quantification. The quantifier peptide for EF-Tu is cloned into a 
linearized pSUMO vector, amplified and the vector ultimately ligated with T4 DNA ligase enzyme. The 
sumo tag and the nucleotide stretch for the cognate peptide are amplified by PCR using primers 
containing homologous region to pET21a vector (Table 12). The product is introduced into a linearized 
pET21a vector and ligated using In-Fusion HD cloning kit (Clontech Laboratories, USA) as described in 
the manufacturer’s protocol. EF-Tu peptides for which the error frequency had to be assessed in the 
SUMO construct are chosen based on experimental data and their nucleotide sequence is introduced 
into the pET21a-SUMO-FESEVYILSK construct by PCR using the primers indicated in the table 12. 
SUMO constructs have been obtained by Christina Kothe.  
 
4.3.3 C-terminal his-tag insertion into the EF-Tu gene 
Insertion of His-tag on the K12 strain W3110 and of the Kan resistance cassette is performed using the 
Gene deletion kit (Gene Bridges) as described in the manual and was performed by Christina Kothe. 
The primers used are listed in Table 13. 
 
4.3.4 Generation of flag EF-Tu 
The pET21a plasmid encoding for EF-Tu protein with the C-terminus octameric flag DYKDDDDK was 
generated by Sarah Lambrecht.  
4.4 Cell cultures 
4.4.1 Cell transformation 
BL21 (DE3) E. coli competent cells are thawed on ice for 10 min and gently mixed with 100 ng of 
plasmid DNA. After 10 min on ice, transformation is induced by incubating cells at 42°C for 1-2 min 
before transferring them back on ice. After 3 minutes, 500 µl LB medium are added and cells are 
allowed to recovery at 37°C for 1hr with gentle agitation using a thermomixer. After the incubation, 
100 µl are plated on an LB agar plates supplemented with the antibiotic of choice and stored overnight 
in a thermostatic oven. 
 
4.4.2 Cell growth  
A saturated LB culture is used to inoculate fresh LB medium. For E.coli K12 chromosomal tag, the 
overnight preinoculum is performed in LB medium supplemented with 50 µg/ml Kan.  E. coli K12 
chromosomal tag, MG1655, rpsD, spsL, and their parental wild type strains are  grown in an incubator 
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shaker at 37°C and 200 rpm to 1 OD600. E.coli BL21 (DE3) cells for EF-Tu mutants and pSUMO-
constructs overexpression are grown in LB medium supplemented with 50 µg/ml Kan (Serva 
Electrophoresis GmbH). Induction is started at 0.7-0.8 OD600 and performed by incubating cells with 
with 1 mM IPTG for 2 hrs. Alternatively, E. coli BL21 (DE3) for His-tagged EF-Tu are grown in TB medium 
in a 5 L fermenter and induced at the beginning of exponential phase with 1mM IPTG for 3 hrs. To test 
the effects of aminoglycoside antibiotics on E. coli K12 chromosomal tag  MG1655 cells are grown in 
LB without antibiotics. At 0.3 OD600, the antibiotic of interest is added and cells are incubated for 120 
min. In the negative control cell culture, no antibiotic is added and after reaching 0.3 OD600, cells are 
grown for 120 min.  Cells are harvested by centrifugation in a refrigerated centrifuge at 5000 rpm (JLA-
8.1000 rotor). 
 
4.4.3 Cell lysis 
E. coli MRE-600 are used for the purification of wild type EF-Tu. Cells are resuspended and lysed in 
buffer A using the Emulsiflex C3 homogenizer after manual homogenization in a Dounce tissue grinder. 
Cell debris are removed by centrifugation for 30 min at 25000 rpm (JA30.1 rotor) and the lysate is 
cleared by 30 min ultracentrifugation at 50000 rpm (50.2Ti rotor). Cells for EF-Tu purification under 
native conditions are solubilized in buffer B or buffer C (for purification under native or denaturing 
conditions, respectively) and sonicated 1 min by 10 s shots at 30 % amplitude followed by 5 s of rest 
using a sonifier cell disruptor.  
 
4.5 PURexpress system for the in-vitro translation of flag EF-Tu 
The EF-Tu carrying the flag DYKDDDDK is translated in vitro to assess the error frequency in a protease-
free environment. For this purpose the commercial kit PURexpress system (New England BioLabs) is 
used as described in the manufacturer´s manual and by others (Tuckey et al., 2014).  
 
4.6 Purification of EF-Tu protein 
EF-Tu purified from different sources was used for the investigation and quantification of 
misincorporations. 
 
4.6.1 Purification under native conditions 
His-tag EF-Tu is purified using Protino Ni-TED 2000 packed columns. After initial column equilibration 
with 4 volumes buffer D, the cleared lysate is loaded onto the column and eluted by gravity. Column 
is washed with 6 volumes of high salt buffer E and re-equilibrated with 4 volumes of buffer D. Protein 
is finally eluted with 3 volumes of elution buffer F and concentrated using Amicon Ultra-4 with a 30 
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KDa cut-off. Buffer is exchanged with TAKM7 before the protein is shock frozen in liquid nitrogen and 
stored at -80°C. EF-Tu from MRE600 and ram strains was purified as described elsewhere (Rodnina et 
al., 1995b).  
 
4.6.2 Purification under denaturing conditions 
A Protiono Ni-TED 2000 column is equilibrated with 4 column volumes of buffer C before the lysate is 
loaded on the column by gravity flow. The column is then washed with 8 volumes of buffer G and 
finally re-equilibrated in 6 volumes of buffer C. Protein is eluted with 4 volumes of elution buffer H, 
concentrated and rebuffered in 3 M Urea and 0.1 M ammonium hydrogencarbonate by centrifugation 
at 4000 rpm in Vivaspin concentrators MWCO 30000 in a refrigerated benchtop centrifuge. 
 
4.6.3 Purification of FLAG-EF-Tu     
In-vitro translated FLAG-EF-Tu is purified from components of the PURexpress in-vitro translation kit, 
using anti-flag M2 magnetic beads (Sigma Aldrich). For each PURExpress kit tube, 40 µl of beads slurry 
are used (corresponding to 20 µl packed gel volume, as stated in the technical bulleting of the 
product). The whole procedure from EF-Tu binding to its elution is carried out at 4°C while tubes are 
rotated in an Intelli-mixer rotating device. Beads are washed to remove the storage buffer and mixed 
with the sample and TBS to a final volume of 1 ml. After 2 hrs incubation, the beads are separated 
from the supernatant with the help of a magnet and washed with high-salt TBS buffer to remove 
unspecific binders. After each washing step the protein content in the buffer is measured 
photometrically and the washing procedure is repeated until the absorbance difference between the 
wash solution aspirated from the beads and the wash solution blank is <0.05 . At this point the washing 
buffer is eliminated and EF-Tu can be eluted from the beads. 
 
4.6.3.1 Elution of FLAG-EF-Tu with 3X flag peptides 
Competitive elution with 3X FLAG peptides (Sigma Aldrich) showed to be the most efficient method 
to detach EF-Tu protein from the beads. They are synthetic peptide of 23 amino acid residue. The Asp-
Tyr-Lys-Xaa-Xaa-Asp motif is repeated three times in the peptide and eight amino acids at the C-
terminus make up the classic FLAG sequence (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys). An excess of 3X FLAG 
peptides is added and beads are incubated with 5 gel packed volumes of 150 ng/µl flag peptides for 
15 min for two times. Buffer is picked up and concentrated using 500 µl Amicon Ultra 10 KDa cut-off 
before being loaded on a 16 % PAGE-SDS for analysis and further in-gel digestion (Figure 43). 
 
 





Figure 43. Purification of FLAG EF-Tu. Purified EF-Tu protein is run together with Perfect Protein Marker 15-150 kDa (M) on 
a 16 % PAGE-SDS. 
 
4.7 SDS-PAGE electrophoresis 
Purified EF-Tu is quantified using a Pierce BCA protein assay kit (Thermo Scientific) as described in the 
manual and its purity is assessed by SDS-PAGE electrophoresis essentially performed as described in 
(Laemmli, 1970). Bands molecular weights are identified by comparison with Perfect Protein Marker 
10-150 kDa (Novagen) or SeeBlue Plus2 Pre-Stained Protein Standard (Thermo Fisher Scientific). 
Stacking gel solution is prepared using Acrylamide:Bisacrylamide (29:1) (Serva Electrophoresis GmbH) 
to a final concentration of 4.8 %. Resolving gel solution is prepared to a final Acrylamide:Bisacrylamide 
(29:1) concentration of 16 %. Gel polymerizatzion is started by the addition of 1:100 (v/v) 10 % APS 
(Calbiochem) and 1:1000 (v/v) TEMED. Gels are run for 1 hr at 180 V before being stained in Coomassie 
Blue solution and finally destained in destaining solution. 
 
4.8 Acetone precipitation of proteins 
EF-Tu (3000 - 30000 pmol) purified under native-conditions is precipitated overnight with 5 volumes 
of ice-cold acetone at -20°C. Precipitated protein is collected by centrifugation at 12000 rpm for 30 
min in a refrigerated benchtop centrifuge and washed with 300 µl of ice-cold ethanol 80 %. The sample 
is centrifuged again to pellet the protein and remove the ethanol supernatant and the pellet is dried 
for 10 min. 
  
4.9 EF-Tu trypsination 
4.9.1 In-solution proteolysis of EF-Tu purified under native conditions 
Unless stated otherwise, the whole proteolysis procedure is carried out in a Thermomixer comfort 
(Eppendorf) at 600 rpm. Dried protein pellet is resuspended in 20 µl of RapiGest 1 % (Waters) in 25 
mM NH4HCO3 and incubated for 10 min at 37°C. Disulfide bonds are reduced by adding 20 µl 50 mM 
M 
50 kDa - 
FLAG 
EF-Tu 
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DTT (in 25 mM NH4HCO3) in a two-steps incubation at 60°C for 10 min and at 37°C for 20 min. 
Alkylation of thiols was achieved adding 20 µl of IAA (in 25 mM NH4HCO3) and incubating the sample 
at 37°C for 30 min in the dark. Rapigest in the sample is diluted to 0.1 % by the addition of 25 mM 
NH4HCO3. Trypsin 1 µg/µl (Promega) dissolved in 25 mM NH4HCO3 is added to the sample (final 
concentration 0.01 µg/µl) and EF-Tu is proteolyzed overnight at 37°C. 
 
4.9.2 In-solution proteolysis of EF-Tu purified in denaturing conditions 
Protein is reduced in 1/10 vol 50 mM DTT and incubated 50 min at 65°C in a thermomixer. Cysteines 
are alkylated in 1/10 vol 100 mM IAA for 30 min at 30°C in the dark. The protein is finally digested 
overnight in trypsin (Promega) at 37°C (1:100 protease to protein ratio).  
 
4.10 Sample preparation for the characterization of aminoglycosides effects  
The induction of stress response and error incorporation caused by aminoglycosides was investigated 
in MG1655 E. coli cells grown at increasing concentration of Kan, Gen, Tob, Neo, Par, Rib, Nea, Apr, 
Hyg B, Str and Spc. Cells (1 OD600) are collected 2 min at 13000 rpm on a benchtop centrifuge and the 
LB medium is removed. The pellet is resuspended in 100 µl RNase-free water and 50 µl 4x Laemmli 
buffer (Biorad) and incubated for 5 min at 95°C. After the incubation, the samples are cooled down to 
room temperature and mixed with 50 µl of a buffer containing 8 M Urea/Tris buffer pH 7.5. Samples 
are centrifuges 5 min at 13000 rpm in a benchtop centrifuge to remove any small particles before 
being separated by electrophoresis.  
To analyze the stress response, 15 µl of lysate are separated on a 16 % SDS-PAGE at 185 V until all 
proteins are in the separation gel. In one lane 5 µl of Perfect Protein Marker 10-150 KDa (Merck) are 
loaded (Figure 44). The gel is then stained in Coomassie Blue solution for 20 min and destained. The 
lysate’s bands are vertically cut with a scalpel, further reduced into smaller pieces and stored in 1.5 













Figure 44. Proteins separation in E.coli lysate for proteome change analysis. The lysate of E.coli MG1655 cells grown at 
increasing concentrations of antibiotic (in the example, Kanamycin B 0.25, 0.5, 1, 2, 4, 8, 16, 32, 64, 128 µM) is loaded on 
the gel. SeeBlue Plus marker is loaded in the first lane L. 
 
To investigate the induction of errors in EF-Tu, 15 µl of lysare are separated on a precasted Mini-
PROTEAN TGX Gel (BioRad) 20 min at 200 V. In one lane 5 µl of the SeeBlue Plus marker (Thermo 
Scientific) are loaded (Figure 45).  The gel is stained and destained as already described and the EF-Tu 
band identified by comparison with the marker, excised with a scalpel and crushed into smaller pieces. 
 
 
Figure 45. Lysate separation for the quantification of misincorporations in EF-Tu. The lysate of E.coli MG1655 cells grown 
at increasing concentration of antibiotic (in the example, Neomycin B 0.25, 0.5, 1, 2, 4, 8, 16, 32, 64, 128 µM) is loaded on 
the gel. EF-Tu is indicated by the red arrow. Seeblue Plus marker is loaded in the first lane L. 
 
4.10.1 In-gel proteolysis of EF-Tu, pSUMO-constructs, and E.coli lysate 
Gel pieces containing the proteins of interest are digested as described by (Shevchenko et al., 2006). 
Digested peptides are then mixed with heavy-labeled reference peptides before the SRM analysis. For 
the list of all peptides used, refer to Appendix (Section B). 
 
4.11 Peptides 
4.11.1 Selection of proteotypic peptides in EF-Tu 
Proteotypic peptides for mass spectrometric absolute quantification are selected from existing mass 
spectrometry data obtained by data-dependent aquistition (DDA) analysis (from Dr. Ingo 
Wohlgemuth). In general, only tryptic peptides between 6 and 20 residues are taken into 
L Kanamycin B 
 
L Neomycin B 
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consideration. The sequence is checked in order to exclude peptides containing highly reactive amino 
acids (e.g., methionine, tryptophan) or missed cleavage (adjacent KK). Peptides sequence is also 
checked in BLAST to be unique for the protein target in the case of peptides used for protein 
quantification (proteotypic (Mallick et al., 2007)) or to exclude a second source in the E. coli proteome 
in the case of peptide used for erroneous peptides enrichment. 
 
4.11.2 Proteolysis of Spike-Tides_TQL 
The highly-quantified Spike-Tides_TQL peptides are purchased from JPT (Berlin) and have to be 
digested prior to mass spectrometric analysis to remove the tag used by the producer for their 
quantification. The tag is removed by trypsin digestion (1:100) for 5 hrs at 37°C performed as indicated 
by the producer. 
 
4.11.3 LC-MS/MS  method development for peptides detection 
The open source program Skyline version 3.5 (MacLean et al., 2010b) is used for the SRM method set 
up and results analysis (MacLean et al., 2010b). For each peptide of the SRM method, the predominant 
charge state of the precusor is experimentally assessed and 3 - 5 transitions per peptide are chosen 
(Lange et al., 2008).  
All peptides used in this study  are separated on an Easy nLCII Nano LC or Ultimate 3000RSLC system 
using an in-house packed columns (14 cm length, 50 µm inner diameter, packed with Reprosil-Pur 120 
C18 3 µm material) at 50°C or Acclaim PepMapRSLC (15 cm length, 75 µm inner diameter, 2µm RP18 
material). Peptides are eluted in a 45 min linear gradient from 5 % ACN/ 0.1 % FA to 50 % ACN/ 0.1 % 
FA at 0.300 µl/min flow. Q1 and Q3 are set to unit resolution 0.7 full width at half maximum (FWHM) 
except for non-cognate peptides analysis where it is set at 0.5 . A spray voltage of 1800 V (TSQ 
Vantage) and 2100 V (TSQ Quantiva) is used with a heated ion transfer tube setting of 270°C ( TSQ 
Vantage) and 325°C (TSQ Quantiva), respectively. The declustering voltage is kept at 10 V ( TSQ 
Vantage) and a Chromfilter setting of 4 (TSQ Vantage) or 3 (TSQ Quantiva). Collision energies are 
optimized as decribed elsewhere (Maclean et al., 2010a). Scheduled transitions are recorded in a 5 
min window and a cycle time of 3 s (TSQ Vantage) or 1 s (TSQ Quantiva) is applied, typically resulting 
in a dwell time of 100-200 ms per transition. 
For data analyisis, raw files are imported into Skyline software that automatically calculates the 
area under each transition peak to yield the light/heavy ratio for each peptide. To achieve high 
identification reliability, only peptides with a dot-product (rdotp) close to 1 are considered. The  
light/heavy ratio of each peptide is ultimately used to calculate the error frequency. 
 
MATERIALS AND METHODS 
102 
 
4.11.4 Peptides stability assessment by LC-MS/MS 
In order to ensure that the determined peptide concentrations of misincorporation-containing 
peptides correctly represent their error frequency in the cell, we validated our quantifications in a 
model system in which these peptides occur at known 1:1 stoichiometry. Misincorporations whose 
quantification was validated were introduced as point mutations in EF-Tu. EF-Tu mutants were 
purified and in-gel digested as  described previously. Cognate AQUA peptides 1 - 4 are mixed 1:1 with 
the AQUA peptide containing the amino acid substitution from the mutant under analysis. The AQUA 
mix is spiked in the sample in a buffer containing 5 % ACN/ 0.1 % FA. 300 fmol of AQUA peptides 
(Thermo Scientific) and endogenous EF-Tu peptides are separated on an Ultimate 3000RSLC system 
(Thermo Fisher Scientific) and analyzed in triplicate on a TSQ Quantiva (Thermo Scientific) mass 
spectrometer in SRM mode (see below for details). Raw files are analyzed using Skyline software and 
the ratio L/H determined.  
 
4.12 Quantification of EF-Tu for multidimensional enrichment of misincorporation-containing 
peptides 
Absolute quantification of digested EF-Tu is performed by mass spectrometric analysis. The final 
volume of tryptic digest is determined. 2 µl of the digestion are diluted 1:20 in 5 % ACN/ 0.5 % FA and 
mixed with varying ratios of cognate AQUA Peptides 1 - 4. The ratio of endogenous/AQUA peptides is 
determined by SRM (see below for details) analysis performed on TSQ Vantage or TSQ Quantiva 
(Thermo Scientific) mass spectrometer in triplicate. The ratios calculated for each peptide are 
averaged and used to determine   the amount of digested EF-Tu. 
 
4.12.1 Multidimensional chromatographic enrichment of misincorporation-containing peptides 
The tryptic digest is spiked with substoichiometric amounts of AQUA peptides containing the 
misincorporations of interest (AQUA: proteolyzed EF-Tu; 1:10000). Normally 10 - 15 misincorporation-
containing peptides are quantified in a single enrichment. Before the enrichment procedure, Rapigest 
is degraded by incubating the sample at acidic pH for 30 min at 37°C and its hydrolytic by-products 
removed by centrifugation. To remove any particles, the supernatant is further filtered using Costar 
Spin-X Centrifuge Tube Filter 0.45 µm Cellulose Acetate and lyophilized in a SpeedVac vacuum 
concentrator. Peptides are dissolved in 200 µl 20 % ACN/ 0.1 % FA and separated by size-exclusion 
chromatography on a Superdex Peptide 10/300 GL column in an isocratic HPLC run (20% ACN/ 0.1 % 
FA; 0.8 ml/min flow, fraction size 0.4 ml) as a first chromatographic dimension. From each fraction, an 
aliquot is taken and diluted 1:5 in 0.1 % FA to dilute the final concentration of ACN and analyzed by 
SRM on TSQ Quantiva mass spectrometer. Depending on the peptides´ distribution, 1 - 3 fractions are 
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pooled and lyophilized. Pooled peptides are redissolved in 10 mM ammonium acetate in 2 % ACN and 
separated by reversed phase chromatography at neutral pH in the second dimension (Immler et al., 
2006) using a LiChrospher WP300 RP-18 (5 µm) column. Peptides are eluted with a 2 - 82 % ACN 
gradient in 10 mM ammonium acetate in 45 min run and 0.8 ml/min flow; fraction size 0.8 ml. The 
elution time for each peptide is established in an independent chromatographic run performed with 
AQUA peptides only, by screening each fraction by SRM analysis. According to this, respective fractions 
from the second dimension are selected, lyophilized and resuspended in 50 µl 5 % ACN/ 0.1 % FA for 
final SRM quantification. For the separation of misincorporation-containing peptides which are similar 
to their respective cognate one (Table 5), a third step of reversed phase chromatography at acidic pH 
is performed using the same LiChrospher WP300 RP-18 (5 µm) column used for the separation at 
neutral pH. Peptides are eluted with a 0 - 65 % ACN gradient in 0.1 % TFA, 10 mM ammonium acetate 
in 65 min run and 0.8 ml/min flow; fraction size 0.8 ml. 
 
4.13 Validation and quantification of misincorporation-containing peptides 
The enriched peptides are separated on nanoflow chromatography system and detected by SRM 
analysis as described before (Material and metod, 4.11.3).  
The identity of enriched peptides is further verified by targeted SIM (tSIM) and parallel reaction 
monitoring (PRM) on a QExactive mass spectrometer. Peptides are separated by a 58 minute linear 
reversed phase gradients from 5 % ACN /0.1 % FA to 50 % acetonitrile/ 0.1 % FA on in-house packed 
columns (28 cm length, packed with Reprosil 1.9 µm C18 material) at 60°C. Eluted peptides are sprayed 
by an ESI-source set at 2400 V and capillary temperature 275°C in a Q-Exactive Plus mass spectrometer 
and t-SIM method is set at microscan 1, resolution 70000, ACG target 5e4, maximum it 70 ms and scan 
range 150 to 2000 m/z and a 3.0 m/z isolation window. PRM method is set at microscan 1, resolution 
of 35000, AGC target 1e6 and maximum IT 300 ms and an isolation windows of 0.4 m/z and inclusion 
list on. Raw files are analyzed using Skyline software. MS1 and MS/MS filtering settings are set at a 
60000 m/z and 35000 m/z resolving power respectively.  
 
4.14 Quantification of error in-gel digested EF-Tu and SUMO-constructs 
In-gel digested EF-Tu is lyophilized and resuspended in 50 µl 5% ACN/ 0.1 % by sonication. The sample 
is centrifuged 10 min at 13000 rpm using a benchtop centrifuge. An aliquot is then taken and mixed 
with AQUA peptides for the amino acid substitutions to quantify and analyzed by SRM.  
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4.15 Quantification of stress response proteins in E. coli lysate 
In-gel digested EF-Tu is lyophilized and resuspended in 50 µl 5 % ACN/ 0.1 % by sonication. For each 
protein to quantify i.e., EF-Tu, RpoH, S10, IbpA and IbpB 2 - 3 AQUA peptides are spiked in and the 
sample is analyzed by SRM. For a list of peptides used refer to Appendix (Section B). 
 
4.16 Quadrupole performance assessment 
30 fmol of PRTC mix (Thermo Fisher Scientific) are routinely used to check the performances in terms 
of signal intensity and chromatographic separation of the TSQ Quantiva mass spectrometer and 
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6.1 Section A. EF-Tu genes sequence 
The sequence of tufA and tufB genes from the various strain used in this projects are reported 
together with the translated sequence of EF-Tu.  
 
                         10        20        30        40        50        60        70        80                
                    ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
BL21-TufA           GTGTCTAAAGAAAAATTTGAACGTACAAAACCGCACGTTAACGTTGGTACTATCGGCCACGTTGACCACGGTAAAACTAC  
BL21-TufB-(over)    A-------------G-----------------------------C-----------------------T--------A--  
W3110-TufA-(chrom)  --------------------------------------------------------------------------------  
W3110-TufB          A-------------G-----------------------------C-----------------------T--------A--  
MRE600-TufA-(wt)    --------------------------------------------------------------------------------  
MRE600-TufB-(wt)    A-------------G-----------------------------C-----------------------T--------A--  
                     M  S  K  E  K  F  E  R  T  K  P  H  V  N  V  G  T  I  G  H  V  D  H  G  K  T  T  
 
                            90       100       110       120       130       140       150       160         
                    ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
BL21-TufA           TCTGACCGCTGCAATCACCACCGTACTGGCTAAAACCTACGGCGGTGCTGCTCGTGCATTCGACCAGATCGATAACGCGC  
BL21-TufB-(over)    G-----------------T-----------------------------------C-------------------------  
W3110-TufA-(chrom)  -------------------------------------------------------------------------------- 
W3110-TufB          G-----------------T-----------------------------------C-------------------------  
MRE600-TufA-(wt)    --------------------------------------------------------------------------------  
MRE600-TufB-(wt)    G-----------------T-----------------------------------C-------------------------  
                      L  T  A  A  I  T  T  V  L  A  K  T  Y  G  G  A  A  R  A  F  D  Q  I  D  N  A  
 
                           170       180       190       200       210       220       230       240        
                    ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
BL21-TufA           CGGAAGAAAAAGCTCGTGGTATCACCATCAACACTTCTCACGTTGAATATGACACCCCGACCCGTCACTACGCACACGTA  
BL21-TufB-(over)    -------------------------------------------------C------------------------------  
W3110-TufA-(chrom)  -------------------------------------------------C------------------------------  
W3110-TufB          -------------------------------------------------C------------------------------  
MRE600-TufA-(wt)    --------------------------------------------------------------------------------  
MRE600-TufB-(wt)    -------------------------------------------------C------------------------------  
                    P  E  E  K  A  R  G  I  T  I  N  T  S  H  V  E  Y  D  T  P  T  R  H  Y  A  H  V  
 
                           250       260       270       280       290       300       310       320        
                    ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
BL21-TufA           GACTGCCCGGGGCACGCCGACTATGTTAAAAACATGATCACTGGTGCTGCTCAGATGGACGGCGCGATCCTGGTAGTTGC  
BL21-TufB-(over)    -----------------------------------------C--------------------------------------  
W3110-TufA-(chrom)  -----------------------------------------C--------------------------------------  
W3110-TufB          -----------------------------------------C--------G-----------------------------  
MRE600-TufA-(wt)    -----------------------------------------C--------------------------------------  
MRE600-TufB-(wt)    -----------------------------------------C--------------------------------------  
                     D  C  P  G  H  A  D  Y  V  K  N  M  I  T  G  A  A  Q  M  D  G  A  I  L  V  V  A  
 
                           330       340       350       360       370       380       390       400        
                    ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
BL21-TufA           TGCGACTGACGGCCCGATGCCGCAGACTCGTGAGCACATCCTGCTGGGTCGTCAGGTAGGCGTTCCGTACATCATCGTGT  
BL21-TufB-(over)    --------------------------------------------------------------------------------  
W3110-TufA-(chrom)  --------------------------------------------------------------------------------  
W3110-TufB          --------------------------------------------------------------------------------  
MRE600-TufA-(wt)    --------------------------------------------------------------------------------  
MRE600-TufB-(wt)    --------------------------------------------------------------------------------  
                      A  T  D  G  P  M  P  Q  T  R  E  H  I  L  L  G  R  Q  V  G  V  P  Y  I  I  V  
 
                           410       420       430       440       450       460       470       480        
                    ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
BL21-TufA           TCCTGAACAAATGCGACATGGTTGATGACGAAGAGCTGCTGGAACTGGTTGAAATGGAAGTTCGTGAACTTCTGTCTCAG  
BL21-TufB-(over)    --------------------------------------------------------------------------------  
W3110-TufA-(chrom)  --------------------------------------------------------------------------------  
W3110-TufB          --------------------------------------------------------------------------------  
MRE600-TufA-(wt)    --------------------------------------------------------------------------------  
MRE600-TufB-(wt)    --------------------------------------------------------------------------------  






                           490       500       510       520       530       540       550       560        
                    ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
BL21-TufA           TACGACTTCCCGGGCGACGACACTCCGATCGTTCGTGGTTCTGCTCTGAAAGCGCTGGAAGGCGACGCAGAGTGGGAAGC  
BL21-TufB-(over)    --T-----------------------------------------------------------------------------  
W3110-TufA-(chrom)  --------------------------------------------------------------------------------  
W3110-TufB          --------------------------------------------------------------------------------  
MRE600-TufA-(wt)    -----T--------------------------------------------------------------G-----------  
MRE600-TufB-(wt)    --T-----------------------------------------------------------------------------  
                     Y  D  F  P  G  D  D  T  P  I  V  R  G  S  A  L  K  A  L  E  G  D  A  E  W  E  A  
 
                          570       580       590       600       610       620       630       640        
                    ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
BL21-TufA           GAAAATCCTGGAACTGGCTGGCTTCCTGGATTCTTACATTCCGGAACCAGAGCGTGCGATTGACAAGCCGTTCCTGCTGC  
BL21-TufB-(over)    --------------------------------------------------------------------------------  
W3110-TufA-(chrom)  ------------------------------------T-------------------------------------------  
W3110-TufB          --------------------------------------------------------------------------------  
MRE600-TufA-(wt)    --------------------------------------------------------------------------------  
MRE600-TufB-(wt)    --------------------------------------------------------------------------------  
                      K  I  L  E  L  A  G  F  L  D  S  Y  I  P  E  P  E  R  A  I  D  K  P  F  L  L  
 
                           650       660       670       680       690       700       710       720        
                    ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
BL21-TufA           CGATCGAAGACGTATTCTCCATCTCCGGTCGTGGTACCGTTGTTACCGGTCGTGTAGAACGCGGTATCATCAAAGTTGGT  
BL21-TufB-(over)    --------------------------------------------------------------------------------  
W3110-TufA-(chrom)  --------------------------------------------------------------------------------  
W3110-TufB          --------------------------------------------------------------------------------  
MRE600-TufA-(wt)    --------------------------------------------------------------------------------  
MRE600-TufB-(wt)    --------------------------------------------------------------------------------  
                    P  I  E  D  V  F  S  I  S  G  R  G  T  V  V  T  G  R  V  E  R  G  I  I  K  V  G  
 
                           730       740       750       760       770       780       790       800        
                    ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
BL21-TufA           GAAGAAGTTGAAATCGTTGGTATCAAAGAGACTCAGAAGTCTACCTGTACTGGCGTTGAAATGTTCCGCAAACTGCTGGA  
BL21-TufB-(over)    --------------------------------------------------------------------------------  
W3110-TufA-(chrom)  --------------------------------------------------------------------------------  
W3110-TufB          --------------------------------------------------------------------------------  
MRE600-TufA-(wt)    --------------------------------------------------------------------------------  
MRE600-TufB-(wt)    --------------------------------------------------------------------------------  
                     E  E  V  E  I  V  G  I  K  E  T  Q  K  S  T  C  T  G  V  E  M  F  R  K  L  L  D  
 
                           810       820       830       840       850       860       870       880        
                    ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
BL21-TufA           CGAAGGCCGTGCTGGTGAGAACGTAGGTGTTCTGCTGCGTGGTATCAAACGTGAAGAAATCGAACGTGGTCAGGTACTGG  
BL21-TufB-(over)    --------------------------------------------------------------------------------  
W3110-TufA-(chrom)  --------------------------------------------------------------------------------  
W3110-TufB          --------------------------------------------------------------------------------  
MRE600-TufA-(wt)    ------T-------------------------------------------------------------------------  
MRE600-TufB-(wt)    ----------------------A---------------------------------------------------------  
                      E  G  R  A  G  E  N  I  G  V  L  L  R  G  I  K  R  E  E  I  E  R  G  Q  V  L  
 
                           890       900       910       920       930       940       950       960        
                    ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
BL21-TufA           CTAAGCCGGGCACCATCAAGCCGCACACCAAGTTCGAATCTGAAGTGTACATTCTGTCCAAAGATGAAGGCGGCCGTCAT  
BL21-TufB-(over)    -------------------------------------------------------------------------T------  
W3110-TufA-(chrom)  --------------------------------------------------------------------------------  
W3110-TufB          --------------------------------------------------------------------------------  
MRE600-TufA-(wt)    --------------------------------------------------------------------------------  
MRE600-TufB-(wt)    --------------------------------------------------------------------------------  
                    A  K  P  G  T  I  K  P  H  T  K  F  E  S  E  V  Y  I  L  S  K  D  E  G  G  R  H  
 
                          970       980       990       1000      1010      1020      1030      1040       
                    ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
BL21-TufA           ACTCCGTTCTTCAAAGGCTACCGTCCGCAGTTCTACTTCCGTACTACTGACGTGACTGGTACCATCGAACTGCCGGAAGG  
BL21-TufB-(over)    --------------------------------------------------------------------------------  
W3110-TufA-(chrom)  --------------------------------------------------------------------------------  
W3110-TufB          --------------------------------------------------------------------------------  
MRE600-TufA-(wt)    -----------------------------------------------------------C--------------------  
MRE600-TufB-(wt)    --------------------------------------------------------------------------------  









                          1050      1060      1070      1080      1090      1100      1110      1120       
                    ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
BL21-TufA           CGTAGAGATGGTAATGCCGGGCGACAACATCAAAATGGTTGTTACCCTGATCCACCCGATCGCGATGGACGACGGTCTGC  
BL21-TufB-(over)    --------------------------------------------------------------------------------  
W3110-TufA-(chrom)  --------------------------------------------------------------------------------  
W3110-TufB          --------------------------------------------------------------------------------  
MRE600-TufA-(wt)    --------------------------------------------------------------------------------  
MRE600-TufB-(wt)    --------------------------------------------------------------------------------  
                      V  E  M  V  M  P  G  D  N  I  K  M  V  V  T  L  I  H  P  I  A  M  D  D  G  L  
 
                          1130      1140      1150      1160      1170      1180      1190      1200       
                    ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
BL21-TufA           GTTTCGCAATCCGTGAAGGCGGCCGTACCGTTGGCGCGGGCGTTGTTGCTAAAGTTCTGGGC  
BL21-TufB-(over)    ----------------------------------------------A--A---------A--CACCACCACCACCACCAC  
W3110-TufA-(chrom)  --------------------------------------------------------------CACCACCACCACCACCAC  
W3110-TufB          ----------------------------------------------A--A---------A--  
MRE600-TufA-(wt)    ----------------------T-----------------------A--A---------A--  
MRE600-TufB-(wt)    ----------------------------------------------A--A---------A--  
                    R  F  A  I  R  E  G  G  R  T  V  G  A  G  V  V  A  K  V  L  G  H  H  H  H  H  H  
























6.2 Section B. SRM optimized parameters 
The optimized SRM parameters for heavy-labeled and endogenous peptides used during enrichment 
workflow are listed. For each peptide, the precursor mass and the fragment mass are indicated (Q1 
and Q3 columns). The transitions used during the SRM scan (fragment) and the optimized collision 
energies (CE) are also indicated. 
 
  Peptide Q1 Q3 Fragment CE 
R45H TYGGAAHAFDQIDNAPEEK light 678.64483 915.44180 y8 24.1 
  678.64483 802.35774 y7 24.1 
  678.64483 687.33080 y6 23.1 
  678.64483 502.25075 y4 27.1 
 TYGGAAHAFDQIDNAPEEK* heavy 681.31623 923.45600 y8 24.1 
  681.31623 810.37194 y7 24.1 
  681.31623 695.34499 y6 23.1 
    681.31623 510.26495 y4 27.1 
R59H AHGITINTSHVEYDTPTR light 671.33258 980.46835 y8 25.8 
  671.33258 881.39994 y7 27.8 
  671.33258 752.35734 y6 25.8 
  671.33258 373.21939 y3 27.8 
 AHGITINTSHVEYDTPTR* heavy 674.66867 990.47662 y8 25.8 
  674.66867 891.40821 y7 27.8 
  674.66867 762.36561 y6 25.8 
    674.66867 383.22766 y3 27.8 
R172H ELLSQYDFPGDDTPIVHGSALK light 801.40066 1406.72742 y14 29.7 
  801.40066 1022.59931 y10 30.7 
  801.40066 921.55163 y9 30.7 
 ELLSQYDFPGDDTPIVHGSALK* heavy 804.07206 1414.74162 y14 29.7 
  804.07206 1030.61351 y10 30.7 
    804.07206 929.56583 y9 30.7 
R231S GTVVTGSVER light 502.77219 747.39954 y7 17 
  502.77219 648.33113 y6 17 
  502.77219 547.28345 y5 15 
 GTVVTGSVER* heavy 507.77632 757.40781 y7 17 
  507.77632 658.33940 y6 17 
    507.77632 557.29172 y5 15 
R231G GTVVTGGVER light 487.76691 717.38898 y7 16.5 
  487.76691 618.32057 y6 18.5 
  487.76691 517.27289 y5 15.5 
 GTVVTGGVER * heavy 492.77104 727.39725 y7 16.5 
  492.77104 628.32883 y6 18.5 
    492.77104 527.28116 y5 15.5 
 
 




 Peptide Q1 Q3 Fragment CE 
R231C GTVVTGC[+57.0]VER light 539.27150 721.32975 y6 18.1 
  539.27150 620.28207 y5 17.1 
  539.27150 563.26061 y4 17.1 
 GTVVTGC[+57.0]VER* heavy 544.27563 731.33802 y6 18.1 
  544.27563 630.29034 y5 17.1 
    544.27563 573.26888 y4 17.1 
R231H GTVVTGHVER  light 527.78563 698.35801 y6 20.7 
  527.78563 597.31033 y5 21.7 
  527.78563 540.28887 y4 21.7 
  527.78563 880.45231 b9 20.7 
 GTVVTGHVER* heavy 532.78976 708.36628 y6 20.7 
  532.78976 607.31860 y5 21.7 
  532.78976 550.29714 y4 21.7 
    532.78976 880.45231 b9 20.7 
R231P GTVVTGPVER light 507.78256 757.42028 y7 16.1 
  507.78256 658.35187 y6 16.1 
  507.78256 557.30419 y5 14.1 
  507.78256 500.28272 y4 16.1 
 GTVVTGPVER* heavy 512.78669 767.42855 y7 16.1 
  512.78669 668.36013 y6 16.1 
  512.78669 567.31246 y5 14.1 
    512.78669 510.29099 y4 16.1 
R231L GTVVTGLVER light 515.79821 674.38317 y6 16.4 
  515.79821 573.33549 y5 17.4 
  515.79821 516.31402 y4 16.4 
  515.79821 628.36645 b7 14.4 
 GTVVTGLVER * heavy 520.80234 684.39143 y6 16.4 
  520.80234 583.34376 y5 17.4 
  520.80234 526.32229 y4 16.4 
    520.80234 628.36645 b7 14.4 
R231Q GTVVTGQVER light 523.28546 403.22996 y3 18.6 
  523.28546 531.28854 y4 15.6 
  523.28546 588.31000 y5 16.6 
  523.28546 689.35768 y6 17.6 
  523.28546 788.42609 y7 18.6 
 GTVVTGQVER* heavy 528.28960 413.23823 y3 18.6 
  528.28960 541.29681 y4 15.6 
  528.28960 598.31827 y5 16.6 
  528.28960 699.36595 y6 17.6 
    528.28960 798.43436 y7 18.6 
R231E GTVVTGEVER light 523.77747 532.27255 y4 16.6 
  523.77747 589.29402 y5 15.6 
  523.77747 644.32498 b7 13.6 
  523.77747 690.34169 y6 17.6 




 GTVVTGEVER* heavy 528.78161 542.28082 y4 16.6 
  528.78161 599.30229 y5 15.6 
  528.78161 644.32498 b7 13.6 
  528.78161 700.34996 y6 17.6 
    528.78161 743.39340 b8 13.6 
R231D GTVVTGDVER light 516.76965 518.25690 y4 15.4 
  516.76965 575.27837 y5 16.4 
  516.76965 676.32604 y6 17.4 
 GTVVTGDVER* heavy 521.77378 528.26517 y4 15.4 
  521.77378 585.28664 y5 16.4 
    521.77378 686.33431 y6 17.4 
R231A GTVVTGAVER light 494.77473 531.28854 y5 15.7 
  494.77473 632.33622 y6 15.7 
  494.77473 731.40463 y7 16.7 
 GTVVTGAVER*heavy 499.77887 541.29681 y5 15.7 
  499.77887 642.34448 y6 15.7 
    499.77887 741.41290 y7 16.7 
R231V GTVVTGVVER light 508.79038 515.28239 b6 14.2 
  508.79038 559.31984 y5 15.2 
  508.79038 614.35080 b7 13.2 
  508.79038 660.36752 y6 16.2 
  508.79038 759.43593 y7 17.2 
 GTVVTGVVER*heavy 513.79452 515.28239 b6 14.2 
  513.79452 569.32811 y5 15.2 
  513.79452 614.35080 b7 13.2 
  513.79452 670.37578 y6 16.2 
    513.79452 769.44420 y7 17.2 
R231Y GTVVTGYVER light 540.78784 566.29329 y4 17.1 
  540.78784 623.31475 y5 17.1 
  540.78784 678.34572 b7 14.1 
  540.78784 724.36243 y6 17.1 
  540.78784 777.41413 b8 14.1 
 GTVVTGYVER*heavy 545.79197 576.30156 y4 17.1 
  545.79197 633.32302 y5 17.1 
  545.79197 678.34572 b7 14.1 
  545.79197 734.37070 y6 17.1 
    545.79197 777.41413 b8 14.1 
R231F GTVVTGFVER light 532.79038 550.29837 y4 16.9 
  532.79038 607.31984 y5 16.9 
  532.79038 662.35080 b7 13.9 
 GTVVTGFVER* heavy 537.79452 560.30664 y4 16.9 
  537.79452 617.32811 y5 16.9 
    537.79452 662.35080 b7 13.9 
R231T GTVVTGTVER light 509.78001 515.28239 b6 13.2 
  509.78001 561.29910 y5 15.2 




  509.78001 761.41519 y7 17.2 
 GTVVTGTVER* heavy 514.78415 515.28239 b6 13.2 
  514.78415 571.30737 y5 15.2 
  514.78415 672.35505 y6 17.2 
    514.78415 771.42346 y7 17.2 
R234H  VEHGIIK light 398.23980 696.40390 y6 14.9 
  398.23980 567.36131 y5 15.9 
  398.23980 430.30240 y4 17.9 
  398.23980 536.28272 b5 17.9 
  398.23980 649.36679 b6 14.9 
 VEHGIIK* heavy 402.24690 704.41810 y6 14.9 
  402.24690 575.37551 y5 15.9 
  402.24690 438.31660 y4 17.9 
  402.24690 536.28272 b5 17.9 
    402.24690 649.36679 b6 14.9 
K249R VGEEVEIVGIR light 600.33515 914.53056 y8 20.9 
  600.33515 785.48797 y7 20.9 
  600.33515 686.41955 y6 18.9 
  600.33515 643.29335 b6 17.9 
  600.33515 756.37741 b7 17.9 
 VGEEVEIVGIR* heavy 605.33929 924.53883 y8 20.9 
  605.33929 795.49623 y7 20.9 
  605.33929 696.42782 y6 18.9 
  605.33929 643.29335 b6 17.9 
    605.33929 756.37741 b7 17.9 
K249N  VGEEVEIVGINETQK light 822.42797 1130.60518 y10 27.6 
  822.42797 1001.56259 y9 27.6 
  822.42797 888.47852 y8 26.6 
  822.42797 855.44583 b8 22.6 
 VGEEVEIVGINETQK* heavy 826.43507 1138.61938 y10 27.6 
  826.43507 1009.57679 y9 27.6 
  826.43507 896.49272 y8 26.6 
    826.43507 855.44583 b8 22.6 
K249Q double VGEEVEIVGIQETQK light 829.43579 1144.62083 y10 28.8 
  829.43579 1015.57824 y9 28.8 
  829.43579 902.49417 y8 30.8 
  829.43579 855.44583 b8 22.8 
 VGEEVEIVGIQETQK* heavy 836.95147 1159.65219 y10 28.8 
  836.95147 1030.60960 y9 28.8 
  836.95147 917.52554 y8 30.8 
    836.95147 855.44583 b8 22.8 
K249Q single VGEEVEIVGIQETQK light 829.43579 1144.62083 y10 30.8 
  829.43579 1015.57824 y9 28.8 
  829.43579 902.49417 y8 30.8 
  829.43579 855.44583 b8 23.8 




  833.44289 1023.59244 y9 28.8 
  833.44289 910.50837 y8 30.8 
    833.44289 855.44583 b8 23.8 
K249T single VGEEVEIVGITETQK light 815.93034 1117.60993 y10 29.4 
  815.93034 988.56734 y9 28.4 
  815.93034 875.48327 y8 26.4 
  815.93034 855.44583 b8 23.4 
 VGEEVEIVGITETQK* heavy 819.93744 1125.62413 y10 29.4 
  819.93744 996.58154 y9 28.4 
  819.93744 883.49747 y8 26.4 
    819.93744 855.44583 b8 23.4 
K249E single VGEEVEIVGIEETQK light 829.92780 1145.60485 y10 28.8 
  829.92780 1016.56225 y9 27.8 
  829.92780 903.47819 y8 26.8 
  829.92780 855.44583 b8 23.8 
 VGEEVEIVGIEETQK* heavy 833.93490 1153.61904 y10 28.8 
  833.93490 1024.57645 y9 27.8 
  833.93490 911.49239 y8 26.8 
    833.93490 855.44583 b8 23.8 
R270H LLDEGHAGENVGVLLR light 564.64069 899.53089 y8 19.7 
  564.64069 770.48830 y7 20.7 
  564.64069 656.44537 y6 19.7 
  564.64069 665.32532 b6 19.7 
 LLDEGHAGENVGVLLR* heavy 567.97678 909.53916 y8 19.7 
  567.97678 780.49657 y7 20.7 
  567.97678 666.45364 y6 19.7 
    567.97678 665.32532 b6 19.7 
R280H AGENVGVLLHGIK light 653.87752 836.53525 y8 24.5 
  653.87752 779.51379 y7 23.5 
  653.87752 680.44537 y6 23.5 
  653.87752 990.53671 b10 24.5 
 AGENVGVLLHGIK* heavy 657.88462 844.54945 y8 24.5 
  657.88462 787.52798 y7 23.5 
  657.88462 688.45957 y6 23.5 
    657.88462 990.53671 b10 24.5 
R284H  HEEIER light 406.69849 675.33080 y5 18.1 
  406.69849 546.28820 y4 18.1 
  406.69849 417.24561 y3 16.1 
  406.69849 638.27803 b5 14.1 
 HEEIER* heavy 411.70263 685.33906 y5 18.1 
  411.70263 556.29647 y4 18.1 
  411.70263 427.25388 y3 16.1 
    411.70263 638.27803 b5 14.1 
F305L LESEVYILSK light 590.82663 347.228896 y3 25.6 
  590.82663 460.31296 y4 19.6 




  590.82663 722.444703 y6 17.6 
  590.82663 938.519324 y8 15.6 
 LESEVYILSK* heavy 594.83373 355.243095 y3 25.6 
  594.83373 468.327159 y4 19.6 
  594.83373 631.390488 y5 16.6 
  594.83373 730.458902 y6 17.6 
    594.83373 946.533523 y8 15.6 
E306D FDSEVYILSK light 600.81098 234.144832 y2 19.9 
  600.81098 347.228896 y3 21.9 
  600.81098 350.134661 b3 16.9 
  600.81098 460.31296 y4 19.9 
  600.81098 623.376289 y5 15.9 
  600.81098 722.444703 y6 18.9 
  600.81098 851.487296 y7 17.9 
  600.81098 938.519324 y8 17.9 
 FDSEVYILSK* heavy 604.81808 263.102633 y2 17.9 
  604.81808 350.134661 y3 16.9 
  604.81808 355.243095 b3 21.9 
  604.81808 468.327159 y4 19.9 
  604.81808 631.390488 y5 15.9 
  604.81808 730.458902 y6 18.9 
  604.81808 859.501495 y7 17.9 
    604.81808 946.533523 y8 17.9 
E308D FESDVYILSK light 600.81098 347.228896 y3 23.9 
  600.81098 460.31296 y4 21.9 
  600.81098 623.376289 y5 17.9 
  600.81098 722.444703 y6 16.9 
  600.81098 837.471646 y7 16.9 
  600.81098 924.503674 y8 16.9 
 FESDVYILSK* heavy 604.81808 355.243095 y3 23.9 
  604.81808 468.327159 y4 21.9 
  604.81808 631.390488 y5 17.9 
  604.81808 730.458902 y6 16.9 
  604.81808 845.485845 y7 16.9 
    604.81808 932.517873 y8 16.9 
Y310H FESEVHILSK light 594.81660 347.228896 y3 25.7 
  594.81660 460.31296 y4 25.7 
  594.81660 696.440286 y6 21.7 
  594.81660 825.482879 y7 23.7 
  594.81660 842.404294 b7 20.7 
  594.81660 912.514908 y8 18.7 
 FESEVHILSK* heavy 598.82370 355.243095 y3 25.7 
  598.82370 468.327159 y4 25.7 
  598.82370 704.454485 y6 21.7 
  598.82370 833.497078 y7 23.7 




    598.82370 920.529107 y8 18.7 
Y310N FESEVNILSK light 583.30860 889.498923 y8 16.4 
  583.30860 802.466895 y7 15.4 
  583.30860 673.424302 y6 16.4 
  583.30860 574.355888 y5 17.4 
  583.30860 460.31296 y4 20.4 
  583.30860 347.228896 y3 22.4 
  583.30860 234.144832 y2 17.4 
 FESEVNILSK* heavy 587.31570 897.513122 y8 16.4 
  587.31570 810.481094 y7 15.4 
  587.31570 681.438501 y6 16.4 
  587.31570 582.370087 y5 17.4 
  587.31570 468.327159 y4 20.4 
  587.31570 355.243095 y3 22.4 
    587.31570 242.159031 y2 17.4 
K314Q FESEVYILSQDEGGR light 576.94069 861.40609 y8 20.2 
  576.94069 748.32202 y7 19.2 
  576.94069 661.28999 y6 19.2 
  576.94069 592.26132 b5 20.2 
  576.94069 755.32465 b6 19.2 
 FESEVYILSQDEGGR* heavy 580.27678 871.41435 y8 20.2 
  580.27678 758.33029 y7 19.2 
  580.27678 671.29826 y6 19.2 
  580.27678 592.26132 b5 20.2 
    580.27678 755.32465 b6 19.2 
K314T  FESEVYILSTDEGGR light 567.93706 834.39519 y8 18.9 
  567.93706 721.31112 y7 18.9 
  567.93706 634.27909 y6 18.9 
  567.93706 592.26132 b5 18.9 
 FESEVYILSTDEGGR* heavy 571.27315 844.40346 y8 18.9 
  571.27315 731.31939 y7 18.9 
  571.27315 644.28736 y6 18.9 
    571.27315 592.26132 b5 18.9 
K314N  FESEVYILSNDEGGR light 572.26881 847.39044 y8 19 
  572.26881 734.30637 y7 19 
  572.26881 647.27434 y6 20 
  572.26881 592.26132 b5 19 
  572.26881 755.32465 b6 20 
 FESEVYILSNDEGGR* heavy 575.60490 857.39870 y8 19 
  575.60490 744.31464 y7 19 
  575.60490 657.28261 y6 20 
  575.60490 592.26132 b5 19 
    575.60490 755.32465 b6 20 
K314E FESEVYILSEDEGGR light 577.26870 862.39010 y8 19.2 
  577.26870 749.30604 y7 19.2 




  577.26870 592.26132 b5 19.2 
  577.26870 755.32465 b6 19.2 
 FESEVYILSEDEGGR* heavy 580.60479 872.39837 y8 19.2 
  580.60479 759.31431 y7 19.2 
  580.60479 672.28228 y6 19.2 
  580.60479 592.26132 b5 19.2 
    580.60479 755.32465 b6 19.2 
K314R FESEVYILSR light 621.82188 879.49344 y7 20.6 
  621.82188 750.45085 y6 23.6 
  621.82188 651.38244 y5 21.6 
  621.82188 755.32465 b6 16.6 
  621.82188 868.40871 b7 16.6 
 FESEVYILSR* heavy 626.82601 889.50171 y7 20.6 
  626.82601 760.45912 y6 23.6 
  626.82601 661.39071 y5 21.6 
  626.82601 755.32465 b6 16.6 
    626.82601 868.40871 b7 16.6 
R319H DEGGHHTPFFK light 424.53164 639.35007 y5 16.4 
  424.53164 538.30240 y4 16.4 
  424.53164 441.24963 y3 20.4 
  424.53164 734.28524 b7 14.4 
 DEGGHHTPFFK* heavy 427.20304 647.36427 y5 16.4 
  427.20304 546.31660 y4 16.4 
  427.20304 449.26383 y3 20.4 
    427.20304 734.28524 b7 14.4 
R328H GYHPQFYFR light 607.79072 857.43045 y6 23.1 
  607.79072 760.37769 y5 25.1 
  607.79072 632.31911 y4 25.1 
  607.79072 358.15098 b3 21.1 
 GYHPQFYFR* heavy  612.79485 867.43872 y6 23.1 
  612.79485 770.38596 y5 25.1 
  612.79485 642.32738 y4 25.1 
    612.79485 358.15098 b3 21.1 
R378H FAIHEGGR light 443.73013 739.38456 y7 18.2 
  443.73013 668.34745 y6 19.2 
  443.73013 555.26338 y5 18.2 
  443.73013 469.25578 b4 16.2 
 FAIHEGGR* heavy 448.73426 749.39283 y7 18.2 
  448.73426 678.35572 y6 19.2 
  448.73426 565.27165 y5 18.2 
    448.73426 469.25578 b4 16.2 
R382H EGGHTVGAGVVAK light 394.54729 544.34532 y6 12.3 
  394.54729 473.30821 y5 13.3 
  394.54729 416.28675 y4 13.3 
  394.54729 482.19939 b5 14.3 




  397.21869 481.32241 y5 13.3 
  397.21869 424.30094 y4 13.3 
    397.21869 482.19939 b5 14.3 
E308D-Y310H FESDVHILSK light 587.80877 234.144832 y2 20.5 
  587.80877 364.150312 b3 21.5 
  587.80877 597.371872 y5 21.5 
  587.80877 811.467229 y7 22.5 
  587.80877 898.499258 y8 19.5 
 FESDVHILSK* heavy 591.81587 242.159031 y2 20.5 
  591.81587 364.150312 b3 21.5 
  591.81587 605.386071 y5 21.5 
  591.81587 819.481428 y7 22.5 
    591.81587 906.513457 y8 19.5 
E306D-Y310H FDSEVHILSK light 587.80877 234.144832 y2 21.5 
  587.80877 597.371872 y5 20.5 
  587.80877 696.440286 y6 19.5 
  587.80877 825.482879 y7 19.5 
  587.80877 912.514908 y8 19.5 
 FDSEVHILSK* heavy 591.81587 242.159031 y2 21.5 
  591.81587 605.386071 y5 20.5 
  591.81587 704.454485 y6 19.5 
  591.81587 833.497078 y7 19.5 
    591.81587 920.529107 y8 19.5 
E306D-E308D FDSDVYILSK light 593.80315 347.228896 y3 22.7 
  593.80315 460.31296 y4 16.7 
  593.80315 623.376289 y5 17.7 
  593.80315 722.444703 y6 16.7 
  593.80315 837.471646 y7 18.7 
  593.80315 924.503674 y8 16.7 
 FDSDVYILSK* heavy 597.81025 355.243095 y3 22.7 
  597.81025 468.327159 y4 16.7 
  597.81025 631.390488 y5 17.7 
  597.81025 730.458902 y6 16.7 
  597.81025 845.485845 y7 18.7 
    597.81025 932.517873 y8 16.7 
E308D-Y310N FESDVNILSK light 576.30078 1004.525866 y9 19.2 
  576.30078 875.483273 y8 18.2 
  576.30078 788.451245 y7 18.2 
  576.30078 673.424302 y6 20.2 
  576.30078 574.355888 y5 19.2 
  576.30078 460.31296 y4 24.2 
  576.30078 347.228896 y3 24.2 
  576.30078 578.245669 b5 16.2 
 FESDVNILSK* heavy 580.30788 1012.540065 y9 19.2 
  580.30788 883.497472 y8 18.2 




  580.30788 681.438501 y6 20.2 
  580.30788 582.370087 y5 19.2 
  580.30788 468.327159 y4 24.2 
  580.30788 355.243095 y3 24.2 
    580.30788 578.245669 b5 16.2 
E306D-Y310N FDSEVNILSK light 576.30078 1004.525866 y9 20.2 
  576.30078 889.498923 y8 18.2 
  576.30078 802.466895 y7 18.2 
  576.30078 673.424302 y6 18.2 
  576.30078 574.355888 y5 17.2 
  576.30078 460.31296 y4 21.2 
  576.30078 347.228896 y3 22.2 
  576.30078 578.245669 b5 15.2 
 FDSEVNILSK* heavy 580.30788 1012.540065 y9 20.2 
  580.30788 897.513122 y8 18.2 
  580.30788 810.481094 y7 18.2 
  580.30788 681.438501 y6 18.2 
  580.30788 582.370087 y5 17.2 
  580.30788 468.327159 y4 21.2 
  580.30788 355.243095 y3 22.2 
    580.30788 578.245669 b5 15.2 
E306D-E308D-Y310H FDSDVHILSK light 387.536389 811.467229 y7 14 
  387.536389 696.440286 y6 15 
  387.536389 597.371872 y5 15 
  387.536389 460.31296 y4 15 
  387.536389 347.228896 y3 17 
  387.536389 234.144832 y2 19 
  387.536389 465.161605 b4 13 
 FDSDVHILSK* heavy 390.207789 819.481428 y7 14 
  390.207789 704.454485 y6 15 
  390.207789 605.386071 y5 15 
  390.207789 468.327159 y4 15 
  390.207789 355.243095 y3 17 
  390.207789 242.159031 y2 19 
    390.207789 465.161605 b4 13 
cognate 1 ELLSQYDFPGDDTPIVR light 982.98364 1394.65867 y12 29.4 
  982.98364 1231.59534 y11 32.4 
  982.98364 1116.56840 y10 34.4 
  982.98364 969.49999 y9 34.4 
  982.98364 484.32419 y4 33.4 
 ELLSQYDFPGDDTPIVR* heavy 987.98777 1404.66694 y12 29.4 
  987.98777 1241.60361 y11 32.4 
  987.98777 1126.57667 y10 34.4 
  987.98777 979.50826 y9 34.4 
    987.98777 494.33246 y4 33.4 




  586.33208 757.48182 y7 20.5 
  586.33208 658.41340 y6 19.5 
  586.33208 643.29335 b6 16.5 
 VGEEVEIVGIK* heavy 590.33918 894.53861 y8 20.5 
  590.33918 765.49602 y7 20.5 
  590.33918 666.42760 y6 19.5 
    590.33918 643.29335 b6 16.5 
cognate 3 FESEVYILSK light 607.81880 851.48730 y7 21.1 
  607.81880 722.44470 y6 18.1 
  607.81880 623.37629 y5 19.1 
  607.81880 755.32465 b6 16.1 
 FESEVYILSK* heavy 611.82590 859.50150 y7 21.1 
  611.82590 730.45890 y6 18.1 
  611.82590 631.39049 y5 19.1 
    611.82590 755.32465 b6 16.1 
cognate 4 TVGAGVVAK light 401.24508 544.34532 y6 15.9 
  401.24508 473.30821 y5 14.9 
  401.24508 416.28675 y4 18.9 
  401.24508 485.27182 b6 10.9 
 TVGAGVVAK* heavy 405.25218 552.35952 y6 15.9 
  405.25218 481.32241 y5 14.9 
  405.25218 424.30094 y4 18.9 
    405.25218 485.27182 b6 10.9 
IbpB 1 ITLALAGFR light 481.295102 848.498864 y8 17.3 
  481.295102 747.451185 y7 15.3 
  481.295102 634.367121 y6 16.3 
  481.295102 563.330007 y5 15.3 
  481.295102 583.381374 b6 12.3 
 ITLALAGFR* heavy 486.299236 858.507133 y8 17.3 
  486.299236 757.459454 y7 15.3 
  486.299236 644.37539 y6 16.3 
  486.299236 573.338276 y5 15.3 
    486.299236 583.381374 b6 12.3 
IbpB 2 QEDLEIQLEGTR light 715.85972 1173.610993 y10 24.4 
  715.85972 1058.58405 y9 26.4 
  715.85972 945.499986 y8 25.4 
  715.85972 816.457393 y7 26.4 
  715.85972 728.346111 b6 20.4 
 QEDLEIQLEGTR* heavy 720.863854 1183.619262 y10 24.4 
  720.863854 1068.592319 y9 26.4 
  720.863854 955.508255 y8 25.4 
  720.863854 826.465662 y7 26.4 
    720.863854 728.346111 b6 20.4 
IbpB 3 NEPEPIAAQR light 562.788369 881.483942 y8 16.8 
  562.788369 784.431178 y7 21.8 




  562.788369 558.335821 y5 14.8 
  562.788369 445.251757 y4 24.8 
  562.788369 374.214643 y3 23.8 
 NEPEPIAAQR* heavy 567.792504 891.492211 y8 16.8 
  567.792504 794.439447 y7 21.8 
  567.792504 665.396854 y6 21.8 
  567.792504 568.34409 y5 14.8 
  567.792504 455.260026 y4 24.8 
    567.792504 384.222912 y3 23.8 
rpoH 1 AEIHEYVLR light 565.303655 929.520327 y7 20.9 
  565.303655 816.436263 y6 21.9 
  565.303655 679.377351 y5 23.9 
  565.303655 580.272552 y4 17.9 
 AEIHEYVLR* heavy 570.30779 939.528596 y7 20.9 
  570.30779 826.444532 y6 21.9 
  570.30779 689.38562 y5 23.9 
    570.30779 580.272552 y4 17.9 
rpoH 2 LHYHGDLEAAK light 418.547288 840.421007 y8 17.2 
  418.547288 703.362095 y7 13.2 
  418.547288 646.340632 y6 15.2 
  418.547288 531.313689 y5 14.2 
  418.547288 723.320899 b6 16.2 
 LHYHGDLEAAK* heavy 421.218688 848.435206 y8 17.2 
  421.218688 711.376294 y7 13.2 
  421.218688 654.354831 y6 15.2 
  421.218688 539.327888 y5 14.2 
    421.218688 723.320899 b6 16.2 
rpoH 3 TLILSHLR light 476.800551 851.546148 y7 19.2 
  476.800551 738.462084 y6 17.2 
  476.800551 625.37802 y5 18.2 
  476.800551 512.293956 y4 19.2 
 TLILSHLR* heavy 481.804686 861.554417 y7 19.2 
  481.804686 748.470353 y6 17.2 
  481.804686 635.386289 y5 18.2 
    481.804686 522.302225 y4 19.2 
L10 1 AAAFEGELIPASQIDR light 844.43613 1198.64263 y11 31.2 
  844.43613 1012.57857 y9 30.2 
  844.43613 899.49451 y8 27.2 
  844.43613 786.41044 y7 27.2 
  844.43613 618.32057 y5 24.2 
  844.43613 403.22996 y3 24.2 
  844.43613 902.46181 b9 23.2 
 AAAFEGELIPASQIDR* heavy 849.44026 1208.65090 y11 31.2 
  849.44026 1022.58684 y9 30.2 
  849.44026 909.50278 y8 27.2 




  849.44026 628.32883 y5 24.2 
  849.44026 413.23823 y3 24.2 
    849.44026 902.46181 b9 23.2 
L10 2 LATLPTYEEAIAR light 724.39320 1049.52620 y9 22.6 
  724.39320 952.47344 y8 29.6 
  724.39320 851.42576 y7 27.6 
  724.39320 430.27724 y4 29.6 
 LATLPTYEEAIAR* heavy 729.39733 1059.53447 y9 22.6 
  729.39733 962.48171 y8 29.6 
  729.39733 861.43403 y7 27.6 
    729.39733 440.28551 y4 29.6 
L10 3 GALSAVVADSR light 523.28546 804.42101 y8 16.6 
  523.28546 717.38898 y7 18.6 
  523.28546 646.35187 y6 15.6 
  523.28546 547.28345 y5 14.6 
  523.28546 448.21504 y4 14.6 
  523.28546 262.15098 y2 23.6 
 GALSAVVADSR* heavy 528.28960 814.42928 y8 16.6 
  528.28960 727.39725 y7 18.6 
  528.28960 656.36013 y6 15.6 
  528.28960 557.29172 y5 14.6 
  528.28960 458.22331 y4 14.6 
    528.28960 272.15925 y2 23.6 
IbpA 1 SAIGFDR light 383.19813 678.35695 y6 15.4 
  383.19813 607.31984 y5 11.4 
  383.19813 494.23577 y4 13.4 
  383.19813 437.21431 y3 13.4 
 SAIGFDR* heavy 388.20226 688.36522 y6 15.4 
  388.20226 617.32811 y5 11.4 
  388.20226 504.24404 y4 13.4 
    388.20226 447.22258 y3 13.4 
IbpA 2 TYLYQGIAER light 607.31422 949.51016 y8 19.1 
  607.31422 836.42609 y7 20.1 
  607.31422 673.36276 y6 19.1 
  607.31422 545.30419 y5 20.1 
  607.31422 488.28272 y4 19.1 
  607.31422 375.19866 y3 19.1 
 TYLYQGIAER* heavy 612.31835 959.51843 y8 19.1 
  612.31835 846.43436 y7 20.1 
  612.31835 683.37103 y6 19.1 
  612.31835 555.31246 y5 20.1 
  612.31835 498.29099 y4 19.1 
    612.31835 385.20693 y3 19.1 
IbpA 3 NFDLSPLYR light 562.79038 863.46214 y7 16.8 
  562.79038 748.43520 y3 15.8 




  562.79038 548.31911 y4 17.8 
  562.79038 262.11862 b2 14.8 
  562.79038 377.14556 b3 15.8 
 NFDLSPLYR* heavy 567.79452 873.47041 y7 16.8 
  567.79452 758.44347 y3 15.8 
  567.79452 645.35941 y5 15.8 
  567.79452 558.32738 y4 17.8 
  567.79452 262.11862 b2 14.8 
    567.79452 377.14556 b3 15.8 
 
6.3 Section C. validation of near-cognate amino acid substitutions 
The position of the substituted amino acid (red) is shown in the context of EF-Tu structure. The identity 
of the error-containing peptide is validated at MS1 (B) and MS/MS (C) level and precursor and 
fragment ions spectra are compared with the fragmentation patter predicted for the peptide (D). For 
the K249R peptide the MS1 spectrum is replaced by the tSIM and PRM signals. The validation of the 
quantification is performed by comparing the stoichiometry of erroneous peptide with respect to four 
cognate EF-Tu peptides (E), as described in Results and Materials and Method. The SRM trace used for 
the determination of error frequency is shown (F). To confirm the absence of contamination by the 
light peptide, the heavy-labeled peptides are analysed by mass spectrometry and the signals for both 














































































































































6.4 Section D. validation of non-cognate amino acid substitutions 
The position of the substituted amino acid (red) is shown in the context of EF-Tu structure. The identity 
of the error-containing peptide is validated by PRM analysis (B). The predicted fragmentation pattern 
for the peptide is shown in (C).  The validation of the quantification is performed by comparing the 
stoichiometry of erroneous peptide with respect to four cognate EF-Tu peptides (D), as described in 
Results and Materials and Method. The SRM trace used for the determination of error frequency is 
shown (E). To confirm the absence of contamination by the light peptide, the heavy-labeled peptides 
are analysed by mass spectrometry and the signals for both light and heavy are recorded (F). The 















































6.5 Section E. SRM signals of peptides for multiple errors investigation 
The SRM signal of enriched heavy-labeled and endogenous peptides is shown (left). To confirm the 
absence of contamination by the light peptide, the heavy-labeled peptides are analysed by mass 
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